|
|
|
Cervical Cancer, January 2025
Retrieve all available abstracts of the following 1857 articles:
|
| Single Articles |
AMEDEO Cervical Cancer is free of charge.
CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor
progression in cervical cancer.
Sci Rep. 2025;15:790.
Abstract
Shared chemoresistance genes in ESCC and cervical Cancer: Insights from
pharmacogenomics and Mendelian randomization.
Int Immunopharmacol. 2025;147:113933.
Abstract
Effect of zoledronic acid on biological characteristics of cervical cancer cells.
Afr J Reprod Health. 2024;28:46-55.
Abstract
Treatment advances across the cervical cancer spectrum.
Nat Rev Clin Oncol. 2025 Jan 3. doi: 10.1038/s41571-024-00977.
Abstract
Vitamin D sensitizes cervical cancer to radiation-induced apoptosis by inhibiting
autophagy through degradation of Ambra1.
Cell Death Discov. 2025;11:1.
Abstract
USP34 regulates PIN1-cGAS-STING axis-dependent ferroptosis in cervical cancer via
SUMOylation.
Int Immunopharmacol. 2025;147:113968.
Abstract
Anti-Estrogen Therapy Achieves Complete Remission and Stability in Recurrent
Cervical Cancer: A Case Study.
Am J Case Rep. 2025;26:e946296.
Abstract
Cervical Cancer.
N Engl J Med. 2025;392:56-71.
Abstract
Should all cervical cancer patients with positive lymph node receive definitive
radiotherapy: a population-based comparative study.
Arch Gynecol Obstet. 2025 Jan 3. doi: 10.1007/s00404-024-07896.
Abstract
KIF18A Is a Novel Target of JNK1/c-Jun Signaling Pathway Involved in Cervical
Tumorigenesis.
J Cell Physiol. 2025;240:e31516.
Abstract
The Association Between D-Dimer Levels and Recurrence in Patients with
Early-Stage Cervical Cancer after Surgical Treatment.
Int J Womens Health. 2024;16:2333-2342.
Abstract
Effects of amide proton transfer imaging in diagnosis, grading and prognosis
prediction of cervical cancer: A systematic review and meta-analysis.
Heliyon. 2024;10:e40291.
Abstract
The clinical utility of circulating human papillomavirus across squamous cell
carcinomas.
Acta Oncol. 2025;64:1-12.
Abstract
Decoding the influence of external beam radiotherapy to brachytherapy duration
and overall treatment on response and early recurrences in cervical cancer
patients treated with chemoradiation.
Radiat Oncol J. 2024;42:257-262.
Abstract
Has_circ_ASH1L acts as a sponge for miR-1254 to promote the malignant progression
of cervical cancer by targeting CD36.
Cancer Gene Ther. 2025 Jan 2. doi: 10.1038/s41417-024-00866.
Abstract
Label credibility correction based on cell morphological differences for cervical
cells classification.
Sci Rep. 2025;15:2.
Abstract
RUNX1 promotes proliferation of cervical cancer through TGFB2-MAPK pathway.
Sci Rep. 2025;15:497.
Abstract
Analysis of precancerous lesion-related microRNAs for early diagnosis of cervical
cancer in the Thai population.
Sci Rep. 2025;15:142.
Abstract
Biological functions of extracellular vesicle double C2-like domain beta in
cervical cancer.
Sci Rep. 2025;15:477.
Abstract
Prevention of gynecological cancers: cervical cancer screening in Turkey: a role
model for the world.
Curr Opin Obstet Gynecol. 2025;37:30-36.
Abstract
Prevention of gynecological cancers: cervical cancer screening in Turkey: a role
model for the world.
Curr Opin Obstet Gynecol. 2024 Dec 9. doi: 10.1097/GCO.0000000000000998.
Abstract
Screening of Hub Genes and Therapeutic Drugs in Cervical Cancer Using Integrated
Bioinformatics Analysis.
J Cancer. 2025;16:92-109.
Abstract
HPV genotypes in invasive cervical cancer: prevalence, risk attribution, and
optimized vaccine strategies in western China.
Front Public Health. 2024;12:1455931.
Abstract
Cervical cancer incidence and trends among women aged 15-29 years by county-level
economic status and rurality - United States, 2007-2020.
Cancer Epidemiol. 2024;94:102730.
Abstract
Impact of Radiotherapy on Endocrine Function and Gut Microbiota in Cervical
Cancer Patients Undergoing Ovarian Transposition.
Int J Womens Health. 2024;16:2319-2331.
Abstract
Spatial transcriptomics reveals unique metabolic profile and key oncogenic
regulators of cervical squamous cell carcinoma.
J Transl Med. 2024;22:1163.
Abstract
Awareness, knowledge, and attitude toward cervical cancer screening and
prevention in Uganda.
Public Health. 2024;238:310-316.
Abstract
A Clinical Prediction Model for Pathologic Upgrade to Invasive Carcinoma
Following Conization of Cervical High-Grade Squamous Intraepithelial Lesions.
Cancer Med. 2025;14:e70540.
Abstract
Integration and acceptability of cervical cancer screening as part of postnatal
care among women attending postnatal clinics in the Accra Metropolis, Greater
Accra Region, Ghana.
PLOS Glob Public Health. 2024;4:e0004070.
Abstract
Effects of Web-Based Decision Aid to Support Cervical Cancer Screening Decision
Among Young Working Women: A Pilot Randomised Controlled Trial.
Int J Behav Med. 2024 Dec 30. doi: 10.1007/s12529-024-10344.
Abstract
Outcomes of Laparoscopic Radical Hysterectomy in Ia1-Ib1 Cervical Cancer
Patients: A Multi-Center Study with 10 Years' Experiences in the Real World.
Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16637.
Abstract
Classification of cervical cancer using Dense CapsNet with Seg-UNet and denoising
autoencoders.
Sci Rep. 2024;14:31764.
Abstract
Bidirectional recurrent neural network approach for predicting cervical cancer
recurrence and survival.
Sci Rep. 2024;14:31641.
Abstract
Cascade of care for people with positive symptoms of common cancers in selected
primary health centres of Puducherry: An explanatory mixed-method study.
Indian J Med Res. 2024;160:457-465.
Abstract
Risk Factors of Catheter-Associated Urinary Tract Infections Following Radical
Hysterectomy for Cervical Cancer: A Propensity Score Matching-Based Study.
Int J Womens Health. 2024;16:2297-2309.
Abstract
Effectiveness of continuity of care in postoperative patients with cervical
cancer: a systematic evaluation and meta-analysis of a randomized controlled
trial.
Front Oncol. 2024;14:1461296.
Abstract
Upregulation of long non-coding RNA ENSG00000267838 is related to the high risk
of progression and non-response to chemoradiotherapy treatment for cervical
cancer.
Noncoding RNA Res. 2024;11:104-114.
Abstract
Silencing of STEAP3 suppresses cervical cancer cell proliferation and migration
via JAK/STAT3 signaling pathway.
Cancer Metab. 2024;12:40.
Abstract
Extensive cervical lesion and treatment outcomes in women with HIV/HPV
co-infection.
AIDS Res Ther. 2024;21:101.
Abstract
Development and validation of a nomogram for predicting venous thromboembolism
risk in post-surgery patients with cervical cancer.
World J Surg Oncol. 2024;22:354.
Abstract
Healthcare access and cervical cancer awareness among Syrian refugee women in
Turkiye: language, cultural, and economic challenges.
BMC Public Health. 2024;24:3610.
Abstract
The Display between HPV Infection and Host Immunity in Cervical Cancer.
Front Biosci (Landmark Ed). 2024;29:426.
Abstract
The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical
cancer: new perspectives on cervical cancer immunotherapy.
Front Oncol. 2024;14:1488730.
Abstract
Comparative Analysis of Clinical and Radiologic Staging of Cervical Cancer: A
Cross-Sectional Study in Ethiopia.
Ethiop J Health Sci. 2024;34.
Abstract
Risk assessment and triage strategy of cervical cancer primary screening on HPV
integration status: 5-year follow-up of a prospective cohort study.
J Natl Cancer Cent. 2024;4:311-317.
Abstract
3D-printed template assisted intracavitary/interstitial brachytherapy for
cervical cancer using repeat FMEA: Correspondence.
Brachytherapy. 2024 Dec 28:S1538-4721(24)00401.
Abstract
Sexual Dysfunction in Patient's Diagnosed with Cervical Cancer in Comparison to
the Healthy Female Population.
Asian Pac J Cancer Prev. 2024;25:4391-4396.
Abstract
Analysis of the Effectiveness and Coverage of Breast, Cervical, and Colorectal
Cancer Screening Programs in Kazakhstan for the Period 2021-2023: Regional
Disparities and Coverage Dynamics.
Asian Pac J Cancer Prev. 2024;25:4371-4380.
Abstract
Health Related Quality of Life and Religiosity of Women with Cervical Cancer in
the Souss-Massa Region, Morocco: A Cross-Sectional Study.
Asian Pac J Cancer Prev. 2024;25:4351-4358.
Abstract
Performance of HPV Self-Sample Collected by a Novel Kit in Comparison with
Clinician Collected Sample for Cervical Cancer Screening.
Asian Pac J Cancer Prev. 2024;25:4211-4216.
Abstract
Effect of NQO1 Downregulation on the Migration and Invasion of HPV16-Positive
Cervical Cancer Cells.
Asian Pac J Cancer Prev. 2024;25:4189-4200.
Abstract
LncRNA PGM5-AS1 Impairs the Resistance of Cervical Cancer to Cisplatin by
Regulating the Hippo and PI3K-AKT Pathways.
Biochem Genet. 2024 Dec 28. doi: 10.1007/s10528-024-11011.
Abstract
Systemic immune-inflammatory index predict short-term outcome in
recurrent/metastatic and locally advanced cervical cancer patients treated with
PD-1 inhibitor.
Sci Rep. 2024;14:31528.
Abstract
BMT: A Cross-Validated ThinPrep Pap Cervical Cytology Dataset for Machine
Learning Model Training and Validation.
Sci Data. 2024;11:1444.
Abstract
The ability of clostridium novyi-NT spores to induce apoptosis via the
mitochondrial pathway in mice with HPV-positive cervical cancer tumors derived
from the TC-1 cell line.
BMC Complement Med Ther. 2024;24:427.
Abstract
Correction: The role of the SOX2 gene in cervical cancer: focus on ferroptosis
and construction of a predictive model.
J Cancer Res Clin Oncol. 2024;151:27.
Abstract
Histological Alterations of Cervical Cancer Following Zanthoxylum acanthopodium
DC Therapy in Relation to E7, pRb, EGFR and p16 Expression.
Pak J Biol Sci. 2024;27:602-612.
Abstract
Clinical comparative study of robot-assisted and traditional laparoscopic surgery
in patients with cervical cancer: a retrospective cohort study.
BMC Surg. 2024;24:423.
Abstract
PMDA regulatory update on approval and revision of the precautions for use of
anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical
cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer
in Japan.
Int J Clin Oncol. 2024 Dec 28. doi: 10.1007/s10147-024-02679.
Abstract
Development and implementation of a 3d-HDR brachytherapy program for cervical
cancer in a sub-Saharan African centre.
Brachytherapy. 2024 Dec 26:S1538-4721(24)00402.
Abstract
G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of
SERPINE1/PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell
Carcinoma Cells In Vitro.
Cancer Genomics Proteomics. 2025;22:13-23.
Abstract
RFC3 Knockdown Decreases Cervical Cancer Cell Proliferation, Migration and
Invasion.
Cancer Genomics Proteomics. 2025;22:127-135.
Abstract
Proteomics for Biomarker Discovery in Gynecological Cancers: A Systematic Review.
J Proteome Res. 2025;24:1-12.
Abstract
Differentiation-inducing factor-1 inhibits EMT by proteasomal degradation of TAZ
and YAP in cervical and colon cancer cell lines.
Eur J Pharmacol. 2025;987:177184.
Abstract
Risk assessment of careHPV testing for the detection of cervical precancerous
lesions: 5-year follow-up of a screening program in China.
J Infect Public Health. 2025;18:102611.
Abstract
The influencing factors in intention making-decision of Human papillomavirus
vaccine in Chinese college students: A qualitative study.
Patient Educ Couns. 2025;131:108594.
Abstract
Thin-layer cervical sample evaluation: Conventional light microscopy versus
digital whole-slide imaging.
Cancer Cytopathol. 2025;133:e22921.
Abstract
Correlation of different HPV genotype viral loads and cervical lesions: A
retrospective analysis of 1585 cases.
Cancer Cytopathol. 2025;133:e22920.
Abstract
Analysis of the sensitivity of high-grade squamous intraepithelial lesion Pap
diagnosis and interobserver variability with the Hologic Genius Digital
Diagnostics System.
Cancer Cytopathol. 2025;133:e22918.
Abstract
Intraoperative peritoneal cytology for cervical gastric-type adenocarcinoma:
Cytopathology and clinical impact.
Cancer Cytopathol. 2025;133:e22915.
Abstract
The Prognostic Value of Sarcopenia in Clinical Outcomes in Cervical Cancer: A
Systematic Review and Meta-Analysis.
J Cachexia Sarcopenia Muscle. 2025;16:e13674.
Abstract
Agreement Between High-Risk Human Papillomavirus Testing in Paired Self-Collected
and Clinician-Collected Samples from Cervical Cancer Screening in Spain.
Cancers (Basel). 2024;17:63.
Abstract
Impact of the Number of Positive Pelvic Lymph Nodes on Risk of Para-Aortic
Recurrence in Patients with Clinically Early Cervical Cancer Treated by a Radical
Hysterectomy and Pelvic Lymphadenectomy.
Cancers (Basel). 2024;17:23.
Abstract
Overcoming Cultural Barriers and Building Healthcare Trust: A Mixed Methods Study
on Cervical Cancer Prevention Among Arab American Women Across Major U.S. Cities.
Cancers (Basel). 2024;17:5.
Abstract
[(18)F]FDG PET/CT Radiomics in Cervical Cancer: A Systematic Review.
Diagnostics (Basel). 2024;15:65.
Abstract
Global status and attributable risk factors of breast, cervical, ovarian, and
uterine cancers from 1990 to 2021.
J Hematol Oncol. 2025;18:5.
Abstract
A new approach for detecting HPV DNA in cervical swabs: comparison of nucleic
acid extraction with direct PCR.
Virol J. 2025;22:8.
Abstract
High-risk factors and predictive models for hemorrhagic chronic radiation
proctitis.
Eur J Med Res. 2025;30:23.
Abstract
A comparative analysis of toxicity and treatment outcomes of adaptive
radiotherapy and intensity-modulated radiotherapy in cervical cancer.
Sci Rep. 2025;15:1609.
Abstract
Challenging and continuing laparoscopic radical hysterectomy for more than
30 Years at a single institution. After the LACC trial, should minimally invasive
surgery for early-stage cervical cancer really be discarded?
Taiwan J Obstet Gynecol. 2025;64:82-85.
Abstract
The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with
bevacizumab in platinum-naive primary stage IVB cervical cancer.
Taiwan J Obstet Gynecol. 2025;64:61-67.
Abstract
Pelvic insufficiency fractures in locally advanced cervical cancer: the
diagnostic yield of post-treatment MRI in a tertiary centre.
Eur J Radiol. 2025;183:111918.
Abstract
Expression of female hormone receptor and prognosis of cervical cancer: Does any
relationship exist?
Taiwan J Obstet Gynecol. 2025;64:6-7.
Abstract
CBX2 promotes cervical cancer cell proliferation and resistance to DNA-damaging
treatment via maintaining cancer stemness.
J Biol Chem. 2025 Jan 8:108170. doi: 10.1016/j.jbc.2025.108170.
Abstract
Are we ready for self-sampling for cervical cancer screening? Insights from
service providers and policy makers in Nepal.
PLOS Glob Public Health. 2025;5:e0004114.
Abstract
Investigation of Women's Knowledge and Beliefs About Cervical Cancer and Cervical
Smear Examination: A Survey Study in Greece.
Cureus. 2024;16:e75486.
Abstract
Retraction: Iso-pencillixanthone A from a marine-derived fungus reverses
multidrug resistance in cervical cancer cells through down-regulating P-gp and
re-activating apoptosis.
RSC Adv. 2025;15:712.
Abstract
Mir-615-5p inhibits cervical cancer progression by targeting TMIGD2.
Hereditas. 2025;162:4.
Abstract
Primary staging with 2[18F]-FDG-PET/CT and -PET/MRI and radiotherapy response
evaluation with MRI in uterine cervical cancer: an interim analysis of a
prospective clinical trial.
EJNMMI Rep. 2025;9:3.
Abstract
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced
cervical cancer: a randomized phase I trial.
Nat Commun. 2025;16:553.
Abstract
Identification of apoptosis-related long non-coding RNAs expression profiles in
patient with cervical intraepithelial neoplasia 3.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024;49:1095-1108.
Abstract
Sociodemographic, behavioral, and clinical risk factors associated with cervical
dysplasia: A case-control study.
Medwave. 2025;25:e3015.
Abstract
The socioeconomic burden of cervical cancer and its implications for strategies
required to achieve the WHO elimination targets.
Expert Rev Pharmacoecon Outcomes Res. 2025.
Abstract
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.
Front Immunol. 2024;15:1485461.
Abstract
Eligibility for and reach of the National Breast and Cervical Cancer Early
Detection Program, 2018-2021.
Cancer Causes Control. 2025 Jan 8. doi: 10.1007/s10552-024-01947.
Abstract
Activation of the WNT4/ beta-catenin/FOXO1 pathway by PDK1 promotes cervical cancer
metastasis and EMT process.
J Mol Histol. 2025;56:68.
Abstract
The influence of time and implants in high-dose rate image-guided adaptive
brachytherapy for locally advanced cervical cancer.
Brachytherapy. 2025 Jan 7:S1538-4721(24)00463.
Abstract
Exploring intersectional determinants of, and interventions for, low uptake of
human papillomavirus vaccine in sub-Saharan Africa: a scoping review protocol.
BMJ Open. 2025;15:e083848.
Abstract
Disability-Adjusted Life Years (DALYs) due to Breast, Cervical, Colorectal and
Oral Cancers in Taiwan Regions.
Cancer Med. 2025;14:e70592.
Abstract
Neoadjuvant radiochemotherapy in patients with high-risk locally advanced
cervical cancer-results of a clinical series.
Strahlenther Onkol. 2025 Jan 8. doi: 10.1007/s00066-024-02340.
Abstract
Exploring the role of Epstein-Barr virus infection on the clinical features and
survival in locally advanced cervical cancer: a retrospective cohort study.
Front Oncol. 2024;14:1522244.
Abstract
Efficacy and safety of camrelizumab for the treatment of cervical cancer: a
systematic review and meta-analysis.
Front Oncol. 2024;14:1526103.
Abstract
Corrigendum to "It was not normal, and I had to find a doctor and tell him."
Kenyan Women's Response to Cervical Cancer Symptoms".
J Patient Exp. 2025;11:23743735241310655.
Abstract
Reply to Iris Batista's Letter to the Editor about "Exploring the Correlation
between Health Literacy and Knowledge of Cervical Cancer and Radiotherapy among
Japanese Women: A Web-based Survey".
J Cancer Educ. 2025 Jan 8. doi: 10.1007/s13187-024-02565.
Abstract
LncRNA-miRNA-mRNA regulatory axes as potential biomarkers in cervical cancer: a
comprehensive overview.
Mol Biol Rep. 2025;52:110.
Abstract
Advances in human papillomavirus detection for cervical cancer screening and
diagnosis: challenges of conventional methods and opportunities for emergent
tools.
Anal Methods. 2025 Jan 7. doi: 10.1039/d4ay01921.
Abstract
A large annotated cervical cytology images dataset for AI models to aid cervical
cancer screening.
Sci Data. 2025;12:23.
Abstract
Study protocol for key interventions to improve the follow-up adherence
postcervical precancerous lesion treatment in Ethiopia: a pragmatic randomised
controlled trial.
BMJ Open. 2025;15:e091693.
Abstract
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination
with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical
cancer: a multicenter, single-arm phase 2a study.
J Immunother Cancer. 2025;13:e010827.
Abstract
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for
recurrent advanced cervical cancer: an open-label phase I/II study.
J Immunother Cancer. 2025;13:e010708.
Abstract
Association between contextual factors and vaccine coverage against human
papilomavirus in adolescents in the state of Minas Gerais, Brazil: global spatial
regressions.
BMC Infect Dis. 2025;25:34.
Abstract
Mapping the HPV Landscape in South African Women: A Systematic Review and
Meta-Analysis of Viral Genotypes, Microbiota, and Immune Signals.
Viruses. 2024;16:1893.
Abstract
Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer
Screening.
Viruses. 2024;16:1852.
Abstract
MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment
Monitoring.
Int J Mol Sci. 2024;25:13271.
Abstract
Relationship Between Population Density, Availability of Gynecological Services,
and Cervical Cancer Incidence and Mortality Across Administrative Units in Serbia
and Bosnia and Herzegovina During 2016-2020.
Medicina (Kaunas). 2024;60:1987.
Abstract
Complex Large-Deformation Multimodality Image Registration Network for
Image-Guided Radiotherapy of Cervical Cancer.
Bioengineering (Basel). 2024;11:1304.
Abstract
Cost Analysis Related to Diagnosis, Treatment and Management of Cervical Cancer
in Antigua and Barbuda: A Prevalence-Based Cost-of-Illness Study.
Int J Environ Res Public Health. 2024;21:1685.
Abstract
Cervical Cancer Screening Uptake Among Women with Disabilities: Findings from a
Cross-Sectional Study in Chile.
Int J Environ Res Public Health. 2024;21:1578.
Abstract
Cervical Cancer Cells Use the CD95 and IL-2 Pathways to Promote Their
Proliferation and Survival.
Biomolecules. 2024;14:1543.
Abstract
Short-term efficacy of laparoscopic type C radical hysterectomy by deep uterine
vein approach for treatment of cervical cancer.
Afr J Reprod Health. 2024;28:73-81.
Abstract
Effectiveness of nursing care for cervical cancer patients undergoing
chemotherapy: Systematic review and meta-analysis.
Afr J Reprod Health. 2024;28:46-51.
Abstract
RETRACTION: Diagnostic Value for Methylation in Cervical Cancer Based on a
Small-Molecule Fluorescent Probe Targeting DNMT1.
Skin Res Technol. 2024;30:e70155.
Abstract
Cervical Cancer and Cervical Cancer Screening in Women with HIV in Guangxi,
China: A Model Simulation Study.
MDM Policy Pract. 2025;10:23814683241308905.
Abstract
Predictors of delay in the cervical cancer care cascade in Kampala, Uganda.
Res Sq [Preprint]. 2024 Dec 18:rs.3.rs-5467551. doi: 10.21203/rs.3.rs-5467551.
Abstract
Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical
cancer: a systematic review and meta-analysis.
Front Oncol. 2024;14:1461175.
Abstract
Impact of achieving WHO's 90-70-90 targets on cervical cancer elimination and
potential benefits in preventing other HPV-related cancers in China: a modelling
study.
EClinicalMedicine. 2024;77:102878.
Abstract
RETRACTION: Preliminary Evaluation of the Value of a Small-Molecule Probe
Targeting DNMT1 in Detecting the Methylation of PAX1 in Cervical Cancer.
Skin Res Technol. 2024;30:e70157.
Abstract
Single-cell RNA sequencing highlights the unique tumor microenvironment of small
cell neuroendocrine cervical carcinoma.
J Transl Med. 2025;23:19.
Abstract
Adenosinergic Signalling in Cervical Cancer Microenvironment.
Expert Rev Mol Med. 2025;27:e5.
Abstract
Differential impact of cervical cancer in immigrant women: a decade-long
epidemiological study in the Marche Region, Italy.
J Epidemiol Community Health. 2025 Jan 6:jech-2024-222564.
Abstract
Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and
Survival Prognosis.
Oncol Res Treat. 2025 Jan 6:1-20. doi: 10.1159/000543409.
Abstract
The Added Value of Apparent Diffusion Coefficient and Histogram Analysis in
Assessing Treatment Response of Locally Advanced Cervical Cancer.
J Comput Assist Tomogr. 2024 Nov 13. doi: 10.1097/RCT.0000000000001642.
Abstract
Intratumoral Lactobacillus iners as a poor prognostic biomarker and potential
therapeutic target for cervical cancer.
Front Cell Infect Microbiol. 2024;14:1469924.
Abstract
The regulatory role of KIAA1429 in epithelial-mesenchymal transition in cervical
cancer via mediating m6A modification of BTG2.
Cytotechnology. 2025;77:34.
Abstract
Association between HPV vaccination and cervical screening policy changes and
cervical cancer incidence and grade-3 cervical intraepithelial neoplasia
incidence in England, 2006-2020: a population-based trends analysis.
Lancet Reg Health Eur. 2024;49:101157.
Abstract
Overexpression of C1orf74 predicts poor outcome and promote cervical cancer
progression.
Heliyon. 2024;10:e40966.
Abstract
CENPE is a diagnostic and prognostic biomarker for cervical cancer.
Heliyon. 2024;10:e40860.
Abstract
Exploration of Cervical Cancer Image Processing and Detection Based on URCNNs.
Curr Med Imaging. 2025 Jan 2. doi: 10.2174/0115734056333197241211162651.
Abstract
Is elimination of cervical cancer in sight in England?
Prev Med. 2025 Jan 3:108218. doi: 10.1016/j.ypmed.2025.108218.
Abstract
Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical
cancer development.
Tissue Cell. 2024;93:102713.
Abstract
Metabolomic and microbiota profiles in cervicovaginal lavage fluid of women with
high-risk human papillomavirus infection.
Sci Rep. 2025;15:796.
Abstract
Feasibility study of hyperspectral colposcopy as a novel tool for detecting
precancerous cervical lesions.
Sci Rep. 2025;15:820.
Abstract
Treatment for SMARCA4-deficient carcinoma of uterine cervix.
BMJ Case Rep. 2025;18:e258711.
Abstract
Association of female genital schistosomiasis and human papillomavirus and
cervical pre-cancer: a systematic review.
BMC Womens Health. 2025;25:2.
Abstract
Preferred labels and language to improve communication about lesions at low risk
of progressing to cancer: qualitative interviews with patients and physicians.
BMJ Open. 2025;15:e087484.
Abstract
Extended HPV genotyping by the BD Onclarity assay: concordance with screening
HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2
study.
Microbiol Spectr. 2025;13:e0089724.
Abstract
Development and evaluation of a CRISPR/Cas12a-based diagnostic test for rapid
detection and genotyping of HR-HPV in clinical specimens.
Microbiol Spectr. 2025;13:e0225324.
Abstract
Presence and extent of lymphovascular invasion in surgical stage I squamous cell
carcinoma of the cervix: a comprehensive, international, multicentre,
retrospective clinicopathological study.
Pathology. 2025;57:17-26.
Abstract
Human papillomavirus vaccine to prevent CIN3 or worse (CIN3+): A nationwide
case-control study in Japan.
Cancer Sci. 2025;116:226-232.
Abstract
[High-grade lesions probability in ASCUS HPV positive patient according to HPV
type].
Gynecol Obstet Fertil Senol. 2025;53:16-19.
Abstract
NCCN guideline-concordant cancer care in sub-Saharan Africa: a population-based
multicountry study of 5 cancers.
J Natl Cancer Inst. 2025;117:120-133.
Abstract
Relationships Among Determinants of Health, Cancer Screening Participation, and
Sexual Minority Identity: A Systematic Review.
LGBT Health. 2025;12:3-19.
Abstract
Migrant women's perception toward cervical and breast cancer screening in
Turkiye: a qualitative analysis.
BMC Public Health. 2025;25:190.
Abstract
Enhanced targeted treatment of cervical cancer using nanoparticle-based
doxycycline delivery system.
Sci Rep. 2025;15:2318.
Abstract
SOX2 promotes the glycolysis process to accelerate cervical cancer progression by
regulating the expression of HK2.
Acta Histochem. 2025;127:152230.
Abstract
Risk-based triage strategy by extended HPV genotyping for women with ASC-US
cytology.
Ann Med. 2025;57:2451183.
Abstract
Potential of non-Western medicines in chemoradiotherapy for cervical cancer.
World J Clin Cases. 2025;13:100198.
Abstract
GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or
advance cervical cancer: a phase 2 trial.
EClinicalMedicine. 2024;74:102716.
Abstract
Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal
Cytologic Findings.
JAMA Netw Open. 2025;8:e2454969.
Abstract
Barriers to early diagnosis and treatment of cervical cancer in Addis Ababa,
Ethiopia: qualitative study.
BMJ Open. 2025;15:e087792.
Abstract
Cervical Neuroendocrine Carcinoma Presenting as Isolated Large Ovarian
Metastasis: A Case Report.
Am J Case Rep. 2025;26:e945078.
Abstract
Cytotoxicity and Cell Death Induction on a Cervical Cancer Cell Line by Crude
Extracellular Product of Omphalotus nidiformis (Agaricomycetes) Mycelium.
Int J Med Mushrooms. 2025;27:35-44.
Abstract
Unveiling the Cytotoxic Potential of Quercetin-Loaded Magnetic Bacterial Bots
against Cervical Cancer.
ACS Appl Mater Interfaces. 2025 Jan 16. doi: 10.1021/acsami.4c17079.
Abstract
Digital cervicography using mobile phones with real-time consultation (DCRC) to
improve performance of Visual Inspection with Acetic Acid (VIA) in cervical
cancer screening of HIV-infected women. A cross-sectional study.
Gynecol Oncol Rep. 2024;57:101661.
Abstract
Factors associated with awareness of and undergoing Pap smear tests among
Jordanian women.
Narra J. 2024;4:e1018.
Abstract
Promising candidate drug target genes for repurposing in cervical cancer: A
bioinformatics-based approach.
Narra J. 2024;4:e938.
Abstract
Global Review of Tools Evaluating Quality of Life in Cervical Cancer Survivors
Treated With Chemoradiation Therapy.
Adv Radiat Oncol. 2024;10:101700.
Abstract
Endocervical adenocarcinomas and HPV genotyping in an HIV endemic milieu - a
retrospective study.
BMC Womens Health. 2025;25:20.
Abstract
Re-evaluating prognostic factors for cervical cancer with lymph node metastasis:
a Japanese multicenter cohort study based on FIGO 2018.
Int J Clin Oncol. 2025 Jan 16. doi: 10.1007/s10147-025-02697.
Abstract
m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1
and IL6/JAK2/STAT3 pathways.
Oncogene. 2025 Jan 15. doi: 10.1038/s41388-024-03260.
Abstract
Short term complications of conisation and long term effects on fertility related
outcomes in Denmark: register based nationwide cohort study.
BMJ. 2025;388:e078140.
Abstract
TSPOAP1-AS1: A Novel Biomarker for the Prognosis and Therapeutic Target in
Cervical Cancer.
Comb Chem High Throughput Screen. 2025.
Abstract
Hydronephrosis and survival in cervical cancer patients: The role of urinary
diversion.
Gynecol Oncol Rep. 2024;57:101660.
Abstract
Double-targeted liposomes coated with matrix metallopeptidase-2-responsive
polypeptide nanogel for chemotherapy and enhanced immunotherapy against cervical
cancer.
Mater Today Bio. 2024;30:101412.
Abstract
Single-cell transcriptomics unveils multifaceted immune heterogeneity in
early-onset versus late-onset cervical cancer.
World J Surg Oncol. 2025;23:12.
Abstract
Exploring the barriers to cervical screening and perspectives on new
self-sampling methods amongst under-served groups.
BMC Health Serv Res. 2025;25:79.
Abstract
A Proposed mHealth Intervention to Address Patient Barriers to Colposcopy
Attendance: Qualitative Interview Study of Clinic Staff and Patient Perspectives.
JMIR Form Res. 2025;9:e55043.
Abstract
Study of the Prevalence of Human Papillomavirus Genotypes in Jeddah, Saudi
Arabia.
J Epidemiol Glob Health. 2025;15:1.
Abstract
A Rare Case of Intraoperative Transfusion-associated Hypotension in a Chinese
Pregnant Patient.
Clin Lab. 2025;71.
Abstract
Hyperproteinemia, Hematuria, and Squamous Cell Shedding in Elderly Cervical
Cancer Patients and the Potential Alternative Screening Tool.
Clin Lab. 2025;71.
Abstract
The Added Role of Diffusion-Weighted Magnetic Resonance Imaging in Staging
Uterine Cervical Cancer.
Cureus. 2024;16:e75707.
Abstract
Cervicitis decidualis mimicking cervical cancer in pregnancy.
Gynecol Oncol Rep. 2024;57:101663.
Abstract
Recent advances in HPV biotechnology: understanding host-virus interactions and
cancer progression - a review.
Int J Surg. 2024;110:8025-8036.
Abstract
Knowledge and attitudes towards cervical cancer and screening among migrant
women: a qualitative study in Portugal.
BMJ Open. 2024;14:e082538.
Abstract
Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM
dendrimer for improvement of the therapeutic efficacy in cervical cancer.
Sci Rep. 2025;15:1813.
Abstract
Vaginal self-sampling for human papillomavirus to improve cervical cancer
screening in patients with immune-mediated inflammatory diseases.
Eur J Intern Med. 2025 Jan 12:S0953-6205(25)00002.
Abstract
Updated Review for Guidelines for Cervical Cancer Screening in Immunosuppressed
Women Without HIV Infection.
J Low Genit Tract Dis. 2025 Jan 13. doi: 10.1097/LGT.0000000000000866.
Abstract
The role and research progress of tumor-associated macrophages in cervical
cancer.
Am J Cancer Res. 2024;14:5999-6011.
Abstract
Educational Interventions to Improve Knowledge and Attitudes Toward Human
Papillomavirus (HPV) Vaccination and Cervical Cancer Screening Among Japanese
University Students.
Cureus. 2024;16:e75558.
Abstract
NIR Triggered Bionic Bilayer Membrane-Encapsulated Nanoparticles for Synergistic
Photodynamic, Photothermal and Chemotherapy of Cervical Cancer.
Int J Nanomedicine. 2025;20:141-159.
Abstract
Whole-Genome Methylation Sequencing Analysis and Functional Verification of
LIM-Homeobox Family Genes in Cervical Cancer.
Int J Gen Med. 2025;18:87-102.
Abstract
RETRACTION: Long Noncoding RNA LINC00958 Regulates Cell Sensitivity to
Radiotherapy Through RRM2 by Binding to microRNA-5095 in Cervical Cancer.
J Cell Physiol. 2025;240:e31525.
Abstract
Pap smear and colposcopy findings in female inmates of a prison unit in the state
of Sao Paulo, Brazil.
Ceska Gynekol. 2024;89:459-468.
Abstract
ConvXGB: A novel deep learning model to predict recurrence risk of early-stage
cervical cancer following surgery using multiparametric MRI images.
Transl Oncol. 2025;52:102281.
Abstract
Molecule interacting with CasL-2 enhances tumor progression and alters
radiosensitivity in cervical cancer.
J Transl Med. 2025;23:44.
Abstract
Deep learning for predicting prognostic consensus molecular subtypes in cervical
cancer from histology images.
NPJ Precis Oncol. 2025;9:11.
Abstract
Nationwide cervical precancer screening in Ghana: concurrent HPV DNA testing and
visual inspection under an expanded hub-and-spoke model.
Sci Rep. 2025;15:1744.
Abstract
U.S. national trends in cervical cancer screening by sexual orientation and
race/ethnicity in cisgender women.
Prev Med. 2025;191:108223.
Abstract
Investigating the delivery of PD-L1-targeted immunoliposomes in a dynamic
cervical cancer-on-a-chip model.
J Control Release. 2025;379:236-250.
Abstract
Integrating CTLA-4/PD-1 blockade into cervical cancer management: Results of
COMPASSION-16.
Med. 2025;6:100558.
Abstract
Disparities in cervical cancer elimination timeframes in the United States: a
comparative modeling study.
J Natl Cancer Inst. 2025 Jan 11:djae319. doi: 10.1093.
Abstract
Effects of different-valent vaccines against human papillomavirus (HPV) to
prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review
and network meta-analysis.
Int J Infect Dis. 2025;151:107363.
Abstract
Cleavable energy transfer labeled oligonucleotide probe for enhanced isothermal
amplification detection and nano digital chip-based readout.
Nanoscale. 2025;17:1381-1391.
Abstract
Image guided cervical brachytherapy practice patterns: 2023/2024 survey of the
American brachytherapy society.
Brachytherapy. 2025;24:18-29.
Abstract
Global prevalence of cervical human papillomavirus in women aged 50 years and
older with normal cytology: a systematic review and meta-analysis.
Lancet Microbe. 2025;6:100955.
Abstract
Is model-based dose calculation based on cone-beam computed tomography suitable
for adaptive treatment planning in brachytherapy?
Strahlenther Onkol. 2025;201:57-70.
Abstract
Impact of MRI-based planning in transperineal interstitial brachytherapy for
locally advanced cervix tumors: Clinical, dosimetric and toxicity outcomes.
Brachytherapy. 2025;24:134-143.
Abstract
N(6)-Methyladenosine Regulates Cilia Elongation in Cancer Cells by Modulating
HDAC6 Expression.
Adv Sci (Weinh). 2025;12:e2408488.
Abstract
Human Papillomavirus vaccination awareness and uptake among healthcare students
in Japan.
J Infect Chemother. 2025;31:102554.
Abstract
Development of a nomogram for predicting postoperative recurrence of cervical
intraepithelial neoplasia using immunohistochemical and clinical parameters.
Expert Rev Anticancer Ther. 2024;24:1261-1269.
Abstract
Knowledge and awareness of human papillomavirus (HPV) influence HPV vaccination
uptake among the catch-up generation in Japan.
J Infect Chemother. 2025;31:102527.
Abstract
Improving cervical screening rates among sexual minorities: Insights from
Aotearoa New Zealand.
Health Promot J Austr. 2025;36:e904.
Abstract
Making Sense of Gynecologic Cancer: A Relational Dialectics Approach.
Health Commun. 2025;40:90-102.
Abstract
Advanced breast, cervical and prostate cancer- Patient needs: systematic review.
BMJ Support Palliat Care. 2024;14.
Abstract
An exploration of the natural and acquired immunological mechanisms to high-risk
human papillomavirus infection and unmasking immune escape in cervical cancer: A
concise synopsis.
Tzu Chi Med J. 2024;37:28-41.
Abstract
Malignant peripheral nerve sheath tumour (MPNST) of the cervix: differential
diagnosis and a favourable oncological outcome with multimodality treatment.
BMJ Case Rep. 2025;18:e260709.
Abstract
Fiber, lactose and fat-modified diet for the prevention of gastrointestinal
chemo-radiotherapy-induced toxicity in patients with cervical cancer: Randomized
clinical trial.
Nutrition. 2025;132:112682.
Abstract
Sociodemographic inequities in overall survival among younger and older women
with cervical cancer.
Cancer Causes Control. 2025 Jan 23. doi: 10.1007/s10552-025-01961.
Abstract
Focus Groups With Guatemalan Community Leaders About Barriers to Cervical Cancer
Prevention and Control.
Health Promot Pract. 2025 Jan 23:15248399241309897.
Abstract
Surgical Advancements, Immunotherapy, Targeted and Conventional Therapies,
Biopsy, Colposcopy, and Pap Smear Integration in the Management of Cervical
Cancer.
Curr Med Chem. 2025 Jan 22. doi: 10.2174/0109298673337745241123054840.
Abstract
Results comparison of cervical cancer early detection using cerviray (R) with VIA
test.
BMC Res Notes. 2025;18:30.
Abstract
Perceptions of cervical screening uptake amongst South Asian women in Ontario,
Canada: a concept mapping study.
BMC Public Health. 2025;25:265.
Abstract
Retraction Note: Screening and identification of susceptibility genes for
cervical cancer via bioinformatics analysis and the construction of an
mitophagy-related genes diagnostic model.
J Cancer Res Clin Oncol. 2025;151:42.
Abstract
Cervical cancer screening by cotesting method for Vietnamese women 25-55 years
old: a cost-effectiveness analysis.
BMJ Open. 2025;15:e082145.
Abstract
Approach to cervical polyps in primary care.
Can Fam Physician. 2025;71:26-30.
Abstract
Mitochondrial oxidative stress related LncRNA predict cervical cancer prognosis
and immunotherapy response: Molecular structure and protein interaction of
ribosomal protein L34.
Int J Biol Macromol. 2025;299:140145.
Abstract
Exploring Cervical Adenocarcinoma: Epidemiological Insights, Diagnostic and
Therapeutic Challenges, and Pathogenetic Mechanisms.
Cancer Med. 2025;14:e70620.
Abstract
Impact of the COVID-19 Pandemic on Cervical Cancer Screening: An International
Comparative Study by INTRePID.
BJOG. 2025 Jan 22. doi: 10.1111/1471-0528.18077.
Abstract
Single-cell RNA sequencing and immune microenvironment analysis reveal
PLOD2-driven malignant transformation in cervical cancer.
Front Immunol. 2025;15:1522655.
Abstract
Survival status of women with cervical cancer in Sub-Saharan Africa: a systematic
review and meta-analysis, 2024.
Front Oncol. 2025;14:1491840.
Abstract
Maternal, delivery and neonatal outcomes in women with cervical cancer. A study
of a population database.
Oncoscience. 2025;12:3-12.
Abstract
MacNet: a mobile attention classification network combining convolutional neural
network and transformer for the differentiation of cervical cancer.
Quant Imaging Med Surg. 2025;15:55-73.
Abstract
[The Effectiveness of a Pap Smear Screening Practical Skills Training Program for
Nurse-Midwifery Students].
Hu Li Za Zhi. 2025;72:41-50.
Abstract
Knowledge, attitude, and reasons for non-uptake of human papilloma virus
vaccination among nursing students.
BMC Med. 2025;23:35.
Abstract
Addition of PARP1-inhibition enhances chemoradiotherapy and thermoradiotherapy
when treating cervical cancer in an in vivo mouse model.
Int J Hyperthermia. 2025;42:2450514.
Abstract
HPV E6/E7-Induced Acetylation of a Peptide Encoded by a Long Non-Coding RNA
Inhibits Ferroptosis to Promote the Malignancy of Cervical Cancer.
Adv Sci (Weinh). 2025 Jan 21:e2414018. doi: 10.1002/advs.202414018.
Abstract
High unmet needs for cervical cancer screening among women living with HIV in six
African countries: A population-based study.
Int J STD AIDS. 2025 Jan 21:9564624251315787. doi: 10.1177/09564624251315787.
Abstract
Performance of artificial intelligence for diagnosing cervical intraepithelial
neoplasia and cervical cancer: a systematic review and meta-analysis.
EClinicalMedicine. 2024;80:102992.
Abstract
Research Status of Clustered Regulary Interspaced Short Palindromic Repeats
Technology in the Treatment of Human Papillomavirus (HPV) Infection Related
Diseases.
Cancer Control. 2025;32:10732748241300654.
Abstract
Predicting the risk of high-grade precancerous cervical lesions based on
high-risk HPV typing in Changsha China.
BMC Womens Health. 2025;25:28.
Abstract
Strategies for strengthening cervical cancer screening programmes in Gwanda
district, Zimbabwe: a qualitative study.
BMC Public Health. 2025;25:235.
Abstract
Effectiveness of HPV vaccination in reducing infection among young Brazilian
women.
BMC Infect Dis. 2025;25:88.
Abstract
Diagnostic accuracy of human papillomavirus testing on self-collected samples
among women referred for colposcopy.
Sci Rep. 2025;15:2513.
Abstract
Spatiotemporal dynamics and prevention strategies of cervical cancer incidence in
Addis Ababa, Ethiopia: an ecological study.
BMJ Open. 2025;15:e089521.
Abstract
Unilateral lower extremity lymphedema followed by COVID-19 vaccination in
patients with cervical cancer history: two case reports.
J Yeungnam Med Sci. 2025;42:23.
Abstract
Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of
Small-Cell Neuroendocrine Carcinoma of the Cervix.
J Med Virol. 2025;97:e70183.
Abstract
The epidemiology of cervical cancer among indigenous women living in Latin
America: A systematic review.
Prev Med Rep. 2024;49:102955.
Abstract
Serum, Cell-Free, HPV-Human DNA Junction Detection and HPV Typing for Predicting
and Monitoring Cervical Cancer Recurrence.
medRxiv [Preprint]. 2025 Jan 6:2024.09.16.24313343.
Abstract
Perspectives on Cervical Cancer Prevention Strategies and a Combination Treatment
for Cervical Precancer in South African Women Living with HIV and Male Partners.
medRxiv [Preprint]. 2025 Jan 7:2025.01.07.25320108.
Abstract
Global Research Trends in Cervical Cancer Survival in the Last Two Decades: A
Bibliometric Analysis.
Malays J Med Sci. 2024;31:103-111.
Abstract
miR-21 promotes cervical cancer by regulating NTF3.
Sci Rep. 2025;15:2442.
Abstract
Corrigendum to "Prognosis and treatment regimens for patients with different
lymph node statuses in locally advanced cervical cancer" [Eur J Surg Oncol. 50
(2024) (11) 108522].
Eur J Surg Oncol. 2025 Jan 18:109558. doi: 10.1016/j.ejso.2024.109558.
Abstract
Global disease burden of cervical cancer and the association of screening
coverage with quality of disease management.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025.
Abstract
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic
cervical cancer: A double-blind, randomized controlled trial.
Med. 2025 Jan 15:100573. doi: 10.1016/j.medj.2024.100573.
Abstract
CRISPR/Cas14a integrated with DNA walker based on magnetic self-assembly for
human papillomavirus type 16 oncoprotein E7 ultrasensitive detection.
Biosens Bioelectron. 2025;272:117135.
Abstract
Elevated mortality risks associated with late diagnosis of cancer in individuals
with psychiatric disorders?
J Psychiatr Res. 2025;181:547-552.
Abstract
Socioeconomic determinants of cancer screening adherence among cancer survivors:
analysis from the 2020 Behavioral Risk Factor Surveillance System.
JNCI Cancer Spectr. 2025;9:pkae127.
Abstract
TRIM3 modulates cisplmatin-resistant of cervical squamous cell carcinoma via
endoplasmic reticulum stress signaling in vitro.
Biochem Cell Biol. 2025;103:1-12.
Abstract
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population
Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus
Infection in the United States.
Ann Intern Med. 2024 Nov 26. doi: 10.7326/M24-0421.
Abstract
An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor Immunity.
Adv Mater. 2025;37:e2411454.
Abstract
Differing conceptual maps of skills for implementing evidence-based interventions
held by community-based organization practitioners and academics: A
multidimensional scaling comparison.
Transl Behav Med. 2025;15:ibae051.
Abstract
Using Culturally Adapted Theater Outreach to Promote Cancer Screening Among
Medically Underserved Minority Communities.
J Racial Ethn Health Disparities. 2025;12:273-284.
Abstract
Discussion on cervical cytology in postmenopausal women.
Minerva Obstet Gynecol. 2024;76:532-539.
Abstract
Assessing impact of a community-based screening campaign to address social
determinants of cervical cancer.
JNCI Cancer Spectr. 2025 Jan 31:pkaf006. doi: 10.1093.
Abstract
Tertiary lymphoid structures are associated with enhanced macrophage activation
and immune checkpoint expression, and predict outcome in cervical cancer.
Cancer Immunol Res. 2025 Jan 31. doi: 10.1158/2326-6066.CIR-24-0979.
Abstract
Recent advances in immunotherapy for cervical cancer.
Int J Clin Oncol. 2025 Jan 31. doi: 10.1007/s10147-025-02699.
Abstract
Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated
NF-kB/iNOS/COX-2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma
Cells.
Drug Dev Res. 2025;86:e70052.
Abstract
RETRACTION: Promotion of Cell Autophagy and Apoptosis in Cervical Cancer by
Inhibition of Long Noncoding RNA LINC00511 via Transcription Factor
RXRA-regulated PLD1.
J Cell Physiol. 2025;240:e31527.
Abstract
Combination of Metabolomics and Bioinformatics to Reveal the Mechanism of
Luteolin in the Treatment of Cervical Cancer.
Chem Biol Drug Des. 2025;105:e70059.
Abstract
Cervical cancer screening using tests that provide same-day results: a study of
test accuracy.
BMJ Oncol. 2024;3:e000234.
Abstract
Diabetes Is Positively Associated With High Risk of Depression in Korean Cervical
Cancer Patients: Korean National Health and Nutrition Examination Survey
2010-2021.
Psychiatry Investig. 2025;22:57-65.
Abstract
ASO Author Reflections: Tackling the Unresolved Topic: Impact of Adjuvant
Chemotherapy on Survival in Patients with Surgically Treated Uterine Cervical
Cancer.
Ann Surg Oncol. 2025 Jan 30. doi: 10.1245/s10434-025-16935.
Abstract
[Management of women with abnormal cervical cytology: Update of INCa
recommendations after the implementation of HPV screening].
Gynecol Obstet Fertil Senol. 2025;53:54-75.
Abstract
Transportation Insecurity, Social Support, and Adherence to Cancer Screening.
JAMA Netw Open. 2025;8:e2457336.
Abstract
High burden of abnormal cervical smears in South African primary health care:
health programmes implications.
Health Promot Int. 2025;40:daae162.
Abstract
Emerging trends in cervical cancer incidence among younger Taiwanese generations:
an urban-rural comparison.
Ann Med. 2025;57:2458765.
Abstract
Activating Transcription Factor 5 Promotes Tumorigenic Capability in Cervical
Cancer Through the Wnt/beta-Catenin Signaling Pathway.
Cancer Manag Res. 2025;17:131-143.
Abstract
Knowledge, attitude and practice of physical therapists in the care of women
undergoing treatment for cervical cancer: a survey of practice in Brazil.
Physiother Theory Pract. 2025 Jan 30:1-9. doi: 10.1080/09593985.2025.2456515.
Abstract
The impact of age at initial HPV vaccination on cervical cancer screening
participation in a nationally representative cohort of women in the United
States.
J Med Screen. 2025 Jan 30:9691413251315879. doi: 10.1177/09691413251315879.
Abstract
Editorial Expression of Concern: Control of PD-L1 expression by
miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in
cervical cancer.
Oncogene. 2025 Jan 29. doi: 10.1038/s41388-025-03285.
Abstract
Psychological resilience, dyadic coping, and dyadic adjustment in couples dealing
with cervical cancer in Northwest China: A cross-sectional study.
Eur J Oncol Nurs. 2025;74:102785.
Abstract
Pan-cancer analysis of DCBLD1 and its association with the diagnosis,
immunotherapy, and prognosis of cervical cancer.
Int Immunopharmacol. 2025;148:114167.
Abstract
Material deprivation, racial inequalities and mortality from female breast,
prostate, and cervical neoplasm in the Brazilian adult population: an ecological
study.
Cien Saude Colet. 2025;30:e02212024.
Abstract
Cervical Cancer Screening in Women With Physical Disabilities.
JAMA Netw Open. 2025;8:e2457290.
Abstract
Evaluation of cervical cancer screening strategies in women living with HIV in
Thailand.
Cancer Commun (Lond). 2025 Jan 29. doi: 10.1002/cac2.70000.
Abstract
Outcomes and associated factors of cervical human papillomavirus infection among
608 women in Shenzhen, China, 2018-2023.
Front Public Health. 2025;12:1523839.
Abstract
Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women:
a systematic review and meta-analysis.
BMC Infect Dis. 2025;25:131.
Abstract
Spatial Epidemiology of Human Papillomavirus Screening Coverage in Mexico,
2013-2019.
Asian Pac J Cancer Prev. 2025;26:215-224.
Abstract
Breaking Barriers in Cancer Screening: Understanding Participant Dropout in
Breast and Cervical Programs in Morocco.
Asian Pac J Cancer Prev. 2025;26:67-75.
Abstract
BRN3A, a transcription factor, regulates the expression of genes involved in
biological processes shaping the HPV induced cervical cancer.
Genes Genomics. 2025 Jan 28. doi: 10.1007/s13258-025-01620.
Abstract
Low-cost interventions to increase uptake of cervical cancer screening among
emergency department patients: Results of a randomized clinical trial.
Acad Emerg Med. 2025 Jan 28. doi: 10.1111/acem.15101.
Abstract
Vacuolated Parabasal Cells in Papanicolaou Smears Are Cellular Changes Caused by
Human Papillomavirus 16 Infection.
J Med Virol. 2025;97:e70191.
Abstract
Knowledge, attitude, practices, and associated factors toward cervical cancer
among female health sciences students of Addis Ababa University, Addis Ababa,
Ethiopia.
Ther Adv Vaccines Immunother. 2025;13:25151355251314733.
Abstract
Prognostic and diagnostic value of circRNA expression in cervical cancer: a meta
analysis.
Front Oncol. 2025;14:1488040.
Abstract
Adenoviral Therapy for Cervical Cancer: From Targeted Modification to
Immunotherapy.
Anticancer Agents Med Chem. 2025.
Abstract
Graphene oxide-enhanced photothermal therapy: laser parameter optimization and
temperature modeling for hela cancer cell mortality.
Lasers Med Sci. 2025;40:50.
Abstract
The combined immunization of cervical cancer therapeutic vaccine based on
Listeria balanced lethal system has a significant therapeutic effect on tumor
model mice.
Int Immunopharmacol. 2025;148:114124.
Abstract
Exploring the Interplay Between Cervicovaginal Microbiome, HPV Infection, and
Cervical Intraepithelial Neoplasia in Taiwanese Women.
J Med Virol. 2025;97:e70190.
Abstract
Corrigendum: DYNLT3 overexpression induces apoptosis and inhibits cell growth and
migration via inhibition of the Wnt pathway and EMT in cervical cancer.
Front Oncol. 2025;14:1545180.
Abstract
Pan-Cancer Analysis Identifies YKT6 as a Prognostic and Immunotherapy Biomarker,
with an Emphasis on Cervical Cancer.
Onco Targets Ther. 2025;18:107-127.
Abstract
Conglomerated Imiquimod and Metronidazole Incorporated Biodegradable Nanofibrous
Mats for Potential Therapy of Cervical Cancer.
Int J Nanomedicine. 2025;20:951-966.
Abstract
Epigenetic alteration in cervical cancer induced by human papillomavirus.
Int Rev Cell Mol Biol. 2025;390:25-66.
Abstract
The experiences of women diagnosed with precancerous cervical lesions, and their
spouses, according to the Roy Adaptation Model: Model-based qualitative research.
Appl Nurs Res. 2025;81:151894.
Abstract
India is boosting vaccination efforts to eradicate cervical cancer.
Lancet Oncol. 2025 Jan 23:S1470-2045(25)00022.
Abstract
Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve
prognosis in ovarian and cervical cancers.
J Ovarian Res. 2025;18:14.
Abstract
An automatic cervical cell classification model based on improved DenseNet121.
Sci Rep. 2025;15:3240.
Abstract
How can cervical screening meet the needs of vulnerable women? A qualitative
comparative study with stakeholder perspectives from seven European countries.
BMJ Open. 2025;15:e090631.
Abstract
Targeted Delivery of SmacN7 Peptide Induces Immunogenic Cell Death in Cervical
Cancer Treatment.
Appl Biochem Biotechnol. 2025 Jan 25. doi: 10.1007/s12010-024-05129.
Abstract
Plant Compounds Inhibit the Growth of W12 Cervical Precancer Cells Containing
Episomal or Integrant HPV DNA; Tanshinone IIA Synergizes with Curcumin in
Cervical Cancer Cells.
Viruses. 2024;17:55.
Abstract
Role of Epigallocatechin Gallate in Selected Malignant Neoplasms in Women.
Nutrients. 2025;17:212.
Abstract
Downregulation of Ezrin Suppresses Migration Potential in Cervical Cancer Cells.
Pharmaceuticals (Basel). 2024;18:3.
Abstract
Gboxin Induced Apoptosis and Ferroptosis of Cervical Cancer Cells by Promoting
Autophagy-Mediated Inhibition of Nrf2 Signaling Under Low-Glucose Conditions.
Int J Mol Sci. 2025;26:502.
Abstract
Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation Versus Adjuvant
Chemotherapy Following Concurrent Chemoradiation for Locally Advanced Cervical
Cancer: A Network Meta-Analysis.
Cancers (Basel). 2025;17:223.
Abstract
Current Paradigm and Future Directions in the Management of Nodal Disease in
Locally Advanced Cervical Cancer.
Cancers (Basel). 2025;17:202.
Abstract
PET CT Imaging with FDG in the Therapeutical Management of Locally Advanced
Cervical Cancer Diagnosed in a 43-Year-Old Patient: Case Report and Review of the
Literature.
Biomedicines. 2025;13:83.
Abstract
Factors Predicting Sexual Satisfaction of Thai Women with Cervical Cancer After
Complete Treatment at Least One Year and Their Spouses.
Healthcare (Basel). 2025;13:112.
Abstract
METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by
inactivating the Hippo/YAP signaling.
Hereditas. 2025;162:9.
Abstract
Detection of cervical cell based on multi-scale spatial information.
Sci Rep. 2025;15:3117.
Abstract
A paper-based HPV E7 oncoprotein assay for cervical precancer detection at the
point of care.
Sci Rep. 2025;15:3041.
Abstract
Comparison of Liquid-Based Cytology EASYPREP and SurePath for Detection of
High-Risk HPV Genotypes.
Ann Clin Lab Sci. 2024;54:856-859.
Abstract
Effect of CXCR2 Deficiency in HeLa Cell on the Regulatory Network of Coding Genes
and Non-Coding RNAs.
Ann Clin Lab Sci. 2024;54:799-809.
Abstract
Factors associated with cervical cancer screening among women of reproductive age
in Moshi municipality, Kilimanjaro, Tanzania: a cross-sectional study.
BMJ Open. 2025;15:e085223.
Abstract
Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV
Vaccines.
Vaccines (Basel). 2025;13:92.
Abstract
Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated
with Chemoradiotherapy.
Curr Oncol. 2025;32:39.
Abstract
Predicting High-Grade Acute Urinary Toxicity and Lower Gastrointestinal Toxicity
After Postoperative Volumetric Modulated Arc Therapy for Cervical and Endometrial
Cancer Using a Normal Tissue Complication Probability Model.
Curr Oncol. 2025;32:26.
Abstract
Programmable Multiplexed Nucleic Acid Detection by Harnessing Specificity Defect
of CRISPR-Cas12a.
Adv Sci (Weinh). 2025;12:e2411021.
Abstract
Systemic hormone therapy after breast and gynecological cancers: an Italian
expert group consensus opinion.
Climacteric. 2025;28:4-14.
Abstract
Application of mass cytometry in multiparametric characterization of precancerous
cervical lesions.
Cytometry B Clin Cytom. 2025;108:55-66.
Abstract
Associations of social support, living arrangements, and residential stability
with cancer screening in the United States.
Cancer Causes Control. 2025;36:157-169.
Abstract
Association between folate level and cervical intraepithelial neoplasia risk: a
systematic review and meta-analysis.
Eur J Cancer Prev. 2025;34:185-192.
Abstract
Clinical significance of atypical glandular cells on cytology: 10 years'
experience of a colposcopic referral center.
Eur J Cancer Prev. 2025;34:106-112.
Abstract
The significance of extensive HPV genotyping for cervical high-grade neoplasia
among women with atypical glandular cells.
Am J Clin Pathol. 2025;163:134-142.
Abstract
Gastric Type Endocervical Adenocarcinoma With Concurrent High-Grade Squamous
Intraepithelial Lesion: A Clinicopathologic Study of Three Patients.
Int J Surg Pathol. 2025;33:13-18.
Abstract
Corrigendum to 'Investigating the delivery of PD-L1-targeted immunoliposomes in a
dynamic cervical cancer-on-a-chip model' [Journal of Controlled Release Volume
379, 10 March 2025, Pages 236-250].
J Control Release. 2025 Feb 6:S0168-3659(25)00099.
Abstract
Rare Gastric Metastasis From Cervical Cancer: A Case Report.
Clin Case Rep. 2025;13:e70181.
Abstract
CINNAMON-GUI: Revolutionizing Pap Smear Analysis with CNN-Based Digital Pathology
Image Classification.
F1000Res. 2024;13:897.
Abstract
Significance of non-steroidal anti-inflammatory drugs in the prevention and
treatment of cervical cancer.
Heliyon. 2025;11:e42055.
Abstract
SLC7A11 is a potential therapeutic target and prognostic biomarker correlated
with immune cell infiltration in cervical cancer.
Discov Oncol. 2025;16:125.
Abstract
Directed evolution of proteoglycan-modifying enzymes: Functional applications in
cervical cancer therapy.
Int J Biol Macromol. 2025 Feb 4:140659. doi: 10.1016/j.ijbiomac.2025.140659.
Abstract
Gemcitabine-induced digital necrosis in a patient with cervical squamous cell
carcinoma: case report and literature review.
Rev Colomb Obstet Ginecol. 2024;75.
Abstract
Molecular epidemiology of human papillomavirus variants in cervical cancer in
India.
Indian J Med Res. 2024;160:531-551.
Abstract
Taking Health into Your Own Hands: Evaluating Patient and Provider Perspectives
of Human Papillomavirus Self-Sampling for Cervical Cancer Screenings and
Opportunities for Education.
J Cancer Educ. 2025 Feb 6. doi: 10.1007/s13187-025-02568.
Abstract
The Combined Prognostic Value of (18)F-FDG PET/CT Metabolic Parameters of Immune
Organs and Hematological Immune-Related Markers in Patients With Locally Advanced
Cervical Cancer.
Cancer Med. 2025;14:e70650.
Abstract
Human papillomavirus, vaginal microbiota and metagenomics: the interplay between
development and progression of cervical cancer.
Front Microbiol. 2025;15:1515258.
Abstract
Major predictive factors for recurrence of CIN after treatment: an exploratory
analysis towards a predictive model.
Eur Rev Med Pharmacol Sci. 2025;29:23-29.
Abstract
Development and evaluation of a novel E7 multi-epitopic vaccine for human
papillomavirus type 16: design, expression, purification, and immunological
characterization.
BMC Infect Dis. 2025;25:174.
Abstract
Single-cell RNA sequencing reveals tumor heterogeneity in small cell
neuroendocrine cervical carcinoma.
Commun Biol. 2025;8:184.
Abstract
Biodegradable Mg-1%Ca alloy inhibits the growth of cervical cancer.
Biomed Mater. 2025 Feb 5. doi: 10.1088/1748.
Abstract
Barriers and Facilitators to the Preadoption of a Computer-Aided Diagnosis Tool
for Cervical Cancer: Qualitative Study on Health Care Providers' Perspectives in
Western Cameroon.
JMIR Cancer. 2025;11:e50124.
Abstract
Performance Evaluation of Large Language Models in Cervical Cancer Management
Based on a Standardized Questionnaire: Comparative Study.
J Med Internet Res. 2025;27:e63626.
Abstract
Spectral computed tomography in the assessment of metastatic lymph nodes in
cervical cancer patients treated with definitive radiotherapy: a single-center,
prospective study.
Clin Exp Metastasis. 2025;42:15.
Abstract
E2F1-Dependent CDCA5 overexpression drives cervical cancer progression and
correlates with poor prognosis.
J Mol Histol. 2025;56:80.
Abstract
Health dashboard for information management in cervical cancer screening.
Rev Lat Am Enfermagem. 2025;33:e4446.
Abstract
Effective cervical cancer prevention in sub-Saharan Africa needs the inclusion of
men as key stakeholders.
Front Oncol. 2025;15:1509685.
Abstract
Cervical cancer screening: Impact of collection technique on human papillomavirus
detection and genotyping.
Prev Med Rep. 2025;50:102971.
Abstract
Comparison of Self-Efficacy and Knowledge of Human Papillomavirus Vaccination
among Various Types of Decision Makers in Indonesia: A Cross-Sectional Study.
Int J Community Based Nurs Midwifery. 2025;13:28-39.
Abstract
An unusual case of post-menopausal bleeding.
World J Surg Oncol. 2025;23:37.
Abstract
Assessment of Phage-Displayed Peptides Targeting Cancer Cell Surface Proteins: A
Comprehensive Molecular Docking Study.
J Pept Sci. 2025;31:e70004.
Abstract
Elevated POSTN expression predicts poor prognosis and is associated with
radioresistance in cervical cancer patients treated with radical radiotherapy.
Sci Rep. 2025;15:4174.
Abstract
Folate-chitosan nanoparticles loaded with an apolar acetogenin inhibiting the
proliferation of cervical cancer cells.
Int J Biol Macromol. 2025;302:140640.
Abstract
Effectiveness of cervical cancer screening with cytology and human papillomavirus
co-testing: A 12-year retrospective study in Oyama district, Japan.
Cancer Epidemiol. 2025;95:102762.
Abstract
Radiotherapy-Associated Cellular Senescence and EMT Alterations Contribute to
Distinct Disease Relapse Patterns in Locally Advanced Cervical Cancer.
Adv Sci (Weinh). 2025 Feb 4:e2412574. doi: 10.1002/advs.202412574.
Abstract
Characterization of the vaginal microbiome of postmenopausal patients receiving
chemoradiation for locally advanced cervical cancer.
JCI Insight. 2025 Feb 4:e176839. doi: 10.1172/jci.insight.176839.
Abstract
Therapeutic target genes and regulatory networks of gallic acid in cervical
cancer.
Front Genet. 2025;15:1508869.
Abstract
Case report: Cutaneous metastasis of squamous cervical carcinoma: complete
regression after molecular diagnosis.
Front Immunol. 2025;15:1528957.
Abstract
Global cervical cancer elimination: quantifying the status, progress, and gaps.
BMC Med. 2025;23:67.
Abstract
SELP(+) TEC:CD8(+) T cell crosstalk associates with improved radiotherapy
efficacy in cervical cancer.
Mol Cancer. 2025;24:41.
Abstract
Gynecologic oncology in 2024: breakthrough trials and evolving treatment
strategies for cervical, uterine corpus, and ovarian cancers.
J Gynecol Oncol. 2025;36:e72.
Abstract
Clinical practice guidelines for cervical cancer: an update of the Korean Society
of Gynecologic Oncology Guidelines.
J Gynecol Oncol. 2025;36:e70.
Abstract
Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy
in patients with locally advanced cervical squamous cell carcinoma.
J Gynecol Oncol. 2025;36:e10.
Abstract
Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan,
2021-2023.
J Gynecol Oncol. 2025;36:e7.
Abstract
Examined lymph node counts affected the staging and survival in cervical cancer:
a retrospective study using the SEER and Chinese cohort.
Ann Med. 2025;57:2459821.
Abstract
Association between health insurance coverage and stage of diagnosis for cervical
cancer among females in Indiana from 2011 - 2019.
Prev Med Rep. 2025;50:102975.
Abstract
Vaginal microbiome distinction in women with HPV+, cervical intraepithelial
neoplasia, and cervical cancer, a retrospective study.
Front Cell Infect Microbiol. 2025;14:1483544.
Abstract
SERINC2-mediated serine metabolism promotes cervical cancer progression and
drives T cell exhaustion.
Int J Biol Sci. 2025;21:1361-1377.
Abstract
Symptoms associated with concurrent chemoradiotherapy in patients with cervical
cancer: Application of latent profile analysis and network analysis.
Asia Pac J Oncol Nurs. 2024;12:100649.
Abstract
Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell
lines.
Epigenetics. 2025;20:2451551.
Abstract
What Are the Current HPV Types Contributing to Cervical High Grade Squamous
Intraepithelial Lesion, Adenocarcinoma in Situ, and Early Cervical Cancer?
J Obstet Gynaecol Can. 2025 Jan 29:102783. doi: 10.1016/j.jogc.2025.102783.
Abstract
Association between psychological flexibility and self-perceived burden in
patients with cervical cancer: A computer-simulated network analysis.
Eur J Oncol Nurs. 2025;74:102822.
Abstract
Clinical characteristics and risk factors to high-grade vaginal intraepithelial
neoplasia: a single-institution study.
BMC Womens Health. 2025;25:44.
Abstract
Quality control study of cervical cancer interstitial brachytherapy treatment
plans using statistical process control.
Brachytherapy. 2025 Jan 31:S1538-4721(25)00005.
Abstract
Eliminating cervical cancer in the Tibetan Plateau.
Lancet. 2025;405:375-376.
Abstract
A 10-year Retrospective Analysis on HPV Genotype Switching in a Tertiary Center
in China: Infection Characterization and Clinical Outcome.
J Med Virol. 2025;97:e70193.
Abstract
Genome-Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify
Susceptibility Loci for Cervical Cancer.
J Med Virol. 2025;97:e70195.
Abstract
Comparison of deep transfer learning models for classification of cervical cancer
from pap smear images.
Sci Rep. 2025;15:3945.
Abstract
Investigating new drugs from marine seaweed metabolites for cervical cancer
therapy by molecular dynamic modeling approach.
Sci Rep. 2025;15:3866.
Abstract
Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in
Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women.
Anticancer Res. 2025;45:677-683.
Abstract
Barriers to breast and cervical cancer screening among adolescent girls and young
women in Kenya: A nationwide cross-sectional survey.
Soc Sci Med. 2025;367:117722.
Abstract
Nanoparticle-based colorimetric assays for early and rapid screening of the
oncogenic HPV variants 16 and 18.
Clin Chim Acta. 2025;568:120144.
Abstract
Bioactivity-guided identification of cytotoxic compounds from Tournefortia
hirsutissima L. by Fast Centrifugal Partition Chromatography.
J Ethnopharmacol. 2025;341:119301.
Abstract
Oncogenic PIK3CA corrupts growth factor signaling specificity.
Mol Syst Biol. 2025;21:126-157.
Abstract
HPV-Related Cancers in Bosnia and Herzegovina: A Comprehensive Review.
Acta Med Acad. 2024;53:237-273.
Abstract
Clinical Effect Analysis and Prognostic Factors of Photodynamic Therapy for
Cervical Precancerous Lesions.
J Biophotonics. 2025;18:e202400454.
Abstract
Clinical application of photoacoustic imaging for cervical precursor lesion
detection.
J Med Ultrason (2001). 2025;52:119-129.
Abstract
Performance of Government-Financed Cervical Cancer Screening in Hunan, China and
Optimization of Triage Strategies.
J Low Genit Tract Dis. 2025 Feb 14. doi: 10.1097/LGT.0000000000000875.
Abstract
Probiotics: A New Approach for the Prevention and Treatment of Cervical Cancer.
Probiotics Antimicrob Proteins. 2025 Feb 14. doi: 10.1007/s12602-025-10479.
Abstract
The Role of Lymphocyte Recovery Index in Prognosis Prediction for Locally
Advanced Cervical Cancer With Radiation-Induced Lymphopenia.
Cancer Med. 2025;14:e70638.
Abstract
Triptolide induces immunogenic cell death in cervical cancer cells via ER stress
and redox modulation.
Am J Cancer Res. 2025;15:69-83.
Abstract
Progress and prospects of the combination of BMI1-targeted therapy and
immunotherapy in cervical cancer.
Am J Cancer Res. 2025;15:217-232.
Abstract
Factors Influencing Cervical Cancer Screening: A Cross-Sectional Study Among
Ethnically Diverse Women in the Kumasi Metropolis of Ghana.
Health Sci Rep. 2025;8:e70433.
Abstract
[Two Cases of Splenic Tumors Safely Resected by Hand-Assisted Laparoscopic
Splenectomy].
Gan To Kagaku Ryoho. 2024;51:1684-1686.
Abstract
Genetic variations and carcinogenicity analysis of E6/E7 oncogenes in HPV31 and
HPV35 in Taizhou, China.
Virol J. 2025;22:35.
Abstract
TUFT1 Modulates Cell Proliferation, Migration, Invasion, Stemness and EGFR
Signaling in Cervical Cancer through Interacting with and Targeting ATF1.
Cell Biochem Biophys. 2025 Feb 13. doi: 10.1007/s12013-025-01673.
Abstract
Knowledge and practice of health promotive lifestyle toward cervical cancer
prevention among women in Africa: A scoping review.
Cancer Treat Res Commun. 2025;43:100877.
Abstract
Identification of differentially expressed MiRNA clusters in cervical cancer.
Discov Oncol. 2025;16:172.
Abstract
Symptom clusters and self-management experiences of cervical cancer patients
undergoing concurrent chemoradiotherapy: a qualitative study.
Support Care Cancer. 2025;33:187.
Abstract
[The methodological approaches to evaluation of economical efficiency of
application of HPV-testing and cytological examination under provision of medical
care on "Obstetrics and Gynecology" profile].
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2025;33:48-52.
Abstract
Delta-radiomics analysis based on magnetic resonance imaging to identify
radiation proctitis in patients with cervical cancer after radiotherapy.
Front Oncol. 2025;15:1523567.
Abstract
The significance of free-hand needles in cervical cancer brachytherapy.
J Contemp Brachytherapy. 2024;16:443-448.
Abstract
Early report on abbreviated brachytherapy schema for cervical cancer during the
COVID-19 pandemic.
J Contemp Brachytherapy. 2024;16:437-442.
Abstract
Dysregulation of G6PD by HPV E6 exacerbates cervical cancer by activating the
STAT3/PLOD2 pathway.
Carcinogenesis. 2025 Feb 13:bgaf005. doi: 10.1093.
Abstract
Inhibition of Kinase Activity and In Vitro Downregulation of the Protein Kinases
in Lung Cancer and Cervical Cancer Cell Lines and the Identified Known Anticancer
Compounds of Ziziphus mucronata.
Plants (Basel). 2025;14:395.
Abstract
Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for
Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma
and Endocervical Adenocarcinoma.
Int J Mol Sci. 2025;26:1362.
Abstract
Methanol Extract of Pueraria lobata (Willd.) Root and Its Active Ingredient,
Puerarin, Induce Apoptosis in HeLa Cells and Attenuates Bacterial Vaginosis in
Gardnerella vaginalis-Infected Mice.
Int J Mol Sci. 2025;26:1342.
Abstract
TMEM160 Promotes Tumor Growth in Lung Adenocarcinoma and Cervical Adenocarcinoma
Cell Lines.
Int J Mol Sci. 2025;26:1097.
Abstract
Long non-coding RNA H19 promotes cervical cancer development via targeting the
microRNA-140/ALDH1A1 axis.
Eur J Med Res. 2025;30:95.
Abstract
Health inequality and improvement gap in the prevalence of gynecological cancers
among perimenopausal women globally, 1990-2019.
BMC Public Health. 2025;25:590.
Abstract
Bioinformatics and experimental insights into F2RL1 as a key biomarker in
cervical cancer diagnosis and prognosis.
Sci Rep. 2025;15:5228.
Abstract
A questionnaire survey of cervical and breast cancer screening among female
employees and employees' spouses.
Sci Rep. 2025;15:5277.
Abstract
Immunization with recombinant HPV16-E7d in fusion with Flagellin as a cancer
vaccine: Effect of antigen-adjuvant orientation on the immune response pattern.
Immunol Res. 2025;73:50.
Abstract
Quinalizarin induces autophagy, apoptosis and mitotic catastrophe in cervical and
prostate cancer cells.
Sci Rep. 2025;15:5252.
Abstract
[Construction and preliminary validation of machine learning predictive models
for cervical cancer screening based on human DNA methylation].
Zhonghua Zhong Liu Za Zhi. 2025;47:193-200.
Abstract
Curcuma Aeruginosa Roxb. [C.zedoaria non Rosc.] Inhibits Human
Papillomavirus-Related Cervical Cancer via Dipeptidyl Peptidase IV.
Tohoku J Exp Med. 2025 Feb 13. doi: 10.1620/tjem.2025.
Abstract
Dynamic changes in peripheral blood immunophenotyping and its prognostic value in
cervical cancer patients undergoing immune checkpoint blockade therapy.
Discov Oncol. 2025;16:167.
Abstract
Andrographolide suppresses cervical cancer progression by targeting angiogenesis
and inducing apoptosis in a CAM-PDX model.
Biomol Biomed. 2025 Feb 11. doi: 10.17305/bb.2025.11432.
Abstract
Assessment of 5A's of Human Papilloma Virus Vaccination: Awareness, Attitude,
Apprehension, Action Expected and Acceptability Amongst Health Care Providers,
Medical Students, Para-Medical and Administration Staff in AIIMS Rajkot.
J Med Virol. 2025;97:e70231.
Abstract
Home-based urinary HPV self-sampling for the detection of cervical cancer
precursor lesions: attitudes and preferences from Belgian females participating
in the CASUS study.
Arch Public Health. 2025;83:32.
Abstract
Unlocking prevention: the role of health literacy in cervical cancer screening:
community nursing perspective.
BMC Nurs. 2025;24:160.
Abstract
The effect of hrHPV prevalence on cervical cancer screening strategies: a
cost-effectiveness study of Bangladesh.
BMC Public Health. 2025;25:561.
Abstract
Coping strategies utilized by patients with cervical cancer: an explorative
qualitative study at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.
BMC Womens Health. 2025;25:59.
Abstract
ASO Author Reflections: How to Individually and Precisely Reduce the Surgical
Scope for Cervical Cancer Patients to Decrease the Incidence of Postoperative
Complications.
Ann Surg Oncol. 2025 Feb 11. doi: 10.1245/s10434-025-16966.
Abstract
Analysis of human papillomavirus infection and its correlation with cervical
lesions in Huizhou women.
Sci Rep. 2025;15:5115.
Abstract
Author Correction: Lignan enriched fraction (LRF) of Phyllanthus amarus promotes
apoptotic cell death in human cervical cancer cells in vitro.
Sci Rep. 2025;15:5131.
Abstract
"High incidence of abnormal pap smears and low awareness of cervical cancer among
women in Rewa, Madhya Pradesh, India: Implications for screening and education".
Cancer Epidemiol. 2025;95:102767.
Abstract
The Impact of Chronic Pelvic Pain and Bowel Morbidity on Quality of Life in
Cervical Cancer Patients Treated With Radio (Chemo) Therapy. A Systematic
Literature Review.
J Pain Res. 2025;18:597-618.
Abstract
Methylation sites of human papillomavirus 16 as potential biomarkers for cervical
cancer progression.
Front Oncol. 2025;15:1481621.
Abstract
Artificial intelligence in high-dose-rate brachytherapy treatment planning for
cervical cancer: a review.
Front Oncol. 2025;15:1507592.
Abstract
Development, validation, and clinical application of a machine learning model for
risk stratification and management of cervical cancer screening based on
full-genotyping hrHPV test (SMART-HPV): a modelling study.
Lancet Reg Health West Pac. 2025;55:101480.
Abstract
The Utility of a Y-tandem Applicator in a Patient With Stage IVA Locally Advanced
Cervical Cancer in the Setting of a Bicornuate Uterus.
Cureus. 2025;17:e77151.
Abstract
METTL3-mediated NFAT5 Upregulation Promotes Cervical Cancer Progression Through
Enhancing the Mitochondrial Function by Transcriptional Regulation of PRDX1.
J Biochem Mol Toxicol. 2025;39:e70162.
Abstract
A multimodal intervention program to improve sexual health and self-perceived
quality of life in patients treated for cervical cancer: a randomized prospective
study (PROVIDENCE trial).
J Gynecol Oncol. 2025 Jan 29. doi: 10.3802/jgo.2025.
Abstract
Mechanistic study of METTL3 inducing ferroptosis to promote cervical cancer
progression through mediating m6A modification of COTE-1.
Cell Signal. 2025;128:111649.
Abstract
Adherence to cervical cancer screening among sexual and racial/ethnic minorities
during the covid-19 pandemic in the United States.
Am J Obstet Gynecol. 2025 Feb 7:S0002-9378(25)00088.
Abstract
Knowledge and Attitude Towards Human Papilloma Virus and Human Papilloma Virus
Vaccine.
J Nepal Health Res Counc. 2024;22:622-626.
Abstract
Stability, Hopf bifurcation and control of a fractional order delay cervical
cancer model with HPV infection.
Comput Methods Biomech Biomed Engin. 2025.
Abstract
Modeling optimal combination of breast and cervical cancer screening strategies
in China.
BMC Womens Health. 2025;25:56.
Abstract
Evaluating the benefits of immunotherapy in metastatic cervical cancer: an
observational retrospective analysis.
Clin Transl Oncol. 2025 Feb 8. doi: 10.1007/s12094-025-03852.
Abstract
Mortality risk stratification based on comorbidity status among cervical cancer
patients in Lagos, Nigeria.
Int Health. 2025 Feb 8:ihaf008. doi: 10.1093.
Abstract
Cryptotanshinone Inhibits Obesity-Related Cervical Cancer by Down-Regulating
CXCL8 Expression in Hela Cells.
Chem Biodivers. 2025 Feb 7:e202403263. doi: 10.1002/cbdv.202403263.
Abstract
Dual-OR Logic-Gated Lateral Flow Strip Assay Based on Colorimetric-Fluorescence
Dual Indication for Screening of HPV16/18 in Multiple Scenarios.
Anal Chem. 2025;97:2963-2971.
Abstract
Health behavior and social crisis in the era of COVID-19 in Malawi: A
decolonizing approach to a qualitative study.
Nurs Outlook. 2025;73:102317.
Abstract
Human umbilical cord mesenchymal stem cells small extracellular vesicles-derived
miR-370-3p inhibits cervical precancerous lesions by targeting DHCR24.
Stem Cells Transl Med. 2025;14:szae087.
Abstract
Evaluation of Human Papillomavirus Vaccination and Cancer Prevention Behaviors
among LGBTQI + Individuals: A Cross-Sectional Study.
J Community Health. 2025;50:98-110.
Abstract
Whole-exome Sequence Analysis of Gastric-type Adenocarcinoma of the Uterine
Cervix and Adjacent Lobular Endocervical Glandular Hyperplasia in the Same Case.
Int J Gynecol Pathol. 2025;44:125-129.
Abstract
Surgical protocols for oral leukoplakia and precancerous lesions across three
different anatomic sites.
Oral Dis. 2025;31:89-98.
Abstract
Cervical cancer screening uptake and its predictors among women aged 30-49 in
Ghana: Providing evidence to support the World Health Organization's cervical
cancer elimination initiative.
BMC Infect Dis. 2025;25:246.
Abstract
Generalizable deep neural networks for image quality classification of cervical
images.
Sci Rep. 2025;15:6312.
Abstract
A novel lightweight multi-scale feature fusion segmentation algorithm for
real-time cervical lesion screening.
Sci Rep. 2025;15:6343.
Abstract
Factors associated with CIN2-3 recurrence: A single center retrospective
analysis.
Hum Vaccin Immunother. 2025;21:2469410.
Abstract
Construction of Dynamic Hydrogel Inducing Effective and Selective 5-Fluorouracil
Monotherapy against Cervical Cancer Cells.
ACS Appl Mater Interfaces. 2025 Feb 21. doi: 10.1021/acsami.4c20276.
Abstract
Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the
Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.
J Low Genit Tract Dis. 2025 Feb 21. doi: 10.1097/LGT.0000000000000885.
Abstract
Clinical and Analytical Evaluation of the Abbott Alinity m HR HPV Assay in a New
Generation First-Void Urine Collector.
J Med Virol. 2025;97:e70254.
Abstract
Novel diagnostics for improved treatment of gynecological cancer.
Ups J Med Sci. 2025;130.
Abstract
Comments on "The mRNA and Protein Levels of the Glycolytic Enzymes Lactate
Dehydrogenase A (LDHA) and Phosphofructokinase Platelet (PFKP) Are Good
Predictors of Survival Time, Recurrence, and Risk of Death in Cervical Cancer
Patients".
Cancer Med. 2025;14:e70691.
Abstract
Addressing Global Disparities in Cervical Cancer Burden: A Narrative Review of
Emerging Strategies.
Curr HIV/AIDS Rep. 2025;22:18.
Abstract
[Not Available].
Salud Publica Mex. 2024;66.
Abstract
Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical
squamous cell carcinoma.
Cell Biol Toxicol. 2025;41:47.
Abstract
Advances in HPV-Associated Cervical Cancer Dynamic Modelling for Prevention and
Control Evaluation.
China CDC Wkly. 2025;7:225-229.
Abstract
Cuproptosis-related genes signature could predict prognosis and the response of
immunotherapy in cervical cancer.
Transl Cancer Res. 2025;14:129-140.
Abstract
Exploration of key pathogenic mechanisms and potential intervention targets of
the traditional Chinese medicine Coptis chinensis in the treatment of cervical
cancer based on network pharmacology and molecular docking techniques.
Transl Cancer Res. 2025;14:626-639.
Abstract
EPB41L4A-AS1 regulates cervical cancer by proliferative cells: mendelian
randomization and single-cell transcriptomics analyses.
Transl Cancer Res. 2025;14:354-370.
Abstract
L1CAM is not prognostic factor in HPV-associated adenocarcinoma and adenosquamous
cell carcinoma of the uterine cervix.
Cancer Biomark. 2024;41:CBM240101.
Abstract
How face-to-face and online patient-provider communication associate with
cervical cancer screening behaviors: The mediating roles of HPV awareness and
cancer worry.
J Health Psychol. 2025 Feb 19:13591053251316502. doi: 10.1177/13591053251316502.
Abstract
Cervical cancer screening: comparative study of human papillomavirus detection
between cervical cytology and urine samples.
BMC Womens Health. 2025;25:71.
Abstract
Eliminating VEGFA+ tumor-associated neutrophils by antibody-drug conjugates
boosts antitumor immunity and potentiates PD-1 immunotherapy in preclinical
models of cervical cancer.
Cell Death Dis. 2025;16:115.
Abstract
Analysis of time trends of prevalence of high-risk HPV infections, high grade
cervical precancer and cervical cancer disease in women from Eastern India over
20 years - Pooled analysis from three studies.
Cancer Epidemiol. 2025;95:102776.
Abstract
[Redox Status and Protein Glutathionylation in Binase-Treated HPV16-Positive SiHa
Carcinoma Cells].
Mol Biol (Mosk). 2024;58:811-820.
Abstract
Assessing the Acceptability of a Vaginal Self-Sampling Device in a Rural Parish
of Cuenca, Ecuador.
J Prim Care Community Health. 2025;16:21501319251320172.
Abstract
Identification of a novel hypermethylation marker, ZSCAN18, and construction of a
diagnostic model in cervical cancer.
Clin Transl Oncol. 2025 Feb 19. doi: 10.1007/s12094-025-03864.
Abstract
Validation of cervical cancer genetic signature in minimally invasive samples.
An Acad Bras Cienc. 2025;97:e20240824.
Abstract
Comprehensive Analysis of Clinical and Molecular Features in Cancer Patients
Associated With Major Human Oncoviruses.
J Med Virol. 2025;97:e70239.
Abstract
Cost-effectiveness analysis of a first-line treatment with cadonilimab plus
platinum-based chemotherapy with or without bevacizumab for persistent,
recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial.
J Pharm Policy Pract. 2025;18:2464781.
Abstract
Investigating the impact of persistent HPV infection on recurrence of lesions
post-surgery for early-stage cervical cancer and related influencing factors.
Front Oncol. 2025;15:1506521.
Abstract
Cer-ConvN3Unet: an end-to-end multi-parametric MRI-based pipeline for automated
detection and segmentation of cervical cancer.
Eur Radiol Exp. 2025;9:20.
Abstract
[The expression of YTHDF2 in cervical lesions and its relationship with prognosis
based on bioinformatics].
Zhonghua Liu Xing Bing Xue Za Zhi. 2025;46:280-287.
Abstract
Impacts of Substance Use and Mental Health Symptoms on Cervical Cancer Screening
and Viral Suppression: A Mixed Methods Study With Reproductive-Age Women With HIV
in Florida.
J Assoc Nurses AIDS Care. 2025 Feb 18. doi: 10.1097/JNC.0000000000000529.
Abstract
Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the
FOSL2-Src/AKT/STAT3 axis.
J Clin Invest. 2025 Feb 18:e177599. doi: 10.1172/JCI177599.
Abstract
Association of CDK8 Gene Polymorphisms with Cervical Cancer in Han Women in
Southwest China.
Genet Test Mol Biomarkers. 2025;29:39-47.
Abstract
Characteristics of Human Papillomavirus Prevalence and Infection Patterns Among
Women Aged 35-65 in Fujian Province, China: A Nine-Year Retrospective
Observational Study.
J Med Virol. 2025;97:e70238.
Abstract
Overview of female healthcare providers' outlooks on cervical cancer screening: a
narrative review.
Front Oncol. 2025;15:1496513.
Abstract
Genotypic analysis of human papillomavirus in cervical exfoliated cells from
women in Zigong.
Virol J. 2025;22:40.
Abstract
Cytotoxic and immunomodulatory properties of Tinospora cordifolia, Boerhaavia
diffusa, Berberis aristata, and Ocimum basilicum extracts against HPV-positive
cervical cancer cell line.
BMC Complement Med Ther. 2025;25:59.
Abstract
Predictors of para-aortic lymph node metastasis based on pathological diagnosis
via surgical staging in patients with locally advanced cervical cancer: A
multicenter study.
Cancer Lett. 2025 Feb 15:217545. doi: 10.1016/j.canlet.2025.217545.
Abstract
Screening for cervical and breast cancer among community health care workers
(ASHAs) of Puri district, Odisha.
Indian J Cancer. 2024;61:805-811.
Abstract
High-risk human papillomavirus infection among women with atypical squamous cells
of undetermined significance in Pap smear: A seven-year follow-up study in South
India.
Indian J Cancer. 2024;61:797-804.
Abstract
RETRACTION: Development of Gene Panel for Predicting Recurrence in Early-Stage
Cervical Cancer Patients.
Environ Toxicol. 2025 Feb 17. doi: 10.1002/tox.24495.
Abstract
Orostachys japonicus induce caspase-dependent apoptosis in HeLa human cervical
cancer cells.
Nutr Res Pract. 2025;19:131-142.
Abstract
Risk factors for pelvic lymph node metastasis in cervical cancer: a retrospective
analysis of 186 patients.
Front Oncol. 2025;15:1525946.
Abstract
Clinical value of miR-216a-5p and miR-34a in early screening for cervical cancer.
Am J Transl Res. 2025;17:462-470.
Abstract
Correlation analysis on risk factors for cervical cancer in perimenopausal women.
Am J Transl Res. 2025;17:211-220.
Abstract
Enhanced recovery after surgery in the perioperative period promotes recovery of
cervical cancer patients undergoing transabdominal radical resection.
Am J Transl Res. 2025;17:230-238.
Abstract
Assessment of Knowledge Gaps in Cervical Cancer Screening and HPV Vaccination
Among Chinese Women: A Comprehensive Population-Based Study.
Cancer Manag Res. 2025;17:267-279.
Abstract
RETRACTION: USP14 Promotes the Proliferation of Cervical Cancer via Upregulating
beta-Catenin.
Environ Toxicol. 2025 Feb 17. doi: 10.1002/tox.24493.
Abstract
Integrated access to cancer screening: expanding access for cervical and
colorectal cancer screening in rural and remote Northern Alberta, Canada using a
mobile service to bring cancer screening closer to home.
BMC Health Serv Res. 2025;25:260.
Abstract
Perineural Invasion in Cervical Cancer.
Cancer Lett. 2025 Feb 14:217561. doi: 10.1016/j.canlet.2025.217561.
Abstract
[Emerging role of primary care health visitors in population-based cervical
screening].
Orv Hetil. 2025;166:263-271.
Abstract
Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a
systematic review and meta-analysis.
BMC Womens Health. 2025;25:65.
Abstract
3D-printed needle guides for cervical cancer brachytherapy: Optimized dosimetry
and improved local control outcomes.
Brachytherapy. 2025 Feb 14:S1538-4721(25)00010.
Abstract
Application of Early Dynamic (18)F-FDG PET/CT in T1 and T2 Cervical Cancer.
Clin Radiol. 2025;83:106816.
Abstract
Oncological outcomes after vaginal and robotic-assisted radical trachelectomy in
patients with cervical cancer - A single-center prospective cohort study.
Eur J Surg Oncol. 2025;51:109671.
Abstract
Addressing the cervical cancer burden in the Rio Grande Valley of Texas through a
multi-component program to improve screening and diagnostic follow-up: A
retrospective cohort study.
Cancer Epidemiol. 2025;95:102772.
Abstract
NSUN7 promotes cervical cancer progression through activation of ErbB signaling
pathway.
Funct Integr Genomics. 2025;25:37.
Abstract
Overexpressed NEK2 contributes to progression and cisplatin resistance through
activating the Wnt/beta-catenin signaling pathway in cervical cancer.
Cancer Cell Int. 2025;25:45.
Abstract
Knowledge of Cervical Cancer Among Women of Childbearing Age: A Qualitative Study
of a Local Council in South-Eastern Nigeria.
Soc Work Public Health. 2025 Feb 14:1-16. doi: 10.1080/19371918.2025.2467399.
Abstract
"It's a low-key thing of eugenics": Disability reproductive injustice in barriers
to cervical cancer screening during the COVID-19 pandemic.
Soc Sci Med. 2025;369:117807.
Abstract
USP43 drives cervical carcinoma progression through regulation of the Hippo/TAZ
pathway.
Int Immunopharmacol. 2025;149:114217.
Abstract
Revolutionizing prognosis: Introducing cell death index (CDI) as a powerful
prognostic tool for CSCC patients.
Environ Toxicol. 2025;40:481-492.
Abstract
Prioritizing performance and outcome indicators for quality assessment of cancer
screening programs in the EU.
Public Health. 2025;239:185-192.
Abstract
A multimodal deep learning model for cervical pre-cancers and cancers prediction:
Development and internal validation study.
Comput Biol Med. 2025;186:109710.
Abstract
Predictors for negative large loop excision of the transformation zone (LLETZ) in
a primary HPV screened population.
J Gynecol Obstet Hum Reprod. 2025;54:102913.
Abstract
Content and quality of consumer websites providing information about human
papillomavirus infection in patients with systemic lupus erythematosus: An
environmental scan.
Patient Educ Couns. 2025;133:108644.
Abstract
Validation of a simplified HPV genotyping assay designed for cervical screening
in low-resource settings.
J Clin Microbiol. 2024 Dec 31:e0163924. doi: 10.1128/jcm.01639.
Abstract
Ureaplasma parvum serovar 6 may be a novel element in the progression of HPV
infection to CIN: A cross-sectional study of 7058 women.
J Infect. 2025;90:106397.
Abstract
Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment
Efforts, 1975-2020.
JAMA Oncol. 2025;11:162-167.
Abstract
Self-Collection for Primary HPV Testing: Acceptability in a Large Urban Emergency
Department.
Ann Emerg Med. 2025;85:249-257.
Abstract
An umbrella review of meta-analyses regarding the incidence of female-specific
malignancies after fertility treatment.
Fertil Steril. 2025;123:506-519.
Abstract
Synthesis of New Chromen-5-one Derivatives from Dimedone and their
Antiproliferative Evaluations against Selected Cancer Cell Lines Together with
Hepatocellular Carcinoma and Cervical Carcinoma.
Anticancer Agents Med Chem. 2025;25:134-149.
Abstract
Estimating the time required to reach HPV vaccination targets across Europe.
Expert Rev Vaccines. 2025;24:165-172.
Abstract
Tissue microarray validation in cervical carcinoma studies. A methodological
approach.
Histol Histopathol. 2025;40:317-325.
Abstract
Targeting the TGF-beta-p21 axis: a critical regulator of bleomycin-induced cell
cycle arrest and apoptosis in vitro-implication for progressive cervical cancer
therapy.
Med Oncol. 2025;42:85.
Abstract
N-acetyltransferase 10 Promotes Cervical Cancer Progression Via N4-acetylation of
SLC7A5 mRNA.
Front Biosci (Landmark Ed). 2025;30:26756.
Abstract
Integrated cervical cancer screening uptake and associated factors among women
attending primary care services at public health centres in Addis Ababa,
Ethiopia: a multicentre cross-sectional study.
BMJ Public Health. 2024;2:e001511.
Abstract
Herpes Simplex Virus Type 1-Induced Cervicitis Without Vulvar Lesions Mimicking
Cervical Cancer in a Healthy Woman.
Cureus. 2025;17:e78128.
Abstract
Skull Oligometastasis From Cervical Cancer: A Case Report.
Cureus. 2025;17:e78115.
Abstract
Wernicke's encephalopathy in a terminally ill patient with primary cervical
cancer: A case report and literature review.
Oncol Lett. 2025;29:186.
Abstract
Protocol for a systematic review and meta-analysis on intention to screen for
cervical cancer and predictors among women of reproductive age in Ethiopia.
BMJ Public Health. 2024;2:e000585.
Abstract
Knowledge, attitudes, behaviors, and information needs of women vaccinated with
the HPV vaccine regarding cervical cancer prevention: a cross-sectional study.
Front Public Health. 2025;13:1493589.
Abstract
High serum levels of soluble PD?1 and PD?L1 are associated with advanced clinical
stages in patients with cervical cancer.
Biomed Rep. 2025;22:70.
Abstract
Factors affecting young women's participation in organized cervical cancer
screening and non-organized testing - A population-based survey study.
J Med Screen. 2025 Feb 27:9691413251320572. doi: 10.1177/09691413251320572.
Abstract
Improving cervical cancer health literacy in Arabic-speaking immigrant women in
the United States through an online patient education tool.
Womens Health (Lond). 2025;21:17455057251323214.
Abstract
Trends in Cervical Precancers Identified Through Population-Based Surveillance -
Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United
States, 2008-2022.
MMWR Morb Mortal Wkly Rep. 2025;74:96-101.
Abstract
PPP1R13L drives cervical cancer progression by suppressing p63-mediated PTEN
transcription.
Cell Mol Life Sci. 2025;82:97.
Abstract
NTRK rearranged spindle cell neoplasm of the uterine cervix: a rare case report
and literature review.
BMC Womens Health. 2025;25:88.
Abstract
Waikato Environment for Knowledge Analysis (WEKA) as a Data Analysis Method
Identifying Potential Hematological Parameters for Early Diagnosis of Cervical
Cancer.
In Vivo. 2025;39:1042-1053.
Abstract
Overexpression of miR-23b-3p+miR-218-5p+miR-124-3p differentially modifies the
transcriptome of C-33A and CaSki cells and the regulation of cellular processes
involved in the progression of cervical cancer.
Comput Biol Med. 2025;188:109886.
Abstract
Knowledge of Human Papillomavirus, Risk Factors and Screening for Cervical Cancer
Among Women in Ghana.
Cancer Control. 2025;32:10732748251323765.
Abstract
3D reconstructed models based on real cervical cancer cases for undergraduate
gynecological oncology education: a pre- and post-test study.
3D Print Med. 2025;11:7.
Abstract
Prognostic model for cervical cancer based on apoptosis-related genes.
Comput Methods Biomech Biomed Engin. 2025.
Abstract
An Immunogenic Cell Death-Related Gene Signature Predicts the Prognosis and
Immune Infiltration of Cervical Cancer.
Cancer Inform. 2025;24:11769351251323239.
Abstract
PERCEPTION AND ACCEPTABILITY OF INTEGRATION OF CERVICAL CANCER SCREENING INTO
ANTENATAL AND POSTNATAL SERVICES IN A TERTIARY HOSPITAL IN NIGERIA.
Ann Ib Postgrad Med. 2024;22:47-53.
Abstract
Synchronous multiple primary cancers involving cervical cancer and follicular
lymphoma: A case report.
Oncol Lett. 2025;29:183.
Abstract
Acceptability of Home-Based Urine Self-Collection for Cervical Cancer Screening
Among Women Receiving Care at the Arab Community Center for Economic and Social
Services in Michigan.
Cancer Med. 2025;14:e70714.
Abstract
HPV-Associated Sexually Transmitted Infections in Cervical Cancer Screening: A
Prospective Cohort Study.
Viruses. 2025;17:247.
Abstract
HTLV-1 Infection and Cervicovaginal Susceptibility to High-Risk HPV: Findings
from Women Living with HTLV-1 in Salvador, Brazil.
Viruses. 2025;17:140.
Abstract
The Past, Present, and Future of Cervical Cancer Vaccines.
Vaccines (Basel). 2025;13:201.
Abstract
Human Papillomavirus Infection in Partners of Women Attending Cervical Cancer
Screening: A Pilot Study on Prevalence, Distribution, and Potential Use of
Vaccines.
Vaccines (Basel). 2025;13:172.
Abstract
Trends in Human Papillomavirus-Related Health Burden in Greece from 1996 to 2021
with a Focus on Cervical and Lip, Oral Cavity, and Pharyngeal Cancer.
Pathogens. 2025;14:197.
Abstract
The Role of Medical Therapies in the Management of Cervical Intraepithelial
Neoplasia: A Narrative Review.
Medicina (Kaunas). 2025;61:326.
Abstract
Impact of Smoking on Cervical Histopathological Changes in High-Risk HPV-Positive
Women: A Matched Case-Control Study.
Medicina (Kaunas). 2025;61:235.
Abstract
Sentinel Lymph Node Detection in Cervical Cancer: Challenges in Resource-Limited
Settings with High Prevalence of Large Tumours.
J Clin Med. 2025;14:1381.
Abstract
Management of Bulky Tumors in Cervical Cancer: Limits of the Surgical Approach.
J Clin Med. 2025;14:1142.
Abstract
The Prevalence of Human Papillomavirus Genotypes in Women with Precancerous
Lesions and Cervical Cancer in Arequipa, Peru.
Life (Basel). 2025;15:267.
Abstract
Evaluating HPV Viral Load and Multiple Infections for Enhanced Cervical Cancer
Risk-Based Assessment.
Life (Basel). 2025;15:153.
Abstract
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with
Cervical Cancer Risk.
Life (Basel). 2025;15:135.
Abstract
Overall Observed Survival of Female Breast, Cervical, Colorectal, and Prostate
Cancers in Antigua and Barbuda, 2017-2021: Retrospective Data from Four Study
Sites.
Int J Environ Res Public Health. 2025;22:235.
Abstract
Role of Pelvic Ultrasound in Predicting the Response to Neoadjuvant Chemotherapy
in Locally Advanced Cervical Cancer.
Diagnostics (Basel). 2025;15:463.
Abstract
Retrospective Analysis of Human Papillomavirus Genotyping and Cytology (Pap
Smears) in Cervical Cancer Screening: An Institutional Experience in the State of
Oregon, USA.
Diagnostics (Basel). 2025;15:419.
Abstract
Understanding Cervical Cancer Screening Attendance: Barriers and Facilitators in
a Representative Population Survey.
Cancers (Basel). 2025;17:706.
Abstract
Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation
Using Headroom Analysis.
Cancers (Basel). 2025;17:612.
Abstract
Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer
Development.
Cancers (Basel). 2025;17:582.
Abstract
Other countries should copy Nepal's approach to tackling cervical cancer.
Nature. 2025;638:891.
Abstract
Development and validation of a deep reinforcement learning algorithm for
auto-delineation of organs at risk in cervical cancer radiotherapy.
Sci Rep. 2025;15:6800.
Abstract
RAB33A promotes metastasis via RhoC accumulation through non-canonical autophagy
in cervical cancer.
Cell Death Dis. 2025;16:130.
Abstract
EFNA1 promotes the tumorigenesis and metastasis of cervical cancer by
phosphorylation pathway and epithelial-mesenchymal transition.
Acta Histochem. 2025;127:152236.
Abstract
Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and
Future Horizons.
J Imaging. 2025;11:63.
Abstract
Evaluation of reproductive and oncological outcomes after fertility-sparing
surgery in cervical cancer patients with tumor > 2 cm.
Gynecol Oncol Rep. 2025;57:101688.
Abstract
Turning the tide: From cervical cancer's grip to complete response: A case
report.
World J Clin Oncol. 2025;16:98219.
Abstract
Prognostic assessment of cervical cancer based on biomarkers: the interaction of
ERRalpha and immune microenvironment.
Virol J. 2025;22:47.
Abstract
Activating transcription factor 3 induces oxidative stress and genotoxicity,
transcriptionally modulating metastasis-related gene expression in human
papillomavirus-infected cervical cancer.
Virol J. 2025;22:46.
Abstract
Characterization of the Genomic Landscape in HPV-positive Cervical and Head and
Neck Squamous Cell Carcinomas by Whole Genome Next Generation Sequencing.
Cancer Genomics Proteomics. 2025;22:188-207.
Abstract
Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer
Progression.
Cancer Genomics Proteomics. 2025;22:271-284.
Abstract
Prevalence and cognitive factors influencing high-risk HPV infection and cervical
diseases in women aged 18-45 in Shijiazhuang city.
Medicine (Baltimore). 2025;104:e41436.
Abstract
Acupuncture treatment of postoperative urinary retention in cervical cancer:
Systematic evaluation and meta-analysis.
Medicine (Baltimore). 2025;104:e41520.
Abstract
Association between mental health and substance use among reproductive-age women
with HIV on cervical cancer screening and viral suppression outcomes.
AIDS Care. 2025 Feb 24:1-8. doi: 10.1080/09540121.2025.2464618.
Abstract
Cervical cancer burden and attributable risk factors across different age and
regions from 1990 to 2021 and future burden prediction: results from the global
burden of disease study 2021.
Front Oncol. 2025;15:1541452.
Abstract
Empowering India's fight against cervical cancer: Harnessing routine HPV
immunisation.
J Family Med Prim Care. 2025;14:22-28.
Abstract
Understanding cervical cancer, human papillomavirus (HPV), and HPV vaccine
acceptance in college-going students: Institutional-based cross-sectional study
from Bihar State.
J Family Med Prim Care. 2025;14:363-370.
Abstract
KAT8 facilitates the proliferation of cancer cells through enhancing E7 function
in HPV-associated cervical cancer.
Acta Biochim Biophys Sin (Shanghai). 2025 Feb 24. doi: 10.3724/abbs.2025022.
Abstract
NAD(+) Metabolism Reprogramming Drives SIRT1-Dependent Deacetylation Inducing
PD-L1 Nuclear Localization in Cervical Cancer.
Adv Sci (Weinh). 2025 Feb 23:e2412109. doi: 10.1002/advs.202412109.
Abstract
The efficacy of anti-angiogenic drugs in gastric-type endocervical
adenocarcinoma: A retrospective study.
J Obstet Gynaecol Res. 2025;51:e16247.
Abstract
Evaluation of the usefulness of sentinel lymph node mapping using indocyanine
green in patients with cervical and endometrial cancers: A single-center
prospective exploratory study.
J Obstet Gynaecol Res. 2025;51:e16254.
Abstract
Synthesis and in vitro and in vivo evaluation of novel bivalent quinolines as
antitumor agents via targeting autophagy in cervical cancer.
Eur J Med Chem. 2025;288:117421.
Abstract
Knowledge and health literacy related to human papillomavirus infection, cervical
cancer, and cervical cancer screening among nursing students in rural and urban
areas of Thailand.
Nurse Educ Today. 2025;148:106624.
Abstract
A randomised controlled non-inferiority trial to compare the efficacy of 'HPV
screen, triage and treat' with 'HPV screen and treat' approach for cervical
cancer prevention among women living with HIV.
Nat Commun. 2025;16:1888.
Abstract
Delay to timely treatment in locally advanced cervical cancer - insurance
inequities in access to gynecologic oncology.
Am J Obstet Gynecol. 2025 Feb 20:S0002-9378(25)00113.
Abstract
Modelling epidemiological and economics processes - the case of cervical cancer.
Health Econ Rev. 2025;15:13.
Abstract
Expression of miRNAs in the Presence of HPV Infection in Cervical Dysplasia
Samples: A Pilot Study.
Exp Oncol. 2025;46:387-392.
Abstract
Factors affecting cervical cancer screening and human papilloma virus vaccination
among Middle Eastern refugee women in Turkiye: indicators for social workers and
nurses.
Ann Med. 2025;57:2468261.
Abstract
Study on the effects and mechanism of RRM2 on three gynecological malignancies.
Cell Signal. 2025;129:111674.
Abstract
Human papillomavirus type 16 and 18 viral clearance and progression to precancer
among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine
trial (CVT).
Vaccine. 2025;50:126841.
Abstract
Magnesium-dependent-protein phosphatase 1B regulates the protein arginine
methyltransferase 5 through the modulation of myosin phosphatase.
J Biol Chem. 2025;301:108107.
Abstract
Single-Cell Transcriptome Sequencing and Analysis Provide a New Approach for the
Treatment of Small Cell Neuroendocrine Carcinoma of the Cervix.
Neuroendocrinology. 2025;115:13-33.
Abstract
Identifying optimum implementation for human papillomavirus self-sampling in
underserved communities: A systematic review.
J Med Screen. 2025;32:2-18.
Abstract
beta-lapachone suppresses carcinogenesis of cervical cancer via interaction with
AKT1.
Front Pharmacol. 2025;16:1509568.
Abstract
Development of a deep learning-based model to evaluate changes during
radiotherapy using cervical cancer digital pathology.
J Radiat Res. 2025 Mar 7:rraf004. doi: 10.1093.
Abstract
Ulvan Microneedles Loaded with Photosensitizer 5-aminolevulinic Acid Inhibits
Human Cervical Cancer HeLa cells In vitro.
Anticancer Agents Med Chem. 2025.
Abstract
New O-alkyl Chalcone Derivative Exhibits Antiproliferative Potential in
Colorectal and Cervical Cancer Cells by Inducing G0/G1 Cell Cycle Arrest and
Mitochondrial-mediated Apoptosis.
Curr Med Chem. 2025 Mar 6. doi: 10.2174/0109298673317485240827093121.
Abstract
Leveraging swin transformer with ensemble of deep learning model for cervical
cancer screening using colposcopy images.
Sci Rep. 2025;15:7900.
Abstract
Ezrin works as a scaffold protein for a macrophage checkpoint molecule CD47,
leading to a poor prognosis for patients with uterine cervical squamous cell
carcinoma.
Taiwan J Obstet Gynecol. 2025;64:239-247.
Abstract
Exploring a conundrum: Evaluating the role of neoadjuvant chemotherapy preceding
chemo-radiotherapy in locally advanced cervical cancer: A review article.
Taiwan J Obstet Gynecol. 2025;64:219-229.
Abstract
Minimally invasive surgery for earl-stage cervical cancer.
Taiwan J Obstet Gynecol. 2025;64:213-215.
Abstract
Is it enough to use cisplatin-paclitaxel-bevacizumab along in the management of
stage IVB cervical cancer patients?
Taiwan J Obstet Gynecol. 2025;64:207-209.
Abstract
Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British
Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic
Oncology consensus statement.
Lancet Oncol. 2025;26:e140-e151.
Abstract
Benefits and challenges of cervical cancer screening since the implementation of
the 'two cancer' screening programme in China: findings from Shangyu, Zhejiang in
2019-23.
J Glob Health. 2025;15:04064.
Abstract
Accuracy of Transvaginal Ultrasonography for Staging of Cervical Cancer Patients:
A Meta-Analysis.
J Clin Ultrasound. 2025 Mar 6. doi: 10.1002/jcu.23946.
Abstract
A Pilot Study on the Feasibility and Integration of High-Risk Human
Papillomavirus (HPV) Testing for Cervical Cancer Prevention in Trinidad and
Tobago.
Cureus. 2025;17:e78389.
Abstract
Investigation and analysis of female HPV infection and genotype distribution in
Xuhui District, Shanghai.
Virol J. 2025;22:59.
Abstract
Cancer screening participation and outcomes among people with an intellectual
disability in the Netherlands: a cross-sectional population-based study.
Lancet Public Health. 2025;10:e237-e245.
Abstract
Improving cervical cancer screening rates at a Federally Qualified Health Center.
J Am Assoc Nurse Pract. 2025 Mar 5. doi: 10.1097/JXX.0000000000001118.
Abstract
Cross-Sectional Study on the Detection of HPV Infections for Cervical Cancer
Screening Using a Self-Sampling Device.
J Low Genit Tract Dis. 2025 Mar 5. doi: 10.1097/LGT.0000000000000884.
Abstract
Cervical cancer screening utilization among healthcare professionals in Ethiopia:
systematic review and meta-analysis.
Front Glob Womens Health. 2025;6:1467313.
Abstract
Author Correction: Analysis of precancerous lesion-related microRNAs for early
diagnosis of cervical cancer in the Thai population.
Sci Rep. 2025;15:7595.
Abstract
Leukocyte-specific protein 1 is associated with the stage and tumor immune
infiltration of cervical cancer.
Sci Rep. 2025;15:7566.
Abstract
Robotic trachelectomy with sentinel lymph node biopsy for cervical cancer: a
prospective study investigating minimally invasive radicality.
Int J Clin Oncol. 2025 Mar 5. doi: 10.1007/s10147-025-02718.
Abstract
Knockdown of RFC2 Prevents the Proliferation, Migration and Invasion of Cervical
Cancer Cells.
Anticancer Res. 2025;45:989-1000.
Abstract
Predictors of advanced-stage presentation among patients with a diagnosis of
breast and cervical cancer in Ethiopia.
Oncologist. 2025;30:oyaf019.
Abstract
Exploring the metabolic alterations in cervical cancer induced by HPV
oncoproteins: From mechanisms to therapeutic targets.
Biochim Biophys Acta Rev Cancer. 2025 Mar 2:189292.
Abstract
Cervical cancer screening uptake and Socio-cultural barriers among women in Addis
Ababa, Ethiopia: Population based study.
Cancer Epidemiol Biomarkers Prev. 2025 Mar 4. doi: 10.1158/1055-9965.EPI-24-1408
Abstract
Cost-Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally Advanced
Cervical Cancer.
JAMA Netw Open. 2025;8:e250033.
Abstract
Application of TransUnet Deep Learning Model for Automatic Segmentation of
Cervical Cancer in Small-Field T2WI Images.
J Imaging Inform Med. 2025 Mar 4. doi: 10.1007/s10278-025-01464.
Abstract
LINC01871 facilitates cervical cancer cell migration and immune escape by
targeting miR-873-3p/MAP3K2 axis.
Kaohsiung J Med Sci. 2025 Mar 4:e12948. doi: 10.1002/kjm2.12948.
Abstract
The psychosocial implications of cervical cancer in women living in sub-Saharan
Africa.
Curationis. 2025;48:e1-e9.
Abstract
Comparative analysis of SD biosensor standard() M10 HPV and seegene anyplex()
II HPV HR for detecting high-risk human papillomavirus: a concordance study.
BMC Infect Dis. 2025;25:304.
Abstract
Causal interaction of metabolic oscillations in monolayers of Hela cervical
cancer cells: emergence of complex networks.
Sci Rep. 2025;15:7423.
Abstract
Systems serology analysis shows IgG1 and IgG3 memory responses six years after
one dose of quadrivalent HPV vaccine.
Nat Commun. 2025;16:2130.
Abstract
N-glycosylation of GSTO1 promotes cervical cancer migration and invasion through
JAK/STAT3 pathway activation.
Funct Integr Genomics. 2025;25:51.
Abstract
A meta-analysis of albumin, globulin, and albumin globulin ratios for predicting
prognosis of cervical cancer.
Eur J Cancer Prev. 2025 Feb 27. doi: 10.1097/CEJ.0000000000000958.
Abstract
Rural-Urban Disparities in Cervical Cancer Incidence and Mortality Among US
Women.
JAMA Netw Open. 2025;8:e2462634.
Abstract
Feasibility of the 3D printer to design an intracavitary applicator for the
treatment of cervical cancer patients with high dose rate brachytherapy system.
Phys Eng Sci Med. 2025 Mar 3. doi: 10.1007/s13246-025-01529.
Abstract
Accuracy of Liferiver HarmoniaHPV and VenusHPV Assays on Urine and Vaginal
Self-Samples.
J Med Virol. 2025;97:e70273.
Abstract
Computational analysis of Ayurvedic herbs to explore their potential role as
anti-cervical cancer agents.
Mol Biol Res Commun. 2025;14:129-141.
Abstract
Prognostic Value of Circulating Lymphocyte Subsets in Cervical Cancer Following
Postoperative Radiotherapy.
Int J Med Sci. 2025;22:1029-1038.
Abstract
Effects of simultaneous multislice acceleration on the stability of radiomics
features in parametric maps of IVIM and DKI in uterine cervical cancer.
J Appl Clin Med Phys. 2025 Mar 2:e70063. doi: 10.1002/acm2.70063.
Abstract
A deep ensemble learning approach for squamous cell classification in cervical
cancer.
Sci Rep. 2025;15:7266.
Abstract
In silico exploration of novel EGFR-targeting compounds: integrative molecular
modeling, docking, pharmacokinetics, and MD simulations for advancing
anti-cervical cancer therapeutics.
Sci Rep. 2025;15:7334.
Abstract
Comparative dosimetric assessment of combined treatment modalities in cervical
cancer radiotherapy for optimal organ protection.
Radiat Environ Biophys. 2025 Mar 1. doi: 10.1007/s00411-025-01113.
Abstract
Analysis of prognosis and related influencing factors of different surgical
approaches for early cervical cancer.
J Cancer Res Clin Oncol. 2025;151:97.
Abstract
From science to sensory art: an inclusive pedagogical tool for the UK blind,
low-vision and diverse-needs community to increase cervical cancer awareness.
Immunol Cell Biol. 2025 Mar 2. doi: 10.1111/imcb.70010.
Abstract
New agreement aims to eliminate cervical cancer across the Americas.
Lancet Oncol. 2025 Feb 27:S1470-2045(25)00126.
Abstract
Meta-analysis of clinical trial on the comparative efficacy and safety profiles
of immunotherapeutic strategies in cervical cancer.
Crit Rev Oncol Hematol. 2025;209:104673.
Abstract
Knowledge, Attitude and Practice on Human Papillomavirus Vaccination among
Healthcare Providers at a Tertiary Care Centre in North Delhi.
Asian Pac J Cancer Prev. 2025;26:671-676.
Abstract
Comparison of Pain, Cortisol, and IL6 Levels Pre and Post SEFT in Stage III B
Cervical Cancer Patients.
Asian Pac J Cancer Prev. 2025;26:625-630.
Abstract
HPV Vaccination Program in Indonesia: Effectiveness, Dose, Scale-Up Costs, Future
Prospects, and Policy Recommendations.
Asian Pac J Cancer Prev. 2025;26:421-434.
Abstract
Tumor ADC value predicts outcome and yields refined prognostication in uterine
cervical cancer.
Cancer Imaging. 2025;25:23.
Abstract
RPL22L1 fosters malignant features of cervical cancer via the modulation of
DUSP6-ERK axis.
J Transl Med. 2025;23:244.
Abstract
Real-world data from patients with gastric-type mucinous carcinoma of the cervix:
a multicenter, retrospective study.
Future Oncol. 2025;21:707-714.
Abstract
Multi-center evaluation of the Alinity m HR HPV assay with liquid-based cytology
cervical specimens in the United States.
Microbiol Spectr. 2025;13:e0191824.
Abstract
Learning curve and proficiency assessment for gynecological brachytherapy amongst
radiation oncology trainees in India: Results from a prospective study.
Brachytherapy. 2025;24:339-347.
Abstract
Dynamic characteristics of high-risk HPV infection in women with low-grade
cervical intraepithelial neoplasia, based on a community longitudinal study.
Eur J Clin Microbiol Infect Dis. 2025 Jan 4. doi: 10.1007/s10096-024-05036.
Abstract
Comparative efficacy of HPV 16/18 DNA and E6/E7 mRNA testing in detecting
high-grade cervical lesions (CIN2+) in women with cervical biopsies.
Diagn Microbiol Infect Dis. 2025;111:116668.
Abstract
Transition from point A to volume based image guided brachytherapy across a
network of centers in India through workshop and mentoring.
Brachytherapy. 2025;24:348-353.
Abstract
Persistence of HPV in cervical smears of vaccinated WLWH support for combined
molecular testing and cytology screening.
Int J STD AIDS. 2024 Dec 24:9564624241310947. doi: 10.1177/09564624241310947.
Abstract
[Human papillomavirus and systemic lupus erythematosus: A systematic review].
Rev Med Interne. 2025;46:164-173.
Abstract
Association Between Recurrence of High-grade Squamous Intraepithelial Lesions of
the Uterine Cervix and p16, C-myc and PIK3CA Proteins-A Single-center
Retrospective Study.
Cell Biochem Biophys. 2025;83:1151-1158.
Abstract
Application of Hysteroscopy in the Treatment of Mullerian Adenosarcoma of the
Cervix in an Adolescent Girl with 7 Years of Follow-up.
J Pediatr Adolesc Gynecol. 2025;38:203-206.
Abstract
Innovative Refractive Index Sensor Utilizing Terahertz Spectrum for Early Cancer
Detection: a Photonic Crystal Fiber Approach.
Cell Biochem Biophys. 2025;83:489-505.
Abstract
HiCervix: An Extensive Hierarchical Dataset and Benchmark for Cervical Cytology
Classification.
IEEE Trans Med Imaging. 2024;43:4344-4355.
Abstract
Immunotherapy in Cervical Cancer: An Evolutionary Paradigm in Women's
Reproductive Health.
Crit Rev Ther Drug Carrier Syst. 2025;42:55-88.
Abstract
Plasma exosomal miR-150-3p, NMT2, and PRDM1 as predictive biomarkers of acute
tumor response in patients with cervical cancer undergoing chemoradiotherapy.
Am J Cancer Res. 2025;15:546-558.
Abstract
Bibliometric analysis: a study of the microenvironment in cervical cancer
(2000-2024).
Front Oncol. 2025;15:1508173.
Abstract
The cross-sectional association between lifestyle behaviors and breast and
cervical cancer screening among Hispanic women along the Texas-Mexico border.
Prev Med Rep. 2025;51:103007.
Abstract
The Global Fund, Cervical Cancer, and HPV infections: what can low- and
middle-income countries do to accelerate progress by 2030?
EClinicalMedicine. 2025;81:103127.
Abstract
Patterns of Care and Outcomes Among Women With Locally Advanced Cervical Cancer
Treated With Curative Intent at a Tertiary Center in South Africa.
Cancer Med. 2025;14:e70712.
Abstract
PD-L1(+) CD49f(+) CD133(+) Circulating tumor cells predict outcome of patients
with vulvar or cervical cancer after radio- and chemoradiotherapy.
J Transl Med. 2025;23:321.
Abstract
Using a social marketing approach to increase the pap-smear test uptake:
randomized controlled trial among women residing in urban region.
BMC Womens Health. 2025;25:114.
Abstract
Characterization of human papillomavirus genotypes infections in patients with
cervical lesions and cervical cancer in Urumqi, Xinjiang from 2016 to 2023.
Virol J. 2025;22:72.
Abstract
Prevalence, trends, and geographic distribution of human papillomavirus infection
in Chinese women: a summative analysis of 2,728,321 cases.
BMC Med. 2025;23:158.
Abstract
A mixed-methods preliminary evaluation of an innovative treatment for cervical
precancer in El Salvador's screen-and-treat program.
BMC Womens Health. 2025;25:115.
Abstract
Roles of C-reactive protein and LOX-1 on cancer and myeloid-derived suppressor
cells in the progression of uterine cervical cancer.
Sci Rep. 2025;15:8774.
Abstract
Novel GAL7-targeted fluorescent molecular imaging probe for high-grade squamous
intraepithelial lesion and cervical cancer screening.
EJNMMI Res. 2025;15:22.
Abstract
Single-cell RNA sequencing revealed changes in the tumor microenvironment induced
by radiotherapy for cervical cancer and the molecular mechanism of mast cells in
immunosuppression.
Funct Integr Genomics. 2025;25:63.
Abstract
Identifying the key barriers, facilitators and factors associated with cervical
cancer screening attendance in young women: A systematic review.
Womens Health (Lond). 2025;21:17455057251324309.
Abstract
Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With
Intermediate-Risk Cervical Cancer.
JAMA Oncol. 2025 Mar 13. doi: 10.1001/jamaoncol.2025.0146.
Abstract
Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical
Cancer Cell Lines to Help Drive Cervical Cancer Research.
Int J Mol Sci. 2025;26:1799.
Abstract
Electrospun Coaxial Polycaprolactone/Polyvinylpyrrolidone Fibers Containing
Cisplatin: A Potential Local Chemotherapy Delivery System for Cervical Cancer
Treatment.
Polymers (Basel). 2025;17:637.
Abstract
Force Map-Enhanced Segmentation of a Lightweight Model for the Early Detection of
Cervical Cancer.
Diagnostics (Basel). 2025;15:513.
Abstract
MRI-Guided Multi-Catheter High-Dose-Rate Interstitial Brachytherapy for Uterine
Cervical Cancer.
Cancers (Basel). 2025;17:770.
Abstract
Why Are US Cervical Cancer Screening Exit Criteria Failing?
JAMA Netw Open. 2025;8:e250488.
Abstract
Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer
Screening.
JAMA Netw Open. 2025;8:e250479.
Abstract
TIAM2S Operates Multifaced Talents to Alleviate Radiosensitivity, Restrict
Apoptosis, Provoke Cell Propagation, and Escalate Cell Migration for Aggravating
Radioresistance-Intensified Cervical Cancer Progression.
Cells. 2025;14:339.
Abstract
Electrochemical Duplex Detection of E2 and E6 Genes of Human Papillomavirus Type
16 and Determination of Physical Status in High-Risk Cervical Carcinoma.
J Med Virol. 2025;97:e70299.
Abstract
Magnetic Resonance Imaging Radiomics-Based Model for Prediction of Lymph Node
Metastasis in Cervical Cancer.
Int J Gen Med. 2025;18:1371-1381.
Abstract
[Catch-up vaccination prevents HPV infection and related precancers when given up
to age 26].
Lakartidningen. 2025;122:24097.
Abstract
Characterization of the Cytotoxic Effect of Naphthalenacetamides Hydrochlorides
on Cervical Cancer-Derived Cells.
Med Chem. 2025;21:239-249.
Abstract
Cathepsins and their role in gynecological cancers: Evidence from two-sample
Mendelian randomization analysis.
Medicine (Baltimore). 2025;104:e41653.
Abstract
PLOD3 as a novel oncogene in prognostic and immune infiltration risk model based
on multi-machine learning in cervical cancer.
Discov Oncol. 2025;16:294.
Abstract
Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive
microenvironment in cervical adenocarcinoma.
Elife. 2025;13:RP97335.
Abstract
Readiness for Discharge, Quality of Discharge Teaching, Anxiety and Depression in
Surgical Patients With Cervical Cancer: A Cross-Sectional Survey.
Patient Prefer Adherence. 2025;19:593-604.
Abstract
Study on the clinical characteristics, persistent infection capability, and viral
load of human papillomavirus type 82 single infection.
Virol J. 2025;22:68.
Abstract
Analysis of HPV-16 viral load, integration status, and p16 expression in relation
to EBV co-infection and cervical lesion severity.
Sci Rep. 2025;15:8329.
Abstract
Persistence and clearance rates of human papillomaviruses in a cohort of women
treated or not treated for cervical dysplasia in northwest Ethiopia.
Sci Rep. 2025;15:8218.
Abstract
Integrated immunological analysis of single-cell and bulky tissue transcriptomes
reveals the role of prognostic value of T cell-related genes in cervical cancer.
Comput Methods Biomech Biomed Engin. 2025.
Abstract
In Vitro alpha/beta Ratio Variations in Cervical Cancer, with Consequent Effects on
Equivalent Dose in 2 Gy Fraction in High-Dose-Rate Brachytherapy.
Adv Radiat Oncol. 2025;10:101725.
Abstract
DNA methyltransferase DNMT3A inhibits TP53AIP1 expression and promotes cervical
cancer development and metastasis.
Cytotechnology. 2025;77:74.
Abstract
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against
cervical cancer.
Front Immunol. 2025;16:1571555.
Abstract
Analysis of the efficacy and safety of camrelizumab combined with chemotherapy
for cervical cancer treatment.
Front Oncol. 2025;15:1502701.
Abstract
Association between the p53 polymorphisms and cervical cancer risk: an updated
meta-analysis.
Front Oncol. 2025;15:1461737.
Abstract
Immunotherapy in cervical cancer: an innovative approach for better treatment
outcomes.
Explor Target Antitumor Ther. 2025;6:1002296.
Abstract
Targeting the interplay between human papillomavirus oncoproteins and hedgehog
signaling: assessment of chemopreventive potential of carvacrol in cervical
cancer.
3 Biotech. 2025;15:73.
Abstract
The Association Between RACK1 Gene Polymorphisms rs1279736 and rs3756585 in
Uterine Cervical Cancer with the Risk Factor of HPV: A Focus on Squamous Cell
Carcinoma (SCC).
Iran J Pathol. 2025;20:24-32.
Abstract
RETRACTION: Pathogenomics Model for Personalized Medicine in Cervical Cancer:
Cross-Talk of Gene Expressions and Pathological Images Related to Oxidative
Stress.
Environ Toxicol. 2025 Mar 10. doi: 10.1002/tox.24510.
Abstract
RETRACTION: An Innovative Predictive Model for Cervical Cancer Constructed Around
a Gene Profile Associated With Cholesterol Metabolism.
Environ Toxicol. 2025 Mar 10. doi: 10.1002/tox.24509.
Abstract
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are
still demanded.
Infect Agent Cancer. 2025;20:16.
Abstract
Microbial metabolites control self-renewal and precancerous progression of human
cervical stem cells.
Nat Commun. 2025;16:2327.
Abstract
Corrigendum to "Identification of circRNA-mediated competing endogenous RNA
network involved in the development of cervical cancer" [Mol. Cell. Probes. 78
(2024) 101984].
Mol Cell Probes. 2025 Mar 7:102021. doi: 10.1016/j.mcp.2025.102021.
Abstract
Histological results of para-aortic lymph node dissection in patients with
negative PET-CT for locally advanced cervical cancer in Reunion Island.
J Gynecol Obstet Hum Reprod. 2025 Mar 6:102934. doi: 10.1016/j.jogoh.2025.102934
Abstract
Extended HPV genotyping and dual stain for the triage of primary HPV
screen-positive cases: Practical guidance for the cytopathology laboratory.
Cancer Cytopathol. 2025;133:e70006.
Abstract
Interventions and Strategies to Increase Cervical Cancer Screening, Treatment,
and Retention in Care among Persons with HIV in Low- and Middle-Income Countries:
A Systematic Review.
AIDS Behav. 2025 Mar 7. doi: 10.1007/s10461-025-04678.
Abstract
Serum Wnt10B/beta-Catenin in Early Diagnosis, Lymph Node Metastasis, and Prognosis
in Cervical Cancer.
J Coll Physicians Surg Pak. 2025;35:318-323.
Abstract
Visual detection of HPV16 using a photoactivatable CRISPR-Cas12 system.
Chem Commun (Camb). 2025;61:4383-4386.
Abstract
Investigating factors affecting the effectiveness of Gardasil 4, Cervarix, and
Gardasil 9 vaccines considering the WHO regions in females: A systematic review.
Cancer Epidemiol. 2025;95:102759.
Abstract
Prevalence of Human Papilloma Virus in Coquimbo, Chile.
Cancer Epidemiol. 2025;95:102757.
Abstract
Process evaluation of quality of precancerous cervical lesion screening program
in selected public health centers in Addis Ababa, Ethiopia.
J Cancer Policy. 2025;43:100557.
Abstract
Unsupervised cervical cell instance segmentation method integrating cellular
characteristics.
Med Biol Eng Comput. 2025;63:773-791.
Abstract
Reduced cervical sampling of hysterectomy specimens with negative margins on
conization: An opportunity to improve resource utilization.
Am J Clin Pathol. 2025;163:435-438.
Abstract
Traditional vs novel out-of-office method for collecting cytology and HPV DNA - a
comparative study.
Ginekol Pol. 2025;96:81-86.
Abstract
Treatment patterns and prognosis of patients with clear cell adenocarcinoma of
the cervix: a population-based cohort study.
Int J Surg. 2025;111:20-30.
Abstract
The Effects of Testosterone on Cervicovaginal Cytology in Transgender and
Gender-Diverse Individuals.
J Am Board Fam Med. 2024;37:1009-1013.
Abstract
Retraction: Silencing of BAG3 inhibits the epithelial-mesenchymal transition in
human cervical cancer.
Oncotarget. 2025;16:219.
Abstract
Haematology results, inflammatory haematological ratios, and inflammatory indices
in cervical cancer: How is the difference between cancer stage?
World J Exp Med. 2025;15:96988.
Abstract
Revision of quality indicators for cervical cancer and trend analysis of existing
indicators in Japan.
J Gynecol Oncol. 2025 Mar 5. doi: 10.3802/jgo.2025.
Abstract
A decade data of HPV genotypes in metropolitan regions of Indonesia: paving the
way for a national cervical cancer elimination strategy.
J Gynecol Oncol. 2025 Mar 2. doi: 10.3802/jgo.2025.
Abstract
Increased cardiovascular disease risk among adolescent and young adult survivors
of cervical cancer.
J Gynecol Oncol. 2025 Mar 4. doi: 10.3802/jgo.2025.
Abstract
Adjuvant chemotherapy after radical hysterectomy yields comparable outcomes to
chemoradiation for stage IB2-IIB and IIIC1-2 cervical cancer: a single-center
retrospective study.
J Gynecol Oncol. 2025 Mar 3. doi: 10.3802/jgo.2025.
Abstract
E7HPV16 Oncogene and 17beta-Estradiol Stress, Promotes Oncogenic microRNA
Expression Patterns, Cell Proliferation and Cervical Intraepithelial Neoplasia 1.
Cell Biochem Funct. 2025;43:e70065.
Abstract
An innovative glutamine metabolism-related gene signature for predicting
prognosis and immune landscape in cervical cancer.
Discov Oncol. 2025;16:368.
Abstract
[Diagnostic performance evaluation of artificial intelligence-assisted diagnostic
systems in cervical cytopathological examination].
Zhonghua Liu Xing Bing Xue Za Zhi. 2025;46:499-505.
Abstract
Outcomes of Loop Electrosurgical Excision Procedures Performed for Severe
Cervical Dysplasia in Botswana.
JCO Glob Oncol. 2025;11:e2400472.
Abstract
Risk Factors of Positive Endocervical Curettage and Predictive Model Construction
Based on Primary Human Papillomavirus Screening.
Technol Cancer Res Treat. 2025;24:15330338241312573.
Abstract
Patient Perspectives on Impact of Weight and Weight Stigma on Breast and Cervical
Cancer Treatment: A Qualitative Study.
Cancer Med. 2025;14:e70823.
Abstract
Multi-Omics Analysis Revealed That TAOK1 Can Be Used as a Prognostic Marker and
Target in a Variety of Tumors, Especially in Cervical Cancer.
Onco Targets Ther. 2025;18:335-353.
Abstract
Reflections Regarding Validation of New HPV Tests With Reduced HPV Genotypes:
Report From an IARC Expert Consultation.
J Med Virol. 2025;97:e70310.
Abstract
Decoding intricate interactions between m6A modification with mRNAs and
non-coding RNAs in cervical cancer: Molecular mechanisms and clinical
implications.
Cell Signal. 2025;131:111745.
Abstract
Recent update on the Development of HPV16 inhibitors for Cervical Cancer.
Crit Rev Oncol Hematol. 2025 Mar 17:104703.
Abstract
Identifying Data-Driven Clinical Subgroups for Cervical Cancer Prevention With
Machine Learning: Population-Based, External, and Diagnostic Validation Study.
JMIR Public Health Surveill. 2025;11:e67840.
Abstract
Clinicopathologic and Etiologic Characteristics of Urinary Tract Infections in
Patients with Cervical Cancer Undergoing Radical Operation with Indwelling
Ureteral Stents.
Surg Infect (Larchmt). 2025 Mar 19. doi: 10.1089/sur.2024.
Abstract
Tolerability, safety and feasibility of metformin combined with chemoradiotherapy
in patients with locally advanced cervical cancer: A phase II, randomized study.
Acta Oncol. 2025;64:439-447.
Abstract
Position-dependent offset corrections for ring applicator reconstruction in
cervical cancer brachytherapy.
J Appl Clin Med Phys. 2025 Mar 19:e70079. doi: 10.1002/acm2.70079.
Abstract
PET/CT-based dose-escalated definitive radiotherapy in cervical cancer: a
single-institution series.
Rep Pract Oncol Radiother. 2025;29:754-763.
Abstract
POSITIVE CONE MARGINS - A DISADVANTAGE OF THE LARGE LOOP EXCISION OF
TRANSFORMATION ZONE TECHNIQUE?
Acta Clin Croat. 2024;63:300-305.
Abstract
Cervical cancer in women under age 40: A cohort study of clinicopathological
characteristics and fertility-sparing surgery outcomes.
Gynecol Oncol Rep. 2025;58:101710.
Abstract
Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in
early-stage disease.
Ann Med. 2025;57:2466667.
Abstract
Dynamic changes of bone microarchitecture and volumetric mineral density assessed
by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a
prospective study.
Biomark Res. 2025;13:46.
Abstract
Challenges in managing atypical glandular cells in cervical smears: Insights from
real-world data and clinicians' perspectives.
J Obstet Gynaecol Res. 2025;51:e16269.
Abstract
Fibroblast Growth Factor 11 Promotes Immune Escape of Cervical Cancer Cells by
Promoting Infiltration of CD4(+) T Cells, Particularly Regulatory T Cells.
Genet Test Mol Biomarkers. 2025;29:85-98.
Abstract
Barriers to cervical cancer screening among refugee women: A systematic review.
PLOS Glob Public Health. 2025;5:e0004225.
Abstract
Cervical cancer patients with and without HIV infection have unique T cell
activation profiles despite similar survival outcomes after chemoradiation.
Cancer Res Commun. 2025 Mar 18. doi: 10.1158/2767-9764.CRC-24-0364.
Abstract
Incorporating Additional Evidence as Prior Information to Resolve
Non-Identifiability in Bayesian Disease Model Calibration: A Tutorial.
Stat Med. 2025;44:e70039.
Abstract
lncRNA HIF1A-AS2 acts as an oncogene to regulate malignant phenotypes in cervical
cancer.
Front Oncol. 2025;15:1530677.
Abstract
Strategically striving to be more inclusive: A recommendation for gender-neutral
human-papillomavirus vaccine policies.
Hum Vaccin Immunother. 2025;21:2480404.
Abstract
Commentary and methodological insights: Reaching girls/women, boys/men and
vulnerable groups to maximise uptake for the Human papillomavirus vaccine.
Hum Vaccin Immunother. 2025;21:2478705.
Abstract
RETRACTION: Effect of Laparoscopic-Assisted Transvaginal Hysterectomy on Wound
Complications in Patients With Early Stage Cervical Cancer: A Meta-Analysis.
Int Wound J. 2025;22:e70359.
Abstract
RETRACTION: Effect of Robotic Versus Laparoscopic Surgery on Postoperative Wound
Infection in Patients With Cervical Cancer: A Meta-Analysis.
Int Wound J. 2025;22:e70355.
Abstract
Cervical cancer screening and risk factor prevalence by sexual identity: A
comparison across three national surveys in the United States.
Prev Med. 2025 Mar 15:108262. doi: 10.1016/j.ypmed.2025.108262.
Abstract
Vulvar Lymphangiectasia After Therapy for Cervical Cancer: A Case Report and
Literature Review.
J Clin Med. 2025;14:1675.
Abstract
Predictive role of HPGD gene in carcinogenesis and immune environment monitoring
in human cervical cancer.
Cancer Biomark. 2024;41.
Abstract
A cost-effectiveness analysis of adult human papillomavirus vaccination
strategies in Italy.
Hum Vaccin Immunother. 2025;21:2474891.
Abstract
Imaging based artificial intelligence for predicting lymph node metastasis in
cervical cancer patients: a systematic review and meta-analysis.
Front Oncol. 2025;15:1532698.
Abstract
A comparative analysis of survival outcomes and adverse effects between
preoperative brachytherapy with radical surgery and concurrent chemoradiotherapy
in patients with locally advanced cervical cancer.
Front Oncol. 2025;15:1511748.
Abstract
Preoperative prediction of recurrence risk factors in operable cervical cancer
based on clinical-radiomics features.
Front Oncol. 2025;15:1492494.
Abstract
An unyielding challenge for refractory hyponatremia in neuroendocrine cervix
carcinoma: a case report.
Front Endocrinol (Lausanne). 2025;16:1451157.
Abstract
Prognostic Value of Ferroptosis-Immunity-Related Signature Genes in Cervical
Cancer Radiotherapy Resistance and Risk Modeling.
Cancer Manag Res. 2025;17:557-575.
Abstract
The effect of bivalent HPV vaccination against invasive cervical cancer and CIN3+
in the Netherlands: a national linkage study.
medRxiv [Preprint]. 2025 Mar 5:2025.02.27.25322519.
Abstract
Maintenance bevacizumab following chemotherapy is associated with improved
survival in patients with advanced and recurrent cervical cancer in a
single-institution retrospective study.
Gynecol Oncol Rep. 2025;58:101706.
Abstract
Long-Term Outcomes of Local Tumor Destruction/Excision Versus Total Hysterectomy
for Stage IA Cervical cancer: A Retrospective Study Based on the SEER Database.
Int J Womens Health. 2025;17:711-725.
Abstract
Closing the Automation Gap: Robust AI for Dual-Stain Cervical Cancer Screening
Triage.
Res Sq [Preprint]. 2025 Mar 4:rs.3.rs-5985837. doi: 10.21203/rs.3.rs-5985837.
Abstract
Deciphering the Expression, Functional Role, and Prognostic Significance of P53
in Cervical Cancer Through Bioinformatics Analysis.
J Obstet Gynaecol India. 2025;75:36-45.
Abstract
Endostar and chemoradiotherapy for advanced cervical cancer: comparing efficacy
and prognosis.
Am J Transl Res. 2025;17:1388-1401.
Abstract
Autologous Peripheral Vgamma9Vdelta2 T Cell Synergizes with alphabeta T Cell Through Antigen
Presentation and BTN3A1 Blockade in Immunotherapy of Cervical Cancer.
Adv Sci (Weinh). 2025 Mar 17:e2401230. doi: 10.1002/advs.202401230.
Abstract
Nanoparticles and the Vaginal Microbiota: Diagnostic and Therapeutic Innovations
in Human Papilloma Virus-associated Cervical Cancer - A Systematic Review.
Niger Postgrad Med J. 2025;32:1-13.
Abstract
Longitudinal study on quality of life following cervical cancer treatment in
Botswana.
BMJ Glob Health. 2025;10:e017206.
Abstract
The association of different body weight classes and survival outcomes in
patients with cervical cancer.
Cancer Epidemiol. 2025;96:102801.
Abstract
Correction: Absence of EpCAM in cervical cancer cells is involved in slug induced
epithelial-mesenchymal transition.
Cancer Cell Int. 2025;25:96.
Abstract
Cervical cancer in pregnancy.
Semin Perinatol. 2025;49:152038.
Abstract
Gracilaria edulis-mediated silver nanoparticles as a targeted strategy for
cervical cancer with integrated toxicity evaluation in zebrafish.
Bioorg Chem. 2025;159:108361.
Abstract
Proteogenomic characterization of molecular and cellular targets for
treatment-resistant subtypes in locally advanced cervical cancers.
Mol Cancer. 2025;24:77.
Abstract
Postoperative adjuvant therapy for stage IA-IIA cervical adenocarcinoma (FIGO
2018) with one intermediate-risk factor: a multicentre retrospective cohort study
of 63,926 cases.
World J Surg Oncol. 2025;23:87.
Abstract
Apoptotic cell-derived extracellular vesicles-MTA1 confer radioresistance in
cervical cancer by inducing cellular dormancy.
J Transl Med. 2025;23:328.
Abstract
The fucoidan delivery system enhanced the anti-cervical cancer effect of caffeic
acid.
Int J Biol Macromol. 2025;307.
Abstract
Sexual Embodiment and Sexual Renegotiation Post-Cancer for LGBTQ People with a
Cervix.
Arch Sex Behav. 2025;54:1105-1120.
Abstract
A feasibility study of automating radiotherapy planning with large language model
agents.
Phys Med Biol. 2025;70.
Abstract
VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein
degradation.
Cell Chem Biol. 2025;32:423-433.
Abstract
Gynecologic Cancer Screening and Prevention: State of the Science and Practice.
Curr Treat Options Oncol. 2025;26:167-178.
Abstract
Clinician Characteristics Associated With Adoption of Updated National Colposcopy
Guidelines.
J Low Genit Tract Dis. 2025;29:153-160.
Abstract
A Mixed-Methods Study Examining Guideline-Concordant Colposcopy Practices Among a
National Cohort of US Colposcopists.
J Low Genit Tract Dis. 2025;29:161-167.
Abstract
A novel method for semi-quantitative detection of HPV16 and HPV18 mRNA with a
low-cost, open-source fluorimeter.
Anal Bioanal Chem. 2025;417:1765-1778.
Abstract
Safety of LEEP in Treating CIN 2-3 During Pregnancy.
J Low Genit Tract Dis. 2025;29:131-133.
Abstract
Benchmarking high-risk human papillomavirus testing against cytology and biopsy
results in the detection of cervical dysplasia to inform clinical screening
guidelines.
J Am Soc Cytopathol. 2025;14:86-90.
Abstract
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal
Human Papillomavirus Test Results: Enduring Guidelines.
J Low Genit Tract Dis. 2025;29:134-143.
Abstract
Neighborhood Factors Related to Cancer Screening in Texas: A Spatioecological
Study.
Am J Prev Med. 2025;68:695-706.
Abstract
Evaluating the Benefits of Endocervical Curettage in Women Infected With
HPV16/18.
J Low Genit Tract Dis. 2025;29:111-117.
Abstract
Case-Control Study of Cervicovaginal Beta-/Gamma-HPV Infection in Women with HIV
and Its Relation with Incident Cervical Precancer.
J Infect Dis. 2024 Nov 27:jiae588. doi: 10.1093.
Abstract
Longer travel times to acute hospitals are associated with lower likelihood of
cancer screening receipt among rural-dwelling adults in the U.S. South.
Cancer Causes Control. 2025;36:297-308.
Abstract
Potential mechanisms of ZiGongDing in treating HPV-induced cervical
intraepithelial neoplasia: a network pharmacology and experimental verification
study.
Naunyn Schmiedebergs Arch Pharmacol. 2025;398:3027-3036.
Abstract
RING box protein-1 promotes the metastasis of cervical cancer through regulating
matrix metalloproteinases via PI3K/AKT signaling pathway.
J Mol Histol. 2025;56:120.
Abstract
New insights into tumor microenvironment and HPV integrations in cervical cancer
pathogenesis revealed by single-cell transcriptome data.
Hum Mol Genet. 2025 Mar 27:ddaf027. doi: 10.1093.
Abstract
Recommendations for a Communication Strategy to Support Informed Decision-Making
About Self or Clinician Sampling for Cervical Screening in the UK: Qualitative
Study.
Health Expect. 2025;28:e70191.
Abstract
Integrated Machine Learning Algorithms-Enhanced Predication for Cervical Cancer
from Mass Spectrometry-Based Proteomics Data.
Bioengineering (Basel). 2025;12:269.
Abstract
The Interplay Between Cervicovaginal Microbiota Diversity, Lactobacillus Profiles
and Human Papillomavirus in Cervical Cancer: A Systematic Review.
Healthcare (Basel). 2025;13:599.
Abstract
Neutrophil/Lymphocyte Ratio (NLR) as a Predictive Marker for p16 Positivity and
Cervical Cancer Progression: Insights from the SCOPE Study.
Cancers (Basel). 2025;17:921.
Abstract
Risk factors of human papillomavirus-related cervical lesions in postmenopausal
women: a cross-sectional study.
BMC Womens Health. 2025;25:143.
Abstract
Cervical cancer prevention behaviors in young Black women.
Womens Health (Lond). 2025;21:17455057251326008.
Abstract
Patterns of Different Cervical Cytokine Expression in High-Risk Human
Papillomavirus-Infected Patients With Cervical Cancer and Its Precancerous
Lesions.
Clin Med Insights Oncol. 2025;19:11795549251316767.
Abstract
Nomogram prediction of the lymph-vascular space invasion in cervical cancer:
comparison of 2009 and 2018 staging systems.
Front Oncol. 2025;15:1505512.
Abstract
Interventional study on cervical cancer health literacy among Anganwadi
teachers-An interprofessional approach.
J Educ Health Promot. 2025;14:63.
Abstract
Interpretable artificial intelligence (AI) for cervical cancer risk analysis
leveraging stacking ensemble and expert knowledge.
Digit Health. 2025;11:20552076251327945.
Abstract
The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence
or Persistence of Cervical Cancer.
Viruses. 2025;17:409.
Abstract
Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and
Risk Stratification in Prevention and Treatment.
Life (Basel). 2025;15:367.
Abstract
Phytochemical Characterization and Anticancer Activity of Clerodendrum chinense
Leaf Extract Against Breast and Cervical Cancer Cells.
Int J Mol Sci. 2025;26:2729.
Abstract
CT83 Promotes Cancer Progression by Upregulation of PDL1 in Adenocarcinoma of the
Cervix.
Int J Mol Sci. 2025;26:2687.
Abstract
Thieno[2,3-b]pyridines as a Novel Strategy Against Cervical Cancer: Mechanistic
Insights and Therapeutic Potential.
Int J Mol Sci. 2025;26:2651.
Abstract
NF-kappaB Activation Is Essential for Cervical Cell Proliferation and Malignant
Transformation.
Int J Mol Sci. 2025;26:2493.
Abstract
TGF-beta Induces the Secretion of Extracellular Vesicles Enriched with CD39 and CD73
from Cervical Cancer Cells.
Int J Mol Sci. 2025;26:2413.
Abstract
Impact of HPV test results and emotional responses on psychosocial burden among
Taiwanese women: a cross-sectional study.
BMC Womens Health. 2025;25:142.
Abstract
APOC1, transcriptionally regulated by FOXM1, promotes M2 macrophage polarization
and cervical cancer progression.
Mutat Res. 2025;830:111904.
Abstract
Epidemiological Profile of HPV Genotypes Among Moroccan Women with High-Grade
Squamous Lesions and Invasive Cervical Cancer from Souss-Massa Region.
Trop Med Infect Dis. 2025;10:61.
Abstract
Unlocking the Interactions Between the Whole-Body Microbiome and HPV Infection: A
Literature Review.
Pathogens. 2025;14:293.
Abstract
Longitudinal Assessment of Fatigue in Pregnancy Complicated by Cervical Cancer: A
Prospective Case Study and Implications for Nursing and Midwifery Practice.
Nurs Rep. 2025;15:108.
Abstract
Discussion of a Simple Method to Generate Descriptive Images Using Predictive
ResNet Model Weights and Feature Maps for Recurrent Cervix Cancer.
Tomography. 2025;11:38.
Abstract
Trachelectomy and Cerclage Placement as Fertility-Sparing Surgery for Cervical
Cancer-An Expert Survey.
J Pers Med. 2025;15:77.
Abstract
Aptamer-Based Graphene Field-Effect Transistor Biosensor for Cytokine Detection
in Undiluted Physiological Media for Cervical Carcinoma Diagnosis.
Biosensors (Basel). 2025;15:138.
Abstract
Quality of Life and Stress-Related Psychological Distress Among Patients with
Cervical Cancer: A Cross-Sectional Analysis.
Diseases. 2025;13:70.
Abstract
A Systematic Review of SBRT Boost for Cervical Cancer Patients Who Cannot Benefit
from Brachytherapy.
Curr Oncol. 2025;32:170.
Abstract
COVID-19 Pandemic Impact on Delays in Diagnosis and Treatment for Cervical Cancer
in Montreal, Canada.
Curr Oncol. 2025;32:147.
Abstract
Clinical Impact of MRI-Guided Intracavitary-Interstitial Brachytherapy in the
Curative Management of Advanced-Stage Cervical Cancer.
Curr Oncol. 2025;32:136.
Abstract
HPV and Cervical Cancer-Biology, Prevention, and Treatment Updates.
Curr Oncol. 2025;32:122.
Abstract
Secular trend of cervical cancer mortality in Brazil and regions.
Cien Saude Colet. 2025;30:e09962023.
Abstract
Elucidating the Molecular Mechanisms of Hederagenin-Regulated Mitophagy in
Cervical Cancer SiHa Cells through an Integrative Approach Combining Proteomics
and Advanced Network Association Algorithm.
J Proteome Res. 2025 Mar 26. doi: 10.1021/acs.jproteome.5c00022.
Abstract
Incidence of cervical intraepithelial neoplasia and cervical cancer in
transmasculine and gender diverse individuals using testosterone: a
retrospective, single-centre cohort study.
EClinicalMedicine. 2025;80:103037.
Abstract
Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic
review and meta-analysis.
Front Immunol. 2025;16:1542850.
Abstract
Dataset of obesity in relation to female-specific cancers in middle eastern
countries, 1990 to 2016.
BMC Res Notes. 2025;18:124.
Abstract
Efficacy and acceptability of a self-collected medical grade tampon as a novel
vaginal sample collection tool for the detection of HPV and STIs.
BMC Womens Health. 2025;25:141.
Abstract
A community-focused cervical and breast cancer screening program using a
sustainable funding model in a training center in Ghana.
BMC Health Serv Res. 2025;25:428.
Abstract
A prospective study of vaginal topical pretreatment of compound sea-buckthorn oil
suppository in postmenopausal women prior to colposcopy.
Sci Rep. 2025;15:10364.
Abstract
Author Correction: Ginseng glucosyl oleanolate inhibit cervical cancer cell
proliferation and angiogenesis via PI3K/AKT/HIF-1alpha pathway.
NPJ Sci Food. 2025;9:40.
Abstract
TAB2 Promotes Immune Escape and Chemoresistance Through NF-kappaB Pathway Activation
in Cervical Cancer.
J Cell Mol Med. 2025;29:e70522.
Abstract
Randomised controlled trial evaluating the impact of different methods of HPV DNA
testing for cervical cancer screening in Singapore's primary care settings: a
study protocol.
BMJ Open. 2025;15:e095091.
Abstract
Different Patterns of the Relationship Between Gynecological Malignancy and
Obesity Index: A Nationwide Retrospective Cohort Study in Korea.
J Korean Med Sci. 2025;40:e31.
Abstract
General Practitioners' Needs and Preferences Regarding the Provision of
Self-sampling Tests for Cervical Cancer Screening in Flanders, Belgium.
J Prim Care Community Health. 2025;16:21501319251320178.
Abstract
The retinoblastoma protein contributes to maintaining the stability of HPV E7 in
cervical cancer cells.
J Virol. 2025 Mar 25:e0220324. doi: 10.1128/jvi.02203.
Abstract
Magnetic resonance imaging and ultrasound examination in preoperative pelvic
staging of early-stage cervical cancer: post-hoc analysis of SENTIX study.
Ultrasound Obstet Gynecol. 2025 Mar 25. doi: 10.1002/uog.29205.
Abstract
Case Report: SVF after chemoradiotherapy for cervical cancer diagnosed by
non-contact hysteroscopic technique.
Front Med (Lausanne). 2025;12:1511052.
Abstract
Effects of perioperative anesthetics on the postoperative prognosis of patients
undergoing surgery for cervical cancer.
Front Pharmacol. 2025;16:1536663.
Abstract
Added value of radiological staging to clinical examination in different
histopathological subtypes of uterine cervical cancer: A retrospective study.
Eur J Obstet Gynecol Reprod Biol X. 2025;26:100376.
Abstract
Chrysin Exhibits Selective Antiproliferative and Antimigratory Activities in a
Wide Range of Human-derived Cervical Cancer Cell Lines.
Anticancer Agents Med Chem. 2025.
Abstract
The participation in cervical cancer screening is not altered by the Hawthorne
effect among patients of doctors participating in the randomized clinical trial
PaCUDAHL.
BMC Res Notes. 2025;18:123.
Abstract
A deep learning model based on Mamba for automatic segmentation in cervical
cancer brachytherapy.
Sci Rep. 2025;15:10152.
Abstract
Correction: Curzerenone inactivates the nuclear factor-kappa B signaling to
suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B.
Hum Cell. 2025;38:77.
Abstract
Knowledge, Attitude, And Practices of The Educated Women of North India Toward
Cervical Cancer.
Indian J Community Med. 2025;50:202-206.
Abstract
TGF-beta-mediated activation of fibroblasts in cervical cancer: implications for
tumor microenvironment and prognosis.
PeerJ. 2025;13:e19072.
Abstract
Revolutionizing Cervical Cancer Screening: Self-Vaginal Sampling for Human
Papillomavirus Detection.
South Asian J Cancer. 2024;14:67-68.
Abstract
A Predictive Model Using Six Genes DNA Methylation Markers to Identify
Individuals With High Risks of High-Grade Squamous Intraepithelial Lesions and
Cervical Cancer.
Int J Womens Health. 2025;17:739-749.
Abstract
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced
Cervical Cancer.
Med Sci Monit. 2025;31:e945964.
Abstract
Social influences on Moroccan and Pakistani immigrant women's access and use of
cervical cancer screening in Catalonia, Spain: a social network analysis.
BMC Womens Health. 2025;25:136.
Abstract
The role of serum inflammatory markers in determining the severity of cervical
lesions.
J Obstet Gynaecol Res. 2025;51:e16278.
Abstract
Long noncoding RNAs and HPV-related cervical cancer: Uncovering molecular
mechanisms and clinical applications.
Transl Oncol. 2025;55:102363.
Abstract
Interstitial-guided automatic clinical tumor volume segmentation network for
cervical cancer brachytherapy.
Comput Med Imaging Graph. 2025;123:102520.
Abstract
Computed tomography-based radiomics modeling to predict patient overall survival
in cervical cancer with intensity-modulated radiotherapy combined with concurrent
chemotherapy.
J Int Med Res. 2025;53:3000605251325996.
Abstract
Based on network pharmacology and molecular docking technology to explore the
pharmacodynamic components and mechanism of Gynostemmae Pentaphylli Herba
reversing Cervical intraepithelial neoplasia.
BMC Complement Med Ther. 2025;25:112.
Abstract
Exploring cervical cancer screening awareness, beliefs, barriers, and practices
among indonesian muslim women in Japan: a qualitative study.
BMC Public Health. 2025;25:1084.
Abstract
ARRB2 promotes cervical cancer progression via stabilizing CDC25A mRNA through
m6A-IGF2BP1-dependent manner.
NPJ Precis Oncol. 2025;9:80.
Abstract
Circular RNA Circ_0002762 promotes cell migration and invasion in cervical
squamous cell carcinoma via activating RelA/nuclear factor kappa B (Nf-kB)
signalling pathway.
RNA Biol. 2025;22:1-13.
Abstract
Independent verification system for intracavitary brachytherapy based on a
reference plan and statistical model.
J Radiat Res. 2025;66:176-184.
Abstract
Decreasing participation in Dutch population-based cancer screening programs:
Trends from 2018 to 2022.
Prev Med. 2025;193:108257.
Abstract
Comparison of Topical 5-Aminolevulinic Acid Photodynamic Therapy With the Loop
Electrosurgical Excision Procedure for Patients With Cervical High-Grade Squamous
Intraepithelial Neoplasia: A Prospective and Propensity-Matched Analysis.
Lasers Surg Med. 2025;57:276-283.
Abstract
Initial experience with the Carina platform in robotic-assisted hysterectomy for
gynecological malignant disease.
Surg Endosc. 2025;39:2346-2353.
Abstract
Comparison of photodynamic therapy and LEEP in women of reproductive age with
cervical squamous intraepithelial neoplasia 2 (CIN2): A prospective observational
study in China.
Photodiagnosis Photodyn Ther. 2025;52:104496.
Abstract
Knowledge, attitudes and practices of women regarding breast and cervical cancer
screening: a qualitative study in India.
Glob Public Health. 2025;20:2467785.
Abstract
A gene-based predictive model for lymph node metastasis in cervical cancer:
superior performance over imaging techniques.
J Transl Med. 2025;23:397.
Abstract
Socioeconomic inequalities in cervical cancer screening practices in Vietnam: a
decomposition analysis.
BMC Public Health. 2025;25:1253.
Abstract
Urodynamic assessment and proteomic analysis of lower urinary tract dysfunction
following nerve-sparing radical hysterectomy.
Sci Rep. 2025;15:11474.
Abstract
Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid
biopsy.
Sci Rep. 2025;15:11480.
Abstract
Worldwide burden of cervical human papillomavirus (HPV) in women over 50 years
with abnormal cytology: a systematic review and meta-analysis.
BMJ Glob Health. 2025;10:e017309.
Abstract
Viral integration and fusion transcript characteristics of possibly high-risk HPV
in cervical cancer.
Infect Genet Evol. 2025 Apr 1:105746. doi: 10.1016/j.meegid.2025.105746.
Abstract
GATA2 promotes cervical cancer progression under the transcriptional activation
of TRIP4.
Cell Signal. 2025 Apr 1:111778. doi: 10.1016/j.cellsig.2025.111778.
Abstract
Barriers to cervical cancer screening and the potential role of HPV selfsampling
in Singapore: A cross-sectional study.
Ann Acad Med Singap. 2025;54:192-194.
Abstract
Human papillomavirus vaccination in rural Malawi: Identifying factors associated
with vaccine uptake using a community-based household survey.
Hum Vaccin Immunother. 2025;21:2485651.
Abstract
Increasing the Uptake of Breast and Cervical Cancer Screening Via the MAwar
Application: Stakeholder-Driven Web Application Development Study.
JMIR Form Res. 2025;9:e65542.
Abstract
RETRACTION: Fibronectin Promotes Cervical Cancer Tumorigenesis Through Activating
FAK Signaling Pathway.
J Cell Biochem. 2025;126:e70022.
Abstract
Etiological Factors and Development of a Predictive Model for Urinary Tract
Infections in Cervical Cancer Patients Undergoing Intensity-Modulated
Radiotherapy.
Infect Drug Resist. 2025;18:1637-1645.
Abstract
[Analysis of human papillomavirus subtype distribution and cervical lesion
characteristics in a cancer hospital in Shenzhen City].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:490-494.
Abstract
[Health economics evaluation of vaccination strategies for different human
papillomavirus vaccines for 12-year-old female adolescents in China].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:425-432.
Abstract
Urologic Fistulas in Czech Women With Gynaecologic Malignancies.
Cancer Rep (Hoboken). 2025;8:e70134.
Abstract
Shifting HPV-cancer burden: from cervical cancer to oropharyngeal cancer.
Infect Agent Cancer. 2025;20:21.
Abstract
A rare case of Alveolar Soft-Part Sarcoma in the Uterine cervix.
Diagn Pathol. 2025;20:33.
Abstract
Barriers, facilitators, needs, and preferences in seeking information regarding
cervical cancer prevention programs among Turkish, Moroccan, and Syrian immigrant
women: a scoping review.
BMC Public Health. 2025;25:1242.
Abstract
The inferred modulation of correlated vaginal microbiota and metabolome by
cervical differentially expressed genes across distinct CIN grades.
BMC Microbiol. 2025;25:189.
Abstract
RETRACTION: Effect of Minimally Invasive Surgery and Laparotomy on Wound
Infection and Postoperative and Intraoperative Complications in the Management of
Cervical Cancer: A Meta-Analysis.
Int Wound J. 2025;22:e70467.
Abstract
RETRACTION: Best Practices for Managing Malodorous and Infected Wounds in
Advanced Cervical Cancer.
Int Wound J. 2025;22:e70486.
Abstract
Cervical Cancer. Reply.
N Engl J Med. 2025;392:1351.
Abstract
Cervical Cancer.
N Engl J Med. 2025;392:1350-1351.
Abstract
Cervical Cancer.
N Engl J Med. 2025;392:1350.
Abstract
Cervical Cancer.
N Engl J Med. 2025;392:1349-1350.
Abstract
Barriers and facilitators to a combined strategy of HPV vaccination and cervical
cancer screening among Mexican women.
Hum Vaccin Immunother. 2025;21:2483018.
Abstract
Evaluating TGF-beta1 gene expression and promoter polymorphism in cervical cancer
progression.
J Mol Histol. 2025;56:126.
Abstract
The Burden of HPV Infections and HPV-Related Diseases Among People With HIV: A
Systematic Literature Review.
J Med Virol. 2025;97:e70274.
Abstract
Outcomes and patterns of recurrence of robot?assisted or laparoscopic radical
hysterectomy in early?stage cervical cancer.
Mol Clin Oncol. 2025;22:43.
Abstract
A novel skeletal muscle quantitative method and deep learning-based sarcopenia
diagnosis for cervical cancer patients treated with radiotherapy.
Med Phys. 2025 Apr 1. doi: 10.1002/mp.17791.
Abstract
Cultural and Linguistic Adaptation of an Evidence-Based Tailored Navigation
Intervention to Increase Cancer Screening Uptake Among Southeast Asian Women.
Cancer Control. 2025;32:10732748251329867.
Abstract
SiaQuant Unveils Serum alpha2,3/alpha2,6 Sialylation Heterogeneities and Predicts
Neoadjuvant Chemotherapy Response in Locally Advanced Cervical Cancer.
Anal Chem. 2025 Apr 1. doi: 10.1021/acs.analchem.4c04952.
Abstract
Serum soluble Tim?3 is elevated in patients with cervical cancer and is higher in
advanced clinical stages.
Biomed Rep. 2025;22:90.
Abstract
Bioinformatics and experimental approach reveal potential prognostic and
immunological roles of key mitochondrial metabolism-related genes in cervical
cancer.
Front Oncol. 2025;15:1522910.
Abstract
Inhibition of p16 and NF-kappaB Oncogenic Activity in Human Papillomavirus-Infected
Cervical Cancer Cells: A New Role for Activating Transcription Factor-3.
Yale J Biol Med. 2025;98:21-32.
Abstract
Knowledge and awareness of cervical cancer and prevention measures among female
students in Poland: a cross-sectional, decade apart study.
J Gynecol Oncol. 2025;36:e23.
Abstract
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical
cancer with suspicious lymph nodes on imaging: a retrospective cohort study.
J Gynecol Oncol. 2025;36:e16.
Abstract
Prognostic implications of tumor volume reduction during radiotherapy in locally
advanced cervical cancer: a risk-stratified analysis.
Radiat Oncol. 2025;20:47.
Abstract
AI-Based Identification Method for Cervical Transformation Zone Within Digital
Colposcopy: Development and Multicenter Validation Study.
JMIR Cancer. 2025;11:e69672.
Abstract
Association of long-term treatment outcomes with changes in PET/MRI
characteristics and the type of early treatment response during concurrent
radiochemotherapy in patients with locally advanced cervical cancer.
Strahlenther Onkol. 2025 Mar 31. doi: 10.1007/s00066-025-02389.
Abstract
Dermatomyositis as a Paraneoplastic Syndrome in Cases of Aggressive Cervical
Cancer.
Cureus. 2025;17:e79838.
Abstract
Effects of perioperative oxycodone as the sole opioid on immunity within a
multi-modal analgesia framework in patients undergoing cervical cancer surgery: A
randomised controlled trial.
Indian J Anaesth. 2025;69:191-199.
Abstract
DNA methyltransferase 1/miR-342-3p/Forkhead box M1 signaling axis promotes
self-renewal in cervical cancer stem-like cells in vitro and nude mice models.
World J Stem Cells. 2025;17:99472.
Abstract
Research hotspots and trends in the field of immune checkpoint inhibitors (ICIs)
for cervical cancer: A bibliometric study from 2014 to 2024.
Hum Vaccin Immunother. 2025;21:2483031.
Abstract
[Advances of targeting EZH2 in gynecological malignancies].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:236-240.
Abstract
[Value of high-risk HPV viral load in cervical cancer screening and triage: a
real world retrospective study based on cervical cancer screening program in
Quanzhou, China].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:193-201.
Abstract
[Advances in cytopathology in China over the past ten years: retrospect and
prospect].
Zhonghua Bing Li Xue Za Zhi. 2025;54:341-347.
Abstract
Activation of TRIM37 by ATF6 and degradation of ACSL4: inhibiting ferroptosis and
propelling cervical cancer progression.
Hereditas. 2025;162:47.
Abstract
An integrated approach of transcriptomics, network pharmacology and molecular
docking uncovers the mechanisms of 5,6,7,4'-tetramethoxyflavone in treating
cervical cancer.
Biochem Biophys Res Commun. 2025;760:151611.
Abstract
Alternative use of droxidopa for treating cervical cancer: inhibiting
transferase, cell cycle signalling, and transport proteins via multitarget
docking, DFT, MD simulations, and binding free energy studies.
Med Oncol. 2025;42:143.
Abstract
Evolution and future of cervical cancer screening: from cytology to primary HPV
testing and the impact of vaccination.
Expert Rev Mol Diagn. 2025 Apr 4:1-8. doi: 10.1080/14737159.2025.2486653.
Abstract
Investigating the Potential Synergistic Effects of Turmeric Extract and Black
Rice Bran as Cytotoxic Agents Against HeLa Cells.
Asian Pac J Cancer Prev. 2025;26:1059-1067.
Abstract
Designing and Implementing a Cancer Screening Program for Underserved Tribal
Women in Jharkhand.
Asian Pac J Cancer Prev. 2025;26:977-984.
Abstract
Disparities in the Uptake of Cervical Cancer Screening in Kuwait: A
Cross-Sectional Analysis of the Nationwide WHO STEPS Survey.
Asian Pac J Cancer Prev. 2025;26:861-868.
Abstract
Role of Cyclooxygenase-2 (COX-2) Expression as a Prediction of Persistent
Cervical Low Grade Squamous Intraepithelial Lesion (LSIL).
Asian Pac J Cancer Prev. 2025;26:791-797.
Abstract
Counselling to Screening: Honing an Institutional Cervical Cancer Screening
Program.
Asian Pac J Cancer Prev. 2025;26:785-789.
Abstract
Role of SNHGs in Adverse Prognostic Factors in Cervical Cancer: A Systematic
Review.
Asian Pac J Cancer Prev. 2025;26:735-741.
Abstract
Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients
With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based
Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study
(JORTC-KMP03).
Integr Cancer Ther. 2025;24:15347354251329346.
Abstract
Optimizing the Follow-Up Interval After Successful Cold Knife Conization of CIN3:
A 10-Year Retrospective Cohort Study.
Cancer Med. 2025;14:e70825.
Abstract
Prevalence and risk factors of high-risk HPV and cervical abnormalities in
HIV-positive women in Bali, Indonesia.
BMC Infect Dis. 2025;25:432.
Abstract
Asking About Cervical Cancer Screening in National Surveys: Implications for
Health Literacy and Research.
Am J Prev Med. 2025 Mar 26:S0749-3797(25)00103.
Abstract
Role of Race, Rurality, and Age in Human Papillomavirus Vaccine Initiation among
US Women.
South Med J. 2025;118:206-210.
Abstract
Keratinocyte-derived extracellular vesicles induce macrophage polarization toward
an M1-like phenotype.
Biochem Biophys Res Commun. 2025;758:151659.
Abstract
Light scattering imaging modal expansion cytometry for label-free single-cell
analysis with deep learning.
Comput Methods Programs Biomed. 2025;264:108726.
Abstract
Prevention and control of HPV-related cancers in people living with HIV.
Lancet HIV. 2025;12:e293-e302.
Abstract
HMIL: Hierarchical Multi-Instance Learning for Fine-Grained Whole Slide Image
Classification.
IEEE Trans Med Imaging. 2025;44:1796-1808.
Abstract
Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for
Early-Stage Endometrial and Cervical Cancers.
AJR Am J Roentgenol. 2025 Jan 8. doi: 10.2214/AJR.24.32157.
Abstract
Further confirmation of a highly prognostic grading scheme based upon tumour
budding and cell cluster size in cervical squamous cell carcinoma.
Histopathology. 2025;86:967-978.
Abstract
Triage performance of DNA methylation for women with high-risk human
papillomavirus infection.
Oncologist. 2025;30:oyae324.
Abstract
Development and validation of the competing risk nomogram and risk classification
system for predicting cancer-specific mortality in patients with cervical
adenosquamous carcinoma treated via radical hysterectomy.
Biomol Biomed. 2025;25:1099-1110.
Abstract
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in
Self-Collected Urine and Vaginal Samples from Japanese Women.
Gynecol Obstet Invest. 2025;90:143-152.
Abstract
HLTF/SERPINE1 Axis Plays a Crucial Pro-Oncogenic Role in the Progression from
Cervical Precancerous Lesions to Cervical Carcinoma in vitro.
Gynecol Obstet Invest. 2025;90:108-119.
Abstract
Availability and Uptake of Cervical Cancer Screening and Treatment Services at 19
Kenyan Health Facilities: A Brief Report.
JCO Glob Oncol. 2025;11:e2400255.
Abstract
Unpacking cervical cancer stigma in healthcare: lessons learnt from Indonesian
patients and health professionals.
Cult Health Sex. 2025 Apr 11:1-16. doi: 10.1080/13691058.2025.2488036.
Abstract
PMDA regulatory update on approval and revision of the precautions for use of
anticancer drugs; approval of amivantamab plus lazertinib for non-small cell lung
cancer, durvalumab for small cell lung cancer, tislelizumab for esophageal
cancer, tisotuma
Int J Clin Oncol. 2025 Apr 11. doi: 10.1007/s10147-025-02758.
Abstract
A rare case of synchronous cervical squamous cell carcinoma and invasive ductal
carcinoma of breast.
J Cancer Res Ther. 2025;21:281-283.
Abstract
Positron emission tomography versus computed tomography -guided intracavitary
brachytherapy for locally advanced cervical cancer: A prospective randomized
study.
J Cancer Res Ther. 2025;21:151-155.
Abstract
The current status of cervical cancer awareness and HPV Vaccination among rural
women of India: An impediment to the WHO cervical cancer elimination initiative.
J Cancer Res Ther. 2025;21:57-63.
Abstract
Determination of Human Papillomavirus Serotypes in Endocervical Samples from
Patients with Normal Cytology from a Mexican Population by Polymerase Chain
Reaction-restriction Fragment Length Polymorphism.
Indian J Public Health. 2025;69:115-118.
Abstract
Insufficient resources for cervical cancer in Pakistan: a significant burden on
public health.
Ann Med Surg (Lond). 2025;87:1114-1116.
Abstract
The effects of human papillomavirus vaccination in Japan.
Hum Vaccin Immunother. 2025;21:2489301.
Abstract
Withaferin A combined with ricolinostat: a potent synergistic therapy for
cervical cancer through regulating p53 ubiquitination and acetylation.
Acta Biochim Biophys Sin (Shanghai). 2025 Apr 10. doi: 10.3724/abbs.2025048.
Abstract
Wealth-related inequalities of women's cervical cancer screening in 11
Sub-Saharan African countries: evidence from a pooled decomposition analysis.
Sci Rep. 2025;15:12289.
Abstract
FDA-approved Levophed as an alternative multitargeted therapeutic against
cervical cancer transferase, cell cycle, and regulatory proteins.
Comput Biol Med. 2025;191:110163.
Abstract
Increasing HPV and Cervical Cancer Education Among Native American Communities
and Healthcare Providers.
J Cancer Educ. 2025 Apr 10. doi: 10.1007/s13187-025-02619.
Abstract
Implementing High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer
Screening in Ghana: A Study (CarciSCAN) Protocol.
Cancer Control. 2025;32:10732748251330698.
Abstract
Promising outcomes of the PD-L1 inhibitor Socazolimab in recurrent and metastatic
cervical cancer: a case report.
Front Oncol. 2025;15:1541760.
Abstract
Trusted health system implementation strategies to increase vaccination (TRUE
SYNERGI): a stepped-wedge cluster randomized trial to reduce HPV-related cancers.
BMC Public Health. 2025;25:1331.
Abstract
Cervical cancer screening data from the case-based national electronic registry
in Bangladesh.
BMC Glob Public Health. 2025;3:34.
Abstract
Identification of immune-related cervical cancer prognostic biomarkers and
construction of prognostic model based on tumor microenvironment.
Eur J Med Res. 2025;30:261.
Abstract
Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of
progression, resistance, and emerging therapeutic strategies.
Gene. 2025 Apr 7:149467. doi: 10.1016/j.gene.2025.149467.
Abstract
Diagnostic Accuracy of the Siriraj Portable Digital Cervicography Device Versus
Standard Colposcopy for Detecting CIN2(+) Lesions.
J Med Virol. 2025;97:e70339.
Abstract
SORBS3-beta suppresses lymph node metastasis in cervical cancer by promoting the
ubiquitination of beta-catenin.
J Transl Med. 2025;23:406.
Abstract
Achieving flexible fairness metrics in federated medical imaging.
Nat Commun. 2025;16:3342.
Abstract
Factors associated with bilateral sentinel lymph node mapping failure using
indocyanine green in patients with apparent early-stage cervical cancer: An
Italian retrospective multi-center study.
Eur J Surg Oncol. 2025;51:109981.
Abstract
[Ectopic ACTH secretion by neuroendocrine carcinoma of the uterine cervix].
Medicina (B Aires). 2025;85:439-444.
Abstract
Vine copula mixed models for meta-analysis of diagnostic accuracy studies without
a gold standard.
Biometrics. 2025;81:ujaf037.
Abstract
A Randomized Control Trial of Two Interventions Compared to Usual Care for
Increasing Cervical Cancer Screening Among Women Living in the Rural Midwest.
Cancer Epidemiol Biomarkers Prev. 2025 Apr 8. doi: 10.1158/1055-9965.EPI-24-0971
Abstract
ATP13A2 as a prognostic biomarker and its correlation with immune infiltration in
cervical cancer: A retrospective study.
J Cell Mol Med. 2025;29:e70097.
Abstract
Identification of N6-methyladenosine-associated ferroptosis biomarkers in
cervical cancer.
Hereditas. 2025;162:53.
Abstract
Factors that contribute to women's reluctance to undergo cervical cancer
screening in clinics of Limpopo Province, South Africa.
BMC Public Health. 2025;25:1303.
Abstract
The long noncoding RNA CCDC144NL-AS1: prognosis significance and potential
biological functions in cervical carcinoma.
J Obstet Gynaecol. 2025;45:2463416.
Abstract
Using Machine Learning to Predict the Prognosis of Cervical Cancer Patients with
Lymph Node Metastasis: An Analysis Based on the SEER Database.
Reprod Sci. 2025 Apr 7. doi: 10.1007/s43032-025-01856.
Abstract
High-risk HPV prevalence in the Czech cervical cancer screening population: a
comparison of clinician-collected and self-collected sampling.
Eur J Public Health. 2025 Apr 7:ckaf045. doi: 10.1093.
Abstract
METTL3-mediated m6A modification of PAK6 drives cervical cancer progression
through activating MAPK14.
Int J Biol Macromol. 2025;309.
Abstract
Screening and identification analysis of core markers for leukemia and cervical
cancer: Calmodulin 3 as a core target.
Medicine (Baltimore). 2025;104:e41665.
Abstract
Genetic analysis of HPV-16 L1 gene mutations and computational screening of
therapeutic inhibitors for cervical cancer treatment.
Med Oncol. 2025;42:153.
Abstract
Advances in Cervical Cancer Diagnostics Based on Immunosensors: Innovative
Approaches and Tumor Biomarkers.
Curr Top Med Chem. 2025 Apr 4. doi: 10.2174/0115680266366335250314081522.
Abstract
miR-627-5p inhibits malignant progression of cervical cancer by targeting
ANGPTL4.
Eur J Histochem. 2025;69.
Abstract
Omics sciences for cervical cancer precision medicine from the perspective of the
tumor immune microenvironment.
Oncol Res. 2025;33:821-836.
Abstract
Efficacy of HPV E6/E7 mRNA assay, HPV DNA test and cytology in detection of high
grade cervical lesions and invasive cancer at a tertiary care center in India.
Malawi Med J. 2024;36:120-127.
Abstract
First Results for the Evaluation of the Cervical Cancer Screening Carried Out in
2021 and 2022 in the Context of the Organized Cancer Screening Program (oKFE):
Part 1 - Primary Screening.
Geburtshilfe Frauenheilkd. 2025;85:417-433.
Abstract
Evaluating the Implementation of fan-beam CT-guided online adaptive re-planning
in definitive cervical cancer radiotherapy.
Front Oncol. 2025;15:1509619.
Abstract
Oncogenic human papillomavirus infection (HPV 16/18) and associated factors among
women in East Gojjam Zone, NorthWest Ethiopia 2021.
Afr Health Sci. 2024;24:9-19.
Abstract
NDRG1/2 as a prognostic predictive biomarker of cervical cancer and its
correlation with immune infiltration.
Biomark Med. 2025 Apr 7:1-11. doi: 10.1080/17520363.2025.2483495.
Abstract
Society of Family Planning Clinical Recommendation: Contraceptive considerations
for individuals with cancer and cancer survivors part 2 - Breast, ovarian,
uterine, and cervical cancer.
Contraception. 2025 Mar 27:110867. doi: 10.1016/j.contraception.2025.110867.
Abstract
Advances in the Prevention of Cervical Cancer by Anti-Human Papillomavirus
Agents.
Cancer Med. 2025;14:e70847.
Abstract
Resveratrol interrupts Wnt/beta-catenin signalling in cervical cancer by activating
ten-eleven translocation 5-methylcytosine dioxygenase 1.
Cytokine. 2025;190:156930.
Abstract
Application of CT in predicting lymph node metastasis in cervical cancer and
construction of a preoperative nomogram.
Sci Rep. 2025;15:11674.
Abstract
The feasibility and acceptability of delivering and evaluating a physical
activity intervention (ACCEPTANCE) for cervical cancer survivors.
Pilot Feasibility Stud. 2025;11:42.
Abstract
Expression of REV7 has prognostic significance in cervical cancer treated with
intensity-modulated radiation therapy.
Discov Oncol. 2025;16:466.
Abstract
A Retrospective Observational Study on the Impact of Digital Strategies to Boost
Cervical Screening Uptake in Primary Care.
Cancer Control. 2025;32:10732748251330705.
Abstract
Exploring the role of cervicovaginal microbiota as risk factor for cervical
cancer in Sub-Saharan Africa: a systematic review and meta-analysis : By.
BMC Womens Health. 2025;25:160.
Abstract
Overcoming HPV vaccine hesitancy: insights from a successful school-based
vaccination campaign in the Saa health district of Cameroon.
BMC Infect Dis. 2025;25:465.
Abstract
Vaginal formulation development: A strategy based on aptamer-guided liposome for
human papillomavirus-induced lesions.
Eur J Pharm Biopharm. 2025;210:114693.
Abstract
IER3: exploring its dual function as an oncogene and tumor suppressor.
Cancer Gene Ther. 2025;32:450-463.
Abstract
[Cancer of the cervix management in Reunion Island from 2016 to 2020].
Bull Cancer. 2025;112:396-402.
Abstract
First-line treatment of locally advanced cervical carcinoma: An updated
systematic review and Bayesian network meta-analysis.
Cancer Treat Rev. 2025;135:102921.
Abstract
A theory-based educational intervention to increase mothers' intention to
vaccinate their daughters against human papillomavirus: A randomised controlled
trial.
Patient Educ Couns. 2025;135:108731.
Abstract
Cervical screening during pregnancy - a review of recommendations.
Ginekol Pol. 2025;96:220-224.
Abstract
Are there any sociodemographic factors associated with non-uptake of HPV
vaccination of girls in high-income countries with school-based vaccination
programmes? A systematic review.
J Epidemiol Community Health. 2025;79:388-396.
Abstract
ADAMDEC1 promotes cervical squamous cell carcinoma by enhancing the JAK/STAT
signaling pathway through modulation of TYMP.
Naunyn Schmiedebergs Arch Pharmacol. 2025;398:6009-6020.
Abstract
Impact of knowledge of HPV positivity on cervical cytology performance in latin
america.
J Natl Cancer Inst. 2024 Nov 12:djae283. doi: 10.1093.
Abstract
Adenoid basal carcinoma cervix - A rare epithelial neoplasm.
J Cancer Res Ther. 2025;21:226-229.
Abstract
Epigenome-wide differential methylation and differential variability as
predictors of high-grade cervical intraepithelial neoplasia (CIN2+).
Am J Epidemiol. 2025;194:1012-1022.
Abstract
Metastasis of Mixed Adenoneuroendocrine Carcinoma of the Uterine Cervix to
Thyroid Gland.
Ear Nose Throat J. 2025;104.
Abstract
RETRACTION: A Meta-Analysis Examining the Impact of Open Surgical Therapy versus
Minimally Invasive Surgery on Wound Infection in Females With Cervical Cancer.
Int Wound J. 2025;22:e70573.
Abstract
Cost-benefit analysis of p16(INK4a) immunocytology and liquid-based cytology
triage after primary HPV testing for cervical cancer screening in China.
Infect Agent Cancer. 2025;20:26.
Abstract
To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell
death.
Cancer Cell Int. 2025;25:153.
Abstract
A Hybrid Model-Based Clinicopathological Features and Radiomics Based on
Conventional MRI for Predicting Lymph Node Metastasis and DFS in Cervical Cancer.
J Imaging Inform Med. 2025 Apr 18. doi: 10.1007/s10278-024-01371.
Abstract
A prediction method for radiation proctitis based on SAM-Med2D model.
Sci Rep. 2025;15:13426.
Abstract
Associations of eHealth Literacy With Cervical Cancer and Human Papillomavirus
Awareness Among Women in Turkiye: A Cross-sectional Study.
Comput Inform Nurs. 2025 Apr 18. doi: 10.1097/CIN.0000000000001314.
Abstract
The Risk of Developing Cervical Cancer in the Elderly; Who Benefits From
Screening After the Age of 60?
J Low Genit Tract Dis. 2025 Apr 18. doi: 10.1097/LGT.0000000000000893.
Abstract
Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent,
or metastatic cervical cancer: a cost-effectiveness analysis.
Front Immunol. 2025;16:1562875.
Abstract
Charged multivesicular body protein 4C promotes the progression of cervical
cancer through the HPV E6/miR?543 axis.
Oncol Lett. 2025;29:275.
Abstract
Developing and validating key performance indicators for breast, cervical, and
colorectal cancer screening programs: a literature review and Delphi survey.
Front Public Health. 2025;13:1491226.
Abstract
After Radical Trachelectomy: Reproductive and Obstetrical Outcomes of
Fertility-Sparing Surgery for Cervical Cancer.
Semin Reprod Med. 2025 Apr 17. doi: 10.1055/s-0045-1808092.
Abstract
Targeting Signaling Excitability in Cervical and Pancreatic Cancer Cells Through
Combined Inhibition of FAK and PI3K.
Int J Mol Sci. 2025;26:3040.
Abstract
Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to
Radiotherapy in Cervical Carcinoma.
Int J Mol Sci. 2025;26:2829.
Abstract
Patterns of Co-infection of HPV52 With Other HPV Genotypes and Their Risks of
Cervical Precancer and Carcinoma.
J Med Virol. 2025;97:e70312.
Abstract
'Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer
in-vitro model by targeting the AKT-USP15/USP11-HPV16 E6/E7 axis.
Biochem Biophys Rep. 2025;42:101987.
Abstract
Minimally invasive surgery for cervical cancer.
Oncol Lett. 2025;29:281.
Abstract
Mass Media Exposure and Cervical Cancer Screening in Rural Sub-Saharan Africa: A
Multi-Country Cross-Sectional Analysis.
Health Sci Rep. 2025;8:e70663.
Abstract
Reasons for not undergoing cervical cancer screening: perspectives from women and
health care providers in Addis Ababa: a qualitative study.
Front Oncol. 2025;15:1456804.
Abstract
Construction of the preoperative staging prediction model for cervical cancer
based on deep learning and MRI: a retrospective study.
Front Oncol. 2025;15:1557486.
Abstract
Thymopoietin-alpha, -beta, and -gamma Isoforms Increased Expression in Cervical Cancer
Cells.
Can J Infect Dis Med Microbiol. 2025;2025:1668482.
Abstract
Epinephrine augments the phosphorylation of EGFR and promote the DNA synthesis
and migration of cervical cancer cells.
3 Biotech. 2025;15:125.
Abstract
Gastrin-releasing peptide receptor: a promising new biomarker to identify
cervical precursor lesions and cancer.
Rev Bras Ginecol Obstet. 2025;47:e-rbgo4.
Abstract
Mycosubtilin Induces G1 Phase Block and Autophagy in Cervical Cancer HeLa Cells.
Probiotics Antimicrob Proteins. 2025 Apr 17. doi: 10.1007/s12602-025-10534.
Abstract
Regional differences in the disease burden and attributable risk factors of
female cancers.
Sci Rep. 2025;15:13092.
Abstract
Exploring the mechanism of Bruceine D against cervical cancer by network
pharmacology and the effect of Bruceine D on the EGFR pathway.
J Pharm Biomed Anal. 2025;262:116887.
Abstract
Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in
cervical cancer.
Transl Oncol. 2025;56:102396.
Abstract
HPV Self-Sampling Promotion Among African American (AA) and Sub-Saharan African
(SAI) Immigrant Women: Adaptation and Usability Testing.
Int J Environ Res Public Health. 2025;22:317.
Abstract
Trends in Medicare payments within the first year of cervical cancer diagnosis,
2010-2019.
JNCI Cancer Spectr. 2025 Apr 16:pkaf043. doi: 10.1093.
Abstract
Endovaginal coil combined with pelvic array coil magnetic resonance imaging for
the preoperative staging of cervical cancer.
Quant Imaging Med Surg. 2025;15:3189-3197.
Abstract
Erratum: [Corrigendum] Calcium efflux from the endoplasmic reticulum regulates
cisplatin?induced apoptosis in human cervical cancer HeLa cells.
Oncol Lett. 2025;29:274.
Abstract
SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1.
Hum Cell. 2025;38:88.
Abstract
Rapidly progressive pneumonitis days after receiving tisotumab vedotin: a new
antibody-drug conjugate.
BMJ Case Rep. 2025;18:e264150.
Abstract
Development and validation of ADC-based nomogram model for predicting the
prognostic factors in preoperative clinical early-stage cervical cancer patients.
Abdom Radiol (NY). 2025 Apr 15. doi: 10.1007/s00261-025-04944.
Abstract
Virome capture sequencing for comprehensive HPV genotyping in cervical samples.
Sci Prog. 2025;108:368504251334515.
Abstract
Factors that influence caregivers' and adolescents' views and practices regarding
human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence
synthesis.
Cochrane Database Syst Rev. 2025;4:CD013430.
Abstract
Comparative Study of Serum Malondialdehyde in Women with Cervical Cancer and
Women with High-Risk Human Papillomavirus Infection at The Lagos State University
Teaching Hospital, Lagos.
West Afr J Med. 2024;41:1120-1128.
Abstract
"The problem is not detection, it is treatment": exploring why women needing
pre-cervical cancer care are lost to follow-up at the hospital in Iquitos, Peru.
BMC Health Serv Res. 2025;25:544.
Abstract
The overtreatment rate, medical cost and psychological affection of see-and-treat
versus three-step approaches in the treatment of cervical intraepithelial
neoplasia: a systematic review and meta-analysis.
BMC Womens Health. 2025;25:179.
Abstract
A hybrid learning network with progressive resizing and PCA for diagnosis of
cervical cancer on WSI slides.
Sci Rep. 2025;15:12801.
Abstract
"Polish mothers and cervical cancer prophylaxis. What do they know and what
attitude do they have towards HPV vaccination?".
J Pediatr Adolesc Gynecol. 2025 Apr 12:S1083-3188(25)00239.
Abstract
Intestinal perforation in recurrent cervical cancer following bevacizumab and
pembrolizumab therapy: A case report.
Medicine (Baltimore). 2025;104:e40473.
Abstract
Role of Fascin-1 in cervical cancer metastasis via Wnt/beta-catenin pathway
activation.
Biomol Biomed. 2025 Mar 14. doi: 10.17305/bb.2025.12114.
Abstract
HPV-Related Knowledge and Impact of Patient-Provider Communication on
HPV-Associated Cervical Cancer Awareness and Pap Smear Completion in US Women
Aged 21-65 Years.
Cancers (Basel). 2025;17:1188.
Abstract
Retraction: "Mir-3150B-3P Inhibits the Proliferation and Invasion of Cervical
Cancer Cells by Targeting Tnfrsf11A".
J Investig Med. 2025 Apr 14:10815589251332430. doi: 10.1177/10815589251332430.
Abstract
Prediction of lymph node metastasis in cervical cancer patients using AdaBoost
machine learning model: analysis of risk factors.
Am J Cancer Res. 2025;15:1158-1173.
Abstract
Development and validation of a risk prediction model for lymph node metastasis
in stage IA2-IIA1 cervical cancer based on laboratory parameters.
Am J Cancer Res. 2025;15:1081-1095.
Abstract
Laparoscopic radical hysterectomy and pelvic lymph node dissection for early
cervical cancer effectively improves surgical efficacy.
Am J Transl Res. 2025;17:2103-2111.
Abstract
Cervical Cancer Screening Rates Among Chinese Women - China, 2023-2024.
China CDC Wkly. 2025;7:321-326.
Abstract
Arsenic enhances cervical cancer cell radiosensitivity by suppressing the DNA
damage repair pathway.
Transl Cancer Res. 2025;14:2078-2094.
Abstract
The impact of bladder volume on dosimetric outcomes in VMAT for cervical cancer
patients after surgery.
J Gynecol Oncol. 2025 Apr 8. doi: 10.3802/jgo.2025.
Abstract
A Chinese prospective cohort research developed and validated a risk prediction
model for patients with cervical cancer.
Cancer Cell Int. 2025;25:142.
Abstract
Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer
screening study in Mozambique.
Infect Agent Cancer. 2025;20:24.
Abstract
Deep learning enabled liquid-based cytology model for cervical precancer and
cancer detection.
Nat Commun. 2025;16:3506.
Abstract
[Calvary of cytology-based cervical screening in Hungary].
Orv Hetil. 2025;166:578-587.
Abstract
Effect of vaccination against HPV in the HPV-positive patients not covered by
primary prevention on the disappearance of infection.
Sci Rep. 2025;15:12642.
Abstract
5-Methylcytosine methylation predicts cervical cancer prognosis, shaping immune
cell infiltration.
J Int Med Res. 2025;53:3000605251328301.
Abstract
Assessment of Health Beliefs and Motivations for Cervical Cancer Screening.
Healthcare (Basel). 2025;13:804.
Abstract
TCR CDR3 chemical complementarity to HPV epitopes is associated with a better
outcome for cervical cancer.
Mamm Genome. 2025 Apr 11. doi: 10.1007/s00335-025-10127.
Abstract
Novel therapeutic strategies for targeting E6 and E7 oncoproteins in cervical
cancer.
Crit Rev Oncol Hematol. 2025;211:104721.
Abstract
Dysregulated circular RNA and long non-coding RNA-Mediated regulatory competing
endogenous RNA networks (ceRNETs) in ovarian and cervical cancers: A non-coding
RNA-Mediated mechanism of chemotherapeutic resistance with new emerging clinical
capacities
Arch Biochem Biophys. 2025;768:110389.
Abstract
Advanced MRI prediction model for anatomical site identification in uterine
carcinoma: enhancing diagnostic accuracy.
Clin Radiol. 2025;84:106852.
Abstract
Clinical validation of the Roche cobas HPV test on the Roche cobas 6800 system
for the purpose of cervical screening and qualification as a second-generation
comparator test.
J Virol Methods. 2025;335:115145.
Abstract
Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus
Prevalence.
J Infect Dis. 2025;231:e638-e649.
Abstract
Rearrangements of viral and human genomes at human papillomavirus integration
events and their allele-specific impacts on cancer genome regulation.
Genome Res. 2025;35:653-670.
Abstract
High burden of human papillomavirus and premalignant cervical lesions among women
starting HIV treatment in KwaZulu-Natal, South Africa.
Sex Transm Infect. 2025;101:187-190.
Abstract
Virtual Screening, Molecular Docking and Molecular Dynamics Simulation of
Bioactive Compounds from Various Indonesian Medicinal Plants as Potential
Inhibitors of Human Papillomavirus Type 16 E6 Protein in Cervical Cancer
Development.
Trop Life Sci Res. 2025;36:1-24.
Abstract
Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a
multicenter retrospective cohort study from the Thai Gynecologic Cancer Society
research group.
J Gynecol Oncol. 2025 Apr 7. doi: 10.3802/jgo.2025.
Abstract
Improving cervical cancer screening participation by introducing HPV vaginal
self-sampling to women living with HIV in Denmark- a pilot study.
BMC Womens Health. 2025;25:202.
Abstract
Barriers of organized cervical cancer screening in Albania and Montenegro.
BMC Public Health. 2025;25:1533.
Abstract
Cervical Cancer Screening by Human Papillomavirus Testing of Vulvar Swabs.
Arch Pathol Lab Med. 2025;149:395.
Abstract
Comparison of Clinical Efficacy of Liquid-Based Cytology and High-Risk Human
Papillomavirus Testing With Partial Genotyping in Cervical Screening of Women
Below 30 Years Old.
Cancer Control. 2025;32:10732748251336414.
Abstract
Epithelial and macrophage cell interaction in cervical cancer through single-cell
RNA-sequencing and spatial analysis.
Front Immunol. 2025;16:1537785.
Abstract
Barriers and facilitators for implementation of HPV-based cervical cancer
screening in Tanzania: a qualitative study among healthcare providers,
stakeholders, and Tanzanian women.
Glob Health Action. 2025;18:2491852.
Abstract
Global Guidelines and Trends in HPV Vaccination for Cervical Cancer Prevention.
Med Sci Monit. 2025;31:e947173.
Abstract
The persistence of HPV type-specific infections in patients following colposcopic
examination: An observational study.
J Obstet Gynaecol Res. 2025;51:e16301.
Abstract
ANGPTL4 suppresses progression and improves cisplatin sensitivity in cervical
cancer.
Sci Rep. 2025;15:14217.
Abstract
Retrospective analysis of treatment and prognosis for clear cell carcinoma of the
uterine cervix: 15-year experience at a single institution.
J Obstet Gynaecol Res. 2025;51:e16300.
Abstract
Capecitabine-Enhanced Brachytherapy in Locally Advanced Cervical Cancer: A Phase
II Non-Randomized Trial on Safety and Efficacy.
Cancer Invest. 2025 Apr 23:1-13. doi: 10.1080/07357907.2025.2493238.
Abstract
Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global
Epidemiology to Innovative Therapies and Prevention Strategies.
Cancer Control. 2025;32:10732748251336415.
Abstract
Cervical cancer mortality trend in Montenegro-1990-2018.
Eur J Public Health. 2025 Apr 23:ckaf059. doi: 10.1093.
Abstract
Human Papilloma Virus Vaccination as a Strategy to Eliminate Cervical Cancer:
Challenges and Opportunities.
Vaccines (Basel). 2025;13:297.
Abstract
Access to pap smear among black women compared to other racial/ethnic groups: a
systematic review with meta-analysis.
Cien Saude Colet. 2025;30:e01852023.
Abstract
Evaluating the understandability and actionability of Japanese human
papillomavirus vaccination educational materials on cervical cancer.
Health Promot Int. 2025;40:daaf034.
Abstract
Immunotherapeutics in Clinical Trials for Cervical Cancer.
Cancer Biother Radiopharm. 2025 Apr 22. doi: 10.1089/cbr.2025.0031.
Abstract
Specialty Palliative Care Consultation in Patients with Cervical Cancer: Who and
Why?
J Palliat Med. 2025 Apr 23. doi: 10.1089/jpm.2024.0344.
Abstract
A bibliometric analysis of artificial intelligence applied to cervical cancer.
Front Med (Lausanne). 2025;12:1562818.
Abstract
Lnc-CNNM3-DT as a protective factor in cervical cancer: regulation of LIAS
expression and intracellular copper levels.
Front Oncol. 2025;15:1571788.
Abstract
The role of tumor-associated macrophages in HPV induced cervical cancer.
Front Immunol. 2025;16:1586806.
Abstract
Rethinking treatment approaches for FIGO stage IVB cervical cancer: personalized
strategies and emerging therapies.
Front Immunol. 2025;16:1567296.
Abstract
Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a
real-world pharmacovigilance study using the FAERS database.
Front Immunol. 2025;16:1582050.
Abstract
Late Bladder Rupture and Strangulated Ileus Following Radical Hysterectomy and
Radiation Therapy for Cervical Cancer.
Cureus. 2025;17:e81016.
Abstract
Statement of Retraction: The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p
(miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer
through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated
kinase (ERK)
Bioengineered. 2025;16:2496006.
Abstract
HSP90 regulates dCK stability and inhibits ionizing radiation-induced ferroptosis
in cervical cancer cells.
Cell Death Discov. 2025;11:191.
Abstract
Building HPV vaccine confidence through codesigned interventions with and for
healthcare workers in Nigeria: protocol for a pilot cluster randomised controlled
trial.
BMJ Open. 2025;15:e098308.
Abstract
Both complete response and long-term survival after combination therapy with
toripalimab in a patient with meta-oligometastases cervical cancer: a case
report.
Front Immunol. 2025;16:1542795.
Abstract
Immunogenic cell death genes in single-cell and transcriptome analyses
perspectives from a prognostic model of cervical cancer.
Front Genet. 2025;16:1532523.
Abstract
Association between tumour necrosis factor-a polymorphism and cervical cancer in
Lagos State, Nigeria.
Ecancermedicalscience. 2025;19:1845.
Abstract
Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer
tumorigenesis via the miR-195-5p/IKBKB axis.
Acta Biochim Biophys Sin (Shanghai). 2025 Apr 22. doi: 10.3724/abbs.2025032.
Abstract
Meta-analysis of the diagnostic value of SOX1 methylation in different types of
cervical cancer.
World J Surg Oncol. 2025;23:147.
Abstract
Lineage analysis of human papillomavirus types 33 and 35 based on E6 gene in
cervical samples from Tehran, Iran.
Sci Rep. 2025;15:13736.
Abstract
Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the
SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in
cervical cancer.
Cell Death Dis. 2025;16:324.
Abstract
Vaginal stump rupture due to sexual activity leading to small intestine vaginal
hernia and intestinal necrosis in a woman after cervical cancer surgery: A case
report.
Medicine (Baltimore). 2025;104:e41788.
Abstract
Histological classification of uterine cervical adenocarcinomas: Its alteration
and current status.
J Obstet Gynaecol Res. 2025;51:e16287.
Abstract
Utility of circulating human papillomavirus DNA as a biomarker for detection and
prognosis of cervical cancer in Japanese patients.
Int J Clin Oncol. 2025 Apr 21. doi: 10.1007/s10147-025-02762.
Abstract
Pre-treatment blood parameters as an economical predictive marker for predicting
treatment response in locally advanced cervical cancer.
F1000Res. 2025;14:118.
Abstract
Factors related to stigma among patients with cervical cancer having chemotherapy
after surgery in China: A cross-sectional study.
Belitung Nurs J. 2025;11:194-204.
Abstract
Omp34-Mediated Acinetobacter baumannii Invasion of Human Cervical Carcinoma
Epithelial, HeLa Cells, and the Influence of Anti-Omp34 Antibodies.
Anal Cell Pathol (Amst). 2025;2025:1931119.
Abstract
Pathologically Complete Response to Camrelizumab and Apatinib in Advanced
Cervical Cancer with PTEN, PIK3CA, MTOR, and ARID1A Mutations: A Case Report.
Case Rep Oncol. 2025;18:480-492.
Abstract
Prognostic significance of circulating tumor DNA detection and quantification in
cervical cancer: a systematic review and meta-analysis.
Front Oncol. 2025;15:1566750.
Abstract
Effect of girls' education on cancer awareness and screening in a natural
experiment in Lesotho.
Nat Commun. 2025;16:3737.
Abstract
Cervical cancer screening: a comparative study of TruScreen vs. Pap Smear.
BMC Womens Health. 2025;25:198.
Abstract
Association between low-grade cervical cytology and histological cervical
intraepithelial neoplasia concurrent vaginal intraepithelial neoplasia among
outpatient colposcopy: A retrospective study.
J Obstet Gynaecol Res. 2025;51:e16289.
Abstract
Sentinel lymph node biopsy mapped with carbon nanoparticle suspensions in
patients with cervical cancer: a systematic review and meta-analysis.
Jpn J Clin Oncol. 2025 Apr 20:hyaf063. doi: 10.1093.
Abstract
HPV16 E7 inhibits HBD2 expression by down-regulation of ASK1-p38 MAPK pathway in
cervical cancer.
Virol J. 2025;22:109.
Abstract
Cervical function in pregnancy and disease: new insights from single-cell
analysis.
Am J Obstet Gynecol. 2025;232.
Abstract
Suicide rates of cervical cancer patients in the United States - Who is most at
risk? A retrospective study of 69,493 patients.
J Cancer Policy. 2025;44:100586.
Abstract
Surface-Enhanced Raman Scattering (SERS) combined with machine learning enables
accurate diagnosis of cervical cancer: from molecule to cell to tissue level.
Crit Rev Oncol Hematol. 2025 Apr 17:104736.
Abstract
Anticancer activity of Momordica charantia-derived extracellular vesicle-like
particle against cervical cancer.
Tissue Cell. 2025;95:102897.
Abstract
Transcriptome analysis reveals possible antitumor mechanism of intracellular
polysaccharide from Phaeodactylum tricornutum on cervical cancer HeLa cells.
Chem Biodivers. 2025 Apr 19:e202402779. doi: 10.1002/cbdv.202402779.
Abstract
Assessing disparities in cancer resources distribution in Mexico.
BMC Health Serv Res. 2025;25:564.
Abstract
Human papillomavirus awareness, vaccination rate, and sociodemographic covariates
of vaccination status in a low-income country: A cross-sectional study in the
rural Busoga region of Uganda.
Vaccine. 2025;53:127089.
Abstract
"If I know about it of course I would give my son and daughter", barriers to and
enablers of accessing human papillomavirus vaccination among women from refugee
and asylum-seeking backgrounds resettling in Melbourne, Australia - A qualitative
study.
Vaccine. 2025;53:127064.
Abstract
Isoxazolyl steroid blocks the Shh signaling pathway and the expression of MMP-2
and MMP-9 in cervical carcinoma cell lines.
Steroids. 2025;217:109599.
Abstract
The impact of plan complexity on dose delivery deviations resulting from
multileaf collimator positioning errors in volumetric modulated arc therapy.
Br J Radiol. 2025;98:785-792.
Abstract
Diagnostic performance of the hologic genius digital diagnostics system for
low-grade squamous intraepithelial lesion (LSIL) ThinPrep papanicolaou tests.
J Am Soc Cytopathol. 2025;14:199-207.
Abstract
How do you do it?: Gynecologic brachytherapy best practices at high volume
institutions within the United States and Canada.
Brachytherapy. 2025;24:365-370.
Abstract
A Multicenter Study on the Relationship of Tumor Lesion Location with Bilateral
Parametrial Involvement and Pelvic Lymph Node Metastasis in Cervical Squamous
Cell Carcinoma.
Ann Surg Oncol. 2025;32:3449-3457.
Abstract
Clinicopathologic and Genomic Features of Invasive Stratified Mucin-producing
Carcinoma of the Uterine Cervix Coexisting With High-grade Squamous
Intraepithelial Lesion.
Int J Gynecol Pathol. 2025;44:268-273.
Abstract
Superficial and Invasive Spread of High-grade Squamous Intraepithelial Lesion and
Squamous Cell Carcinoma: A Case Report.
Int J Gynecol Pathol. 2025;44:265-267.
Abstract
A Population-based Study Investigating the Incidence of Human
Papillomavirus-Associated and Human Papillomavirus-Independent Cervical
Adenocarcinomas.
Int J Gynecol Pathol. 2025;44:249-254.
Abstract
Detection of precancerous lesions in cervical images of perimenopausal women
using U-net deep learning.
Afr J Reprod Health. 2025;29:108-119.
Abstract
Knowledge, Practices, and Perceptions of the Healthcare Providers on Cervical
Cancer Screening Among HIV-Positive Women at Lira Regional Referral Hospital,
Lira City.
Biomed Res Int. 2025;2025:1156001.
Abstract
ZINC1797251, a novel natural product small molecule targets viral oncoprotein E6
in human papillomavirus-16 positive cervical cancer cells.
J Biomol Struct Dyn. 2025 May 1:1-13. doi: 10.1080/07391102.2025.2497459.
Abstract
Evaluation of Efficacy of Neoadjuvant Immunochemotherapy for Cervical Metastatic
Squamous Cell Carcinoma of Unknown Primary.
Cancer Med. 2025;14:e70869.
Abstract
Comparative efficacy of non-ablative radiofrequency and promestriene in
management of the genitourinary syndrome and sexual dysfunction in cervical
cancer survivors: a pilot randomized trial.
J Sex Med. 2025 May 2:qdaf083. doi: 10.1093.
Abstract
For girls and women (4GW) HPV RCT protocol: a crowdsourced, pragmatic
stepped-wedge cluster randomized trial to improve uptake of HPV vaccination and
screening among mother-daughter dyads in Nigeria.
Implement Sci. 2025;20:18.
Abstract
Letter to the editor "Prognosis and treatment regimens for patients with
different lymph node statuses in locally advanced cervical cancer".
Eur J Surg Oncol. 2025 Apr 25:110098. doi: 10.1016/j.ejso.2025.110098.
Abstract
Examining disparities in cervical cancer diagnosis at the intersection of
disability and sexual orientation.
Disabil Health J. 2025 Apr 23:101838. doi: 10.1016/j.dhjo.2025.101838.
Abstract
Magnetic Resonance Imaging in the Management of Women with Low-Risk Early-Stage
Cervical Cancer: A Narrative Review.
Diagnostics (Basel). 2025;15:985.
Abstract
[From hypothesis to prevention of HPV and cervical cancer].
Ugeskr Laeger. 2025;187:V07240716.
Abstract
[The elimination of cervical cancer in Denmark].
Ugeskr Laeger. 2025;187:V08240524.
Abstract
Anxiety, depression, and coping styles among cervical cancer patients during
radiotherapy and their correlations with uncertainty in illness.
World J Psychiatry. 2025;15:103510.
Abstract
Individual-Level Factors that Contribute to Delayed Cervical Cancer Diagnosis
among Patients in Kenya; A Hospital-Based Assessment.
J Cancer Sci Clin Ther. 2024;8:jcsct.
Abstract
A novel and cost-effective model to screen and treat cervical cancer and
precancers at the point of care.
Front Public Health. 2025;13:1527172.
Abstract
MiR-484 Regulates the IL-6/STAT3 Signaling Pathway by Down-Regulating KLF12 to
Inhibit the Malignant Progression of Cervical Cancer.
Int J Womens Health. 2025;17:1165-1174.
Abstract
Analysis of the disease burden of malignancies in the female reproductive system
in China from 1990 to 2019: an age-period-cohort study and joinpoint analysis.
BMJ Open. 2025;15:e081511.
Abstract
Harnessing nano-delivery systems to un-cover the challenges for cervical cancer
therapy.
Int J Pharm. 2025 Apr 28:125657. doi: 10.1016/j.ijpharm.2025.125657.
Abstract
Perceptions of barriers and facilitators for cervical cancer screening from women
and healthcare workers in Ghana: Applying the Dynamic Sustainability Framework.
PLOS Glob Public Health. 2025;5:e0003011.
Abstract
ONC201 (Dordaviprone) Induces Integrated Stress Response and Death in Cervical
Cancer Cells.
Biomolecules. 2025;15:463.
Abstract
The increased matrix stiffness caused by LOXL2 activates Piezo1 channels to
promote the migration and invasion of cervical cancer cells.
Discov Oncol. 2025;16:644.
Abstract
Optimising the effectiveness of the see and treat program for cervical
intracellular neoplasia among HIV-positive women, Addis Ababa Ethiopia.
Afr J Reprod Health. 2025;29:16-27.
Abstract
Determinants of Cervical Cancer Screening in Latina Women.
Hisp Health Care Int. 2025 Apr 30:15404153251339806.
Abstract
RETRACTION: miR-25-3p Reverses Epithelial-Mesenchymal Transition via Targeting
Sema4C in Cisplatin-Resistance Cervical Cancer Cells.
Cancer Sci. 2025 Apr 30. doi: 10.1111/cas.70083.
Abstract
The TFRC as a prognostic biomarker and potential therapeutic target in cervical
cancer: a preliminary study.
Front Oncol. 2025;15:1523137.
Abstract
Down-regulation of miR-125b by HPV16 E6 might promote cervical cancer progression
through TAZ/TEAD.
Front Oncol. 2025;15:1444874.
Abstract
TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting
pyroptosis.
Theranostics. 2025;15:5420-5439.
Abstract
Construction of a Prognostic Model for Cervical Cancer Related to lncRNA Based on
Differential Co-expression Network and Functional Study of Key Gene EGFR-AS1.
J Cancer. 2025;16:2321-2338.
Abstract
Knowledge of breast and cervical cancer symptoms and perceived barriers to seek
treatment among urban underserved women.
Women Health. 2025 Apr 30:1-12. doi: 10.1080/03630242.2025.2496933.
Abstract
Deep learning-based decision support system for cervical cancer identification in
liquid-based cytology pap smears.
Technol Health Care. 2025 Apr 30:9287329251330081.
Abstract
Risk and survival of third primary cancers in a population-based cohort of
patients with a cervical, endometrial, or ovarian cancer.
J Obstet Gynaecol Res. 2025;51:e16297.
Abstract
Phase II Study to Evaluate the Safety and Efficacy of Neoadjuvant Chemotherapy
with Weekly Paclitaxel and Carboplatin Followed by Radical Chemoradiation in
Locally Advanced Cervical Cancer in Egyptian Population.
Asian Pac J Cancer Prev. 2025;26:1459-1468.
Abstract
Experience of Cervical Cytology and High-Risk HPV Testing (Physician vs
Self-Collected) for Primary Cervical Cancer Screening in an Urban Hospital of
Thailand.
Asian Pac J Cancer Prev. 2025;26:1401-1405.
Abstract
Incidence and Survival Trends of Cervical Cancer in Khon Kaen, Thailand.
Asian Pac J Cancer Prev. 2025;26:1393-1400.
Abstract
Scrutiny of the Co-Cytotoxic Impact of Metformin-Omeprazole on the Cervical
Cancer Cell Line and Their Aptitude to Target Heat Shock 60.
Asian Pac J Cancer Prev. 2025;26:1353-1363.
Abstract
Awareness about Cervical Cancer and Acceptance of Pap Smear for Screening among
Women Attending a Tertiary Care Center.
Asian Pac J Cancer Prev. 2025;26:1209-1217.
Abstract
The potential for de-escalation radical surgery in women with stage IB2 cervical
cancer (FIGO 2018): a multi-institutional experience of 63,926 cases over a
14-year period in China.
BMC Surg. 2025;25:187.
Abstract
A dosimetric evaluation of ureteric doses with and without ureter as avoidance
organ in patients treated with MR hybrid brachytherapy for cervical cancer.
Brachytherapy. 2025 Apr 28:S1538-4721(25)00039.
Abstract
3D HDR brachytherapy for cervical cancer in LMIC: Audit of a single institution
experience in Lagos, Nigeria.
Brachytherapy. 2025 Apr 28:S1538-4721(25)00016.
Abstract
Mendelian randomization reveals immune cell composition as a key determinant of
cervical cancer prognosis.
Discov Oncol. 2025;16:635.
Abstract
HPV genotypes in Africa: comprehensive analysis of genetic diversity and
evolutionary dynamics.
Arch Virol. 2025;170:116.
Abstract
Investigating Cisplatin Resistance in Squamous Cervical Cancer: Proteomic
Insights into DNA Repair Pathways and Omics-Based Drug Repurposing.
J Proteome Res. 2025 Apr 29. doi: 10.1021/acs.jproteome.4c00885.
Abstract
[Educational strategy for prevention of cervical cancer in Indigenous peoples: a
participatory action research experience].
Cad Saude Publica. 2025;41:e00170423.
Abstract
Structural Racism in Cervical Cancer Care and Survival Outcomes: A Systematic
Review of Inequities and Barriers.
Curr Epidemiol Rep. 2025;12:7.
Abstract
Dosimetric evaluation of image-guided adaptive radiotherapy for locally advanced
cervical cancer.
Medicine (Baltimore). 2025;104:e42280.
Abstract
Effect of HPV integration on prognosis of young women with CIN2 in China:
protocol for a multicentre prospective cohort study.
BMJ Open. 2025;15:e093863.
Abstract
Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces
Aggressiveness of Cervical Carcinoma Cells.
Anticancer Res. 2025;45:1793-1805.
Abstract
Role of Stromal CD25+/CD8+ Lymphocyte Ratio in Patients With Grade 2-3 Cervical
Intraepithelial Neoplasia (CIN 2-3): A Retrospective Single-center Study.
Anticancer Res. 2025;45:2041-2050.
Abstract
Colposcopic Alterations Are More Frequent in Smokers and Appear at a Younger Age.
In Vivo. 2025;39:1453-1457.
Abstract
[Aurora-A overexpression promotes cervical cancer cell invasion and metastasis by
activating the NF-kappaBp65/ARPC4 signaling axis].
Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:837-843.
Abstract
Improving the Sensitivity-Specificity Balance of Human Papillomavirus Testing on
Self- and Clinician-Collected Samples in South Africa.
JCO Glob Oncol. 2025;11:e2500037.
Abstract
Determinants of cervical cancer knowledge and barriers to human papillomavirus
vaccine uptake among female university students: A cross-sectional study.
Womens Health (Lond). 2025;21:17455057251335446.
Abstract
Assessing the global implications of the COVID-19 pandemic on the cervical cancer
elimination initiative.
PLOS Glob Public Health. 2025;5:e0004419.
Abstract
Misconceptions and knowledge gaps about HPV, cervical cancer, and HPV vaccination
among central American immigrant parents in the United States.
Hum Vaccin Immunother. 2025;21:2494452.
Abstract
Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer.
Open Life Sci. 2025;20:20221052.
Abstract
Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a
Nomogram for Prognosis in Patients with Cervical Cancer Treated with
Radiotherapy.
J Inflamm Res. 2025;18:5371-5382.
Abstract
An offline adaptive planning method based on delivered accumulated dose for
brachytherapy in cervical cancer.
Clin Transl Radiat Oncol. 2025;53:100964.
Abstract
Cervical cancer in Morocco: a literature review on risk factors, prevalence, and
healthcare challenges.
Pan Afr Med J. 2025;50:11.
Abstract
Effect of integrated care model on urinary retention after radical hysterectomy
for cervical cancer.
Pak J Med Sci. 2025;41:963-967.
Abstract
[Placenta increta into the scar in combination with high-grade squamous
intraepithelial lesion of the cervix].
Arkh Patol. 2025;87:64-68.
Abstract
Analysis of the Histopathological Characteristics and Expression of RIPK1 and NF-
kappaB in Cervical Cancer in Kumasi, Ghana.
Niger J Clin Pract. 2025;28:496-501.
Abstract
A biosensor based on tetrahydroxyborate-bismuth vanadate for early diagnosis
towards lncRNA markers in cervical cancer tumors.
Talanta. 2025;294:128218.
Abstract
Study on the detection rate, genetic polymorphism, viral load, persistent
infection capacity, and pathogenicity of human papillomavirus type 33.
Virol J. 2025;22:121.
Abstract
A cross-sectional analysis of factors associated with cervical cancer screening
in a large midwest primary care setting.
BMC Womens Health. 2025;25:204.
Abstract
[Clinical application of transvaginal core needle biopsy for pelvic masses under
finger guidance via vagino-recto-abdominal examination].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:297-303.
Abstract
[Multi?disciplinary treatment approach in cervical cancer care: chinese
gynecologic oncologists consensus].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:241-259.
Abstract
Papillomavirus-Induced Oncogenesis: Bridging Molecular Mechanisms, Diagnostics,
and Global Prevention Strategies.
Viruses. 2025;17:515.
Abstract
CTLA4 Haplotype Structures and -318 C>T (rs5742909) Genetic Variant Contribute to
the Susceptibility of HPV Infection and Cervical Cancer.
Viruses. 2025;17:453.
Abstract
A Minimally Invasive Treatment Approach for Early-Stage Uterine Cervical Cancer:
The Impact of the LACC Trial and a Literature Review.
Medicina (Kaunas). 2025;61:620.
Abstract
Adjuvant Therapy in "Intermediate-Risk" Early-Stage Cervical Cancer: To Treat or
Not to Treat? Systematic Review and Meta-Analysis.
Cancers (Basel). 2025;17:1320.
Abstract
The effect of the music-supported education program on the awareness and health
beliefs of Roma women about cervical cancer and screening.
BMC Public Health. 2025;25:1536.
Abstract
G-Protein-coupled Estrogen Receptor 1 (GPER1) Overexpression Affects
Aggressiveness of Cervical Carcinoma Cells Depending on Histological Entity.
Cancer Genomics Proteomics. 2025;22:397-414.
Abstract
Expression of "Hallmarks of Cancer" Genes in Cervical Carcinoma Is Differentially
Affected by GPER1 Overexpression Depending on Histologic Entity.
Cancer Genomics Proteomics. 2025;22:415-433.
Abstract
Galectin-1-targeted theranostic nanoprobe for multimodal imaging and photothermal
therapy in cervical cancer lymph node metastases.
Colloids Surf B Biointerfaces. 2025;253:114714.
Abstract
[Colitis cystica profunda induced by radiation 27 years later. Case report].
Rev Med Inst Mex Seguro Soc. 2025;63:e6332.
Abstract
Elemental Composition of Women's Fingernails: A Comparative Analysis Between
Cervical Cancer Patients and Healthy Individuals.
Biol Trace Elem Res. 2025 Apr 25. doi: 10.1007/s12011-025-04628.
Abstract
Integrating Novel and Classical Prognostic Factors in Locally Advanced Cervical
Cancer: A Machine Learning-Based Predictive Model (ESTHER Study).
J Pers Med. 2025;15:153.
Abstract
Human papillomavirus (HPV) infection and liquid-based cytologic tests among
cervical screening participants in Shannan City, Tibet, China, during 2021-2022.
BMC Infect Dis. 2025;25:599.
Abstract
Cervical, Breast, and Colorectal Cancer Screening Outcomes Among Refugees in
Philadelphia, Pennsylvania.
J Immigr Minor Health. 2025;27:480-488.
Abstract
Persistent Effect of Redlining on Survival from Screenable Cancers in Washington
State, 2000-2018.
J Urban Health. 2025;102:290-304.
Abstract
Iparomlimab and Tuvonralimab: First Approval.
Drugs. 2025;85:699-706.
Abstract
Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800
and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples.
J Mol Diagn. 2025;27:419-429.
Abstract
Spatial analysis of HPV infection and contextual factors associated with higher
HPV prevalence.
Ann Epidemiol. 2025;105:8-14.
Abstract
High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender
women and people with a cervix living with perinatally acquired HIV.
HIV Med. 2025 Feb 25. doi: 10.1111/hiv.70001.
Abstract
The Expression of Programmed Cell Death Ligand-1 and its Relationship with
Infiltration, Metastasis and Prognosis in Cervical Squamous Cell Carcinoma.
Reprod Sci. 2025;32:1676-1684.
Abstract
Patient Perceptions on the Follow-Up of Abnormal Cancer Screening Test Results.
J Gen Intern Med. 2025;40:1280-1287.
Abstract
Dissecting the Single-Cell Diversity and Heterogeneity Underlying Cervical
Precancerous Lesions and Cancer Tissues.
Reprod Sci. 2025;32:1502-1519.
Abstract
Multiple Lines of Treatment in a Patient with Small Cell Neuroendocrine Carcinoma
of the Cervix: A Case Report.
Ann Clin Lab Sci. 2025;55:286-292.
Abstract
Deciphering the mechanism of baicalein in cervical cancer via bioinformatics,
machine learning and computational simulations: PIM1 and CDK2 are key target
proteins.
Int J Biol Macromol. 2025 May 6:144014. doi: 10.1016/j.ijbiomac.2025.144014.
Abstract
A cascaded amplification carrier-free nanoplatform for synergistic
photothermal/ferroptosis therapy via dual antioxidant pathway disruption in
cervical cancer.
J Mater Chem B. 2025 May 8. doi: 10.1039/d5tb00627.
Abstract
Feasibility and acceptability of human papillomavirus self-sampling compared with
clinician sampling in urban areas of western China: a cross-sectional survey.
Front Public Health. 2025;13:1524796.
Abstract
Intermediate?risk factors affecting oncological outcome in patients with FIGO
2018 stage IB2 cervical cancer who do not receive adjuvant therapy.
Oncol Lett. 2025;29:308.
Abstract
Vaginal radical hysterectomy in early stage cervical cancer.
Gynecol Oncol Rep. 2025;59:101744.
Abstract
Targeting ferroptosis for precision medicine in cervical cancer.
Apoptosis. 2025 May 7. doi: 10.1007/s10495-025-02120.
Abstract
NDUFA8 promotes cell viability and inhibits ferroptosis and cisplatin sensitivity
by stabilizing Fe-S clusters in cervical cancer.
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 8. doi: 10.1007/s00210-025-04237.
Abstract
Four genes shared between rheumatoid arthritis and cervical cancer are associated
with cervical cancer prognosis.
Sci Rep. 2025;15:15884.
Abstract
Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy for
locally advanced cervical cancer: a multicenter real-world study.
Sci Rep. 2025;15:15877.
Abstract
Applying the Information-Motivation-Behavioral Skills model to a video-assisted
HPV intervention to promote self-screening uptake: a qualitative study in Western
Kenya.
BMJ Glob Health. 2025;10:e017616.
Abstract
Rapid prediction of cervical cancer and high-grade precursor lesions: An
integrated approach using low-field (1)H NMR and chemometric analysis.
Clin Chim Acta. 2025;574:120346.
Abstract
Orychophragvioline A, a Novel Alkaloid Isolated from Orychophragmus violaceus
with Anti-Cervical Cancer Activity.
Molecules. 2025;30:1759.
Abstract
Correlates of cervical cancer awareness among women aged 30-49 in five
sub-Saharan African nations: Evidence from the Demographic and Health Survey
(DHS)-2017-2023.
PLOS Glob Public Health. 2025;5:e0003344.
Abstract
Human papillomavirus vaccination: if the vaccine is important and available, why
not use it?
Rev Assoc Med Bras (1992). 2025;71:e20240865.
Abstract
Analysis of the Predictive Efficacy and Influencing Factors of Serum Tie-1,
FoxO3a, and PKD1 for Lymph Node Metastasis in Cervical Cancer.
Int J Womens Health. 2025;17:1215-1224.
Abstract
Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a
Commercial software as survival predictors in radiotherapy for cervical cancer
Objectives.
Clin Transl Radiat Oncol. 2025;53:100965.
Abstract
Tissue-resident immune cells in cervical cancer: emerging roles and therapeutic
implications.
Front Immunol. 2025;16:1541950.
Abstract
Tumor innervation in cervical cancer: Prognostic insights from myelin-associated
risk signatures.
FASEB Bioadv. 2025;7:e70004.
Abstract
A Case of Hemorrhagic Shock From Newly Diagnosed Cervical Cancer.
Cureus. 2025;17:e81793.
Abstract
Innovative Noninvasive HPV Screening Using a Feminine Pad: A Pilot Study for
Enhanced Cervical Cancer Detection.
Obstet Gynecol Int. 2025;2025:9344596.
Abstract
Coordinating under constraint: a qualitative study of communication and teamwork
along Ethiopia's cervical cancer care continuum.
BMC Health Serv Res. 2025;25:652.
Abstract
[Oncolytic virus-mediated base editing for targeted killing of cervical cancer
cells].
Sheng Wu Gong Cheng Xue Bao. 2025;41:1382-1394.
Abstract
The clinical performance of different cervical cancer screening strategies in
premenopausal and postmenopausal women.
Menopause. 2025 May 6. doi: 10.1097/GME.0000000000002546.
Abstract
Estimated health outcomes of breast cancer screening in the national breast and
cervical cancer early detection program by race/ethnicity.
Cancer Causes Control. 2025 May 6. doi: 10.1007/s10552-025-02006.
Abstract
Hsa_circ_0007905 as a modulator of miR-330-5p and VDAC1: Enhancing stemness and
reducing apoptosis in cervical cancer stem cells.
Gen Physiol Biophys. 2025;44:213-226.
Abstract
Implementation of an electronic health information system using DHIS2 tracker to
manage and evaluate the National cervical screening programme in Bangladesh.
BMC Public Health. 2025;25:1649.
Abstract
Vaginal myomectomy of multiple cervical myomas.
BMJ Case Rep. 2025;18:e264879.
Abstract
Association Between Screening History and Prognosis of Cervical Carcinoma in Situ
and Invasive Cervical Cancer: A Population-Based Cohort Study.
Ann Epidemiol. 2025 May 3:S1047-2797(25)00089.
Abstract
Lifetime Cervical Cancer Screening and Social Determinants of Health in the
Canadian Longitudinal Study on Aging.
J Low Genit Tract Dis. 2025 May 2. doi: 10.1097/LGT.0000000000000895.
Abstract
The interplay between angiogenesis and cervical cancer: a comprehensive review.
Expert Rev Anticancer Ther. 2025 May 5. doi: 10.1080/14737140.2025.2501073.
Abstract
Retraction Note: LncRNA SNHG14 promotes the development of cervical cancer and
predicts poor prognosis.
Eur Rev Med Pharmacol Sci. 2025;29:151.
Abstract
Cost-effectiveness of a behavioral insights-informed digital campaign to increase
HPV vaccination in Bangladesh.
Hum Vaccin Immunother. 2025;21:2500264.
Abstract
Preoperative prediction of p16 expression in cervical cancer by amide proton
transfer imaging combined with diffusion kurtosis imaging: a retrospective study.
PeerJ. 2025;13:e19387.
Abstract
Exosomal miRNA-based theranostics in cervical cancer: bridging diagnostics and
therapy.
Med Oncol. 2025;42:193.
Abstract
The ester derivative Palmitoylcarnitine abrogates cervical cancer cell survival
by enhancing lipotoxicity and mitochondrial dysfunction.
Cell Commun Signal. 2025;23:213.
Abstract
The biomarker potential of circPOLD1 and its binding protein YBX1 in cervical
carcinogenesis.
J Transl Med. 2025;23:506.
Abstract
Dynamic causal effects of gut microbiota on cervical Cancer lesion progression.
Sci Rep. 2025;15:15490.
Abstract
Galectin-3 suppresses CD8(+) T cells function via myeloid-derived suppressor
cells recruitment in cervical cancer.
Int J Biol Macromol. 2025 May 1:143683. doi: 10.1016/j.ijbiomac.2025.143683.
Abstract
Spatial-temporal analysis of cervical cancer screening and social and health
indicators in Brazil.
Public Health. 2025;243:105747.
Abstract
Prognostic Differences and Survival Predictive Models for Mucinous Versus
Usual-Type Adenocarcinoma of the Uterine Cervix.
Cancer Med. 2025;14:e70927.
Abstract
Cervical cancer prevention - interventions to improve screening.
Scott Med J. 2025;70:25-26.
Abstract
Supine/prone position fixation treatment in cervical cancer radiotherapy.
J Cancer Res Ther. 2025;21:401-408.
Abstract
Predicting the incidence of hematologic toxicity in concurrent chemoradiotherapy
for cervical cancer using pelvic MRI imaging.
J Cancer Res Ther. 2025;21:354-361.
Abstract
Computational analysis of lupenone derivatives as potential inhibitor of human
papillomavirus oncoprotein E6 associated cervical cancer.
Sci Rep. 2025;15:15402.
Abstract
Thymoquinone enhances efficacy of cervical Cancer therapeutic vaccines via
modulating CD8(+) T cells.
Int Immunopharmacol. 2025 Apr 9:114605. doi: 10.1016/j.intimp.2025.114605.
Abstract
Exosomal miR16 Induced by Allyl Isothiocyanate (AITC) Inhibits Tumor Growth in
Cervical Cancer via Modulation of Apoptotic and Inflammatory Pathways.
Arch Biochem Biophys. 2025 Apr 30:110446. doi: 10.1016/j.abb.2025.110446.
Abstract
Effect of chemical peeling therapy for treatment of cervical intraepithelial
neoplasia on cervicovaginal microbiota.
J Appl Microbiol. 2025;136:lxaf080.
Abstract
Human papillomavirus genotype distribution among high-grade cervical lesions in
French women born between 1972 and 1993.
J Gynecol Obstet Hum Reprod. 2025;54:102945.
Abstract
Risk of HPV-associated precancer and cancer in women with systemic lupus
erythematosus.
Ann Rheum Dis. 2025;84:760-766.
Abstract
HPV genotype-specific prevalence and infection risks: A 10-year population-based
study from the United States.
J Natl Cancer Inst. 2024 Dec 10:djae327. doi: 10.1093.
Abstract
Limited diagnostic performance of imaging evaluation for staging in gastric-type
endocervical adenocarcinoma: a multi-center study.
Jpn J Radiol. 2025;43:810-819.
Abstract
Prevalence of cervical human papillomavirus in kidney transplant recipients: A
systematic review and meta-analysis.
Prev Med. 2024;182:107927.
Abstract
Piezo1 regulates actin cytoskeleton remodeling to drive EMT in cervical cancer
through the RhoA/ROCK1/PIP2 signaling pathway.
Discov Oncol. 2025;16:787.
Abstract
Barriers to adherence to cervical cancer screening care in Northern Tanzania.
Oncologist. 2025;30:oyaf111.
Abstract
In vitro anti-tumour activities of a novel recombinant immunotoxin targeting
differentially overexpressed Leucine-rich repeat-containing G-protein-coupled
receptor 5 in cervical cancer.
Immunopharmacol Immunotoxicol. 2025.
Abstract
MRI-based image-guided adaptive brachytherapy for locally advanced cervical
cancer in clinical routine: a single-institution experience.
Pathol Oncol Res. 2025;31:1612077.
Abstract
Complete remission of a high-risk, locally advanced cervical cancer with
para-aortic lymph node metastases treated with first-line tislelizumab plus
bevacizumab combined with chemotherapy followed by radiotherapy with maintenance
therapy: a case repor
Front Immunol. 2025;16:1573202.
Abstract
[Evaluation of high-risk HPV genotyping detection in cervical cancer screening
based on a prospective cohort study].
Zhonghua Zhong Liu Za Zhi. 2025;47:435-442.
Abstract
An Explainable Deep Learning Framework for Predicting Postoperative
Radiotherapy-Induced Vaginal Stenosis in Surgically Treated Cervical Cancer
Patients.
Ann Ital Chir. 2025;96:602-616.
Abstract
Feasibility study of automatic radiotherapy treatment planning for cervical
cancer using a large language model.
Radiat Oncol. 2025;20:77.
Abstract
Correction: CircVPRBP inhibits nodal metastasis of cervical cancer by impeding
RACK1 O-GlcNAcylation and stability.
Oncogene. 2025 May 15. doi: 10.1038/s41388-025-03440.
Abstract
[A Meta-analysis of the application of artificial intelligence in cervical
cytopathology diagnosis].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:572-580.
Abstract
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple,
Modified, or Radical Hysterectomy.
JAMA Netw Open. 2025;8:e2510717.
Abstract
Management of Stage IVB Cervical Cancer Including the Role of Radiotherapy.
Curr Treat Options Oncol. 2025 May 15. doi: 10.1007/s11864-025-01325.
Abstract
RETRACTION: The Increased PTK7 Expression Is a Malignant Factor in Cervical
Cancer.
Dis Markers. 2025;2025:9817180.
Abstract
A Nomogram Based on Fibrinogen-to-Neutrophil Ratio as a Novel Predictor of Lymph
Node Metastasis in Patients with Cervical Cancer and Type 2 Diabetes Mellitus.
Cancer Manag Res. 2025;17:933-954.
Abstract
Trends in cervical cancer incidence and mortality in the United States,
1975-2018: a population-based study.
Front Med (Lausanne). 2025;12:1579446.
Abstract
KLHL17 as a Prognostic Indicator and Therapeutic Target in Cervical Cancer: A
Comprehensive Analysis.
Comb Chem High Throughput Screen. 2025.
Abstract
Optimizing strategy for cervical cancer prevention in china: a comprehensive
modeling analysis.
Cost Eff Resour Alloc. 2025;23:20.
Abstract
Prognostic value of platelet to lymphocyte ratio in patients with cervical
cancer: an updated systematic review and meta-analysis.
World J Surg Oncol. 2025;23:187.
Abstract
The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids,
cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021.
BMC Public Health. 2025;25:1774.
Abstract
Causality between 22 personal traits and cervical cancer: a two-sample Mendelian
randomization study.
J Affect Disord. 2025 May 12:S0165-0327(25)00780.
Abstract
Diagnostic Accuracy of Serum P16ink4A and FOX-P3 Concentrations for Detection of
Cervical Lesions Among Women Attending a Cervical Cancer Clinic in Western
Uganda: A Case-Control Study.
Anal Cell Pathol (Amst). 2025;2025:1931921.
Abstract
Construction and validation of nomograms for predicting overall survival and
cause-specific survival in cervical cancer patients undergoing radical
radiotherapy based on the SEER database.
Front Med (Lausanne). 2025;12:1587465.
Abstract
Influencing factors on attendance in cervical cancer screening among women with
diabetes in Hungary: a cross-sectional study using European Health Interview
Surveys 2009-2019.
Front Oncol. 2025;15:1501654.
Abstract
Comparative Outcomes of Laparoscopic Radical Hysterectomy and Nerve-Sparing
Technique in Cervical Cancer Patients.
JSLS. 2025;29:e2024.
Abstract
BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon
Signaling through Stabilizing STING.
Adv Sci (Weinh). 2025 May 14:e70005. doi: 10.1002/advs.202414637.
Abstract
The Diagnostic Performance of Pap Smear during Both Phases of the Menstrual
Cycle: A Community-based Study in Southern Nigeria.
Niger Postgrad Med J. 2025;32:120-126.
Abstract
Advanced Feature Extraction for Cervical Cancer Image Classification: Integrating
Neural Feature Extraction and AutoInt Models.
Sensors (Basel). 2025;25:2826.
Abstract
Topological Distribution of the Sex Hormone Receptor Expressions Highlights the
Importance of Stromal ERalpha and Epithelial PR in Malignant Transformation of the
Uterine Cervix.
Int J Mol Sci. 2025;26:4418.
Abstract
The Significance of Circulating Microbial Signatures in the Prognosis and Immune
Microenvironment of Patients with Cervical Cancer.
Int J Mol Sci. 2025;26:4293.
Abstract
Comparative Analysis of Serum N-Glycosylation in Endometriosis and Gynecologic
Cancers.
Int J Mol Sci. 2025;26:4105.
Abstract
Induction of Cell Death and Regulation of Autocrine Vitamin D Metabolism in
Cervical Cancer by Physiological and GI20 Doses of 25-Hydroxycholecalciferol.
Int J Mol Sci. 2025;26:4008.
Abstract
Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical
Dysplasia: A Narrative Review.
Int J Mol Sci. 2025;26:3954.
Abstract
Advancing Cervical Cancer Prevention Equity: Innovations in Self-Sampling and
Digital Health Technologies Across Healthcare Settings.
Diagnostics (Basel). 2025;15:1176.
Abstract
Debunking Myths and Misinformation in Cervical Cancer: A Narrative Review on
Navigating Complex Treatment Choices in Locally Advanced Cases and Exploring
Beyond Standard Protocols.
Diagnostics (Basel). 2025;15:1174.
Abstract
Mediation of Ethnic Disparity in the 5-Year Mortality of Cervical Cancer Patients
in the US, 2001-2019.
Healthcare (Basel). 2025;13:964.
Abstract
The Role of Ion Channels in Cervical Cancer Progression: From Molecular
Biomarkers to Diagnostic and Therapeutic Innovations.
Cancers (Basel). 2025;17:1538.
Abstract
Risk stratification of node-positive early-stage cervical cancer treated with
radical hysterectomy followed by chemoradiotherapy: a retrospective single-center
study.
Radiat Oncol. 2025;20:73.
Abstract
Outcomes following conization and factors on HPV regression among young females
in Wuxi.
BMC Womens Health. 2025;25:223.
Abstract
Risk stratification and conservative management of women aged 25-40 years with
cervical intraepithelial neoplasia grade 2(CIN2).
BMC Infect Dis. 2025;25:696.
Abstract
[HPV screening coverage and cancer].
Lakartidningen. 2025;122:25007.
Abstract
Supporting women undergoing radiotherapy for cervical cancer: A pilot
intervention.
Health SA. 2025;30:2815.
Abstract
The Relationship between Systemic Expression Levels of Immune Cells and Tumor
Markers and High-Risk HPV Infection in Patients with Cervical Cancer, Cervical
Intraepithelial Neoplasia, and Chronic Cervicitis, and its Clinical Significance.
Int J Womens Health. 2025;17:1263-1270.
Abstract
Analysis of the Relationship Between Cervical Cancer Progression and the
Microbiome.
Int J Gen Med. 2025;18:2449-2460.
Abstract
A pragmatic randomized trial to compare strategies for implementing primary HPV
testing for routine cervical cancer screening in a large healthcare system.
Implement Sci. 2025;20:21.
Abstract
Comparison of oncological outcomes between radical hysterectomy and
radiochemotherapy for International Federation of Gynecology and Obstetrics 2018
stage IIIC1 cervical adenocarcinoma: A retrospective multicenter cohort study.
J Obstet Gynaecol Res. 2025;51:e16307.
Abstract
EGFR/STAT3 signaling mediates the upregulation of CD47 in HPV-positive cervical
cancer by activating p65 and exosome transporter RAB31.
Neoplasma. 2025;72.
Abstract
Piperlongumine mediated apoptosis in cervical cancer cells beyond docking
predictions.
Toxicol Rep. 2025;14:102031.
Abstract
A predictive model for the transformation from cervical inflammation to cancer
based on tumor immune-related factors.
Front Immunol. 2025;16:1532048.
Abstract
Single-cell combined transcriptome probes prognostic mechanisms of
sialylation-related genes in cervical cancer.
Front Oncol. 2025;15:1534247.
Abstract
Reproductive and Sexual Predictors of Late-Stage Cervical Cancer Presentation in
Lagos, Nigeria.
Cureus. 2025;17:e81934.
Abstract
Using See, Test & Treat(R) to Increase Uptake of Breast and Cervical Cancer
Screenings: Report from the Field.
J Health Care Poor Underserved. 2025;36:757-764.
Abstract
[Role of Toll-like receptors in persistent infection of cervical high-risk human
papillomavirus based on "latent pathogen theory"].
Zhongguo Zhong Yao Za Zhi. 2025;50:1974-1979.
Abstract
Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical
cancer patients after primary radio-chemotherapy.
J Gynecol Oncol. 2025 Apr 24. doi: 10.3802/jgo.2025.
Abstract
Immunohistochemical Study of Cyclin D1 and HER2/neu in Pre-neoplastic and
Neoplastic Epithelial Lesions of Cervix.
Gulf J Oncolog. 2024;1:14-23.
Abstract
Evaluating the role of robotic surgery in gynecological cancer treatment.
Eur J Surg Oncol. 2025;51:109630.
Abstract
Predictors of recurrence in early-stage cervical cancer without adjuvant
treatment after radical surgery.
Eur J Surg Oncol. 2025;51:110121.
Abstract
Postoperative quality of life in patients with early-stage cervical cancer: A
prospective 10-year follow-up study.
Eur J Surg Oncol. 2025;51:110119.
Abstract
Client perspectives and satisfaction with integrating facility and
community-based HPV self-sampling for cervical cancer screening with family
planning: a mixed method study.
BMC Public Health. 2025;25:1718.
Abstract
Impact of the COVID-19 Pandemic on Cervical Cancer Treatment Delays in Botswana.
JCO Glob Oncol. 2025;11:e2400300.
Abstract
Insights Into Cancer Awareness and Health Practices in Rural Kenya: A
Cross-Sectional Study of Esophageal, Breast, Prostate, Cervical, and Colorectal
Cancers.
JCO Glob Oncol. 2025;11:e2400421.
Abstract
Evaluation of the National cervical cancer surveillance program in Bangladesh:
Performance, strengths, and opportunities for improvement.
PLOS Glob Public Health. 2025;5:e0004595.
Abstract
Multi-Task Collaborative Assisted Training Method for Grouping Fuzzy Categories
Classification of Cervical Cancer Cells.
IEEE J Biomed Health Inform. 2025;PP.
Abstract
Mendelian randomization analysis of immune cell traits and their association with
cervical cancer risk.
Discov Oncol. 2025;16:709.
Abstract
Cervical cancer treatment outcomes and survival in Botswana by HIV status:
Ipabalele study results.
JNCI Cancer Spectr. 2025 May 8:pkaf045. doi: 10.1093.
Abstract
A qualitative study on ASHA workers' perspective on HPV self-sampling in Sikkim
India.
Sci Rep. 2025;15:15985.
Abstract
Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected
and self-collected vaginal swabs for detecting HPV: a comparative study.
J Clin Microbiol. 2025 Apr 11:e0185224. doi: 10.1128/jcm.01852.
Abstract
Head-to-head immunogenicity comparison of one-dose Cecolin and Gardasil in
Chinese girls aged 9-14 years: A randomized and open-label clinical trial.
Vaccine. 2025;55:127015.
Abstract
Sentinel lymph node biopsy in gynecological malignancies: A modern approach to
surgical staging - A narrative review.
Eur J Surg Oncol. 2025;51:109757.
Abstract
Metformin-induced E6/E7 inhibition prevents HPV-positive cancer progression
through p53 reactivation.
Anticancer Drugs. 2025;36:468-477.
Abstract
Predicted impact of HPV vaccination and primary HPV screening on precancer
treatment rates and adverse pregnancy outcomes in Australia 2010-2070: Modelling
in a high income, high vaccination coverage country with HPV-based cervical
screening.
Vaccine. 2025;54:126986.
Abstract
HPV Vaccine Uptake and its Predictors among Adolescent Girls and Young Women
Living with HIV-in Central Uganda.
AIDS Behav. 2025;29:1859-1865.
Abstract
Neuroendocrine tumors of the gynecological tract: A narrative literature review.
Eur J Surg Oncol. 2025;51:109735.
Abstract
Human Papillomavirus Infections and Sequela in Women.
Clin Obstet Gynecol. 2025;68:188-193.
Abstract
An updated understanding of the natural history of cervical human papillomavirus
infection-clinical implications.
Am J Obstet Gynecol. 2025;232:453-460.
Abstract
PathoCoder: Rethinking the Flaws of Patch-Based Learning for Multi-Class
Classification in Computational Pathology.
Microsc Res Tech. 2025;88:1712-1726.
Abstract
Evaluation of HPV and Related Cancer Awareness and Vaccination Attitudes Among
Patients with Anogenital Warts: a Survey-Based Study.
J Community Health. 2025;50:560-567.
Abstract
CERVIXNET: An Efficient Approach for the Detection and Classifications of the
Cervigram Images Using Modified Deep Learning Architecture.
Curr Med Imaging. 2025;21:e15734056343690.
Abstract
Association of Cancer Risk Perception and Patient-provider Communication with Pap
Test Among African American and Sub-Saharan African-born Women.
J Community Health. 2025;50:434-441.
Abstract
Cancer diagnosis during pregnancy is associated with severe maternal and neonatal
morbidity.
Am J Obstet Gynecol. 2024 Oct 22:S0002-9378(24)01083.
Abstract
The role of microRNA-9 in ovarian and cervical cancers: An updated overview.
Eur J Surg Oncol. 2025;51:108546.
Abstract
The immune landscape and prognostic analysis of CXCL8 immune-related genes in
cervical squamous cell carcinoma.
Environ Toxicol. 2025;40:902-911.
Abstract
Prognostic value of circ_0000043/miR-590-5p in cervical cancer and regulation of
tumor progression.
Discov Oncol. 2025;16:879.
Abstract
Integrated analysis of microbiome and metabolome reveals insights into cervical
neoplasia aggravation in a Chinese cohort.
Front Cell Infect Microbiol. 2025;15:1556153.
Abstract
Implementing treatment according to the guidelines is of paramount importance in
locally advanced cervical cancer: a real-world study.
Front Oncol. 2025;15:1562067.
Abstract
The safety of combining Endostar with concurrent chemoradiotherapy for the
treatment of locally advanced cervical cancer and the evaluation of its
anti-angiogenic effects via transrectal contrast-enhanced ultrasound.
Front Oncol. 2025;15:1514425.
Abstract
Age-related distribution of human papillomavirus genotypes in women with cervical
squamous cell carcinoma from Linyi, China, 2015-2023.
Virol J. 2025;22:157.
Abstract
Cervical and breast cancer screening outcomes among Metis people in Alberta,
Canada.
BMC Womens Health. 2025;25:246.
Abstract
HPV-associated squamous cell carcinoma and adenocarcinoma in distinct cervical
sites: a case report.
BMC Infect Dis. 2025;25:732.
Abstract
Elucidating the tumor microenvironment interactions in breast, cervical, and
ovarian cancer through single-cell RNA sequencing.
Sci Rep. 2025;15:17846.
Abstract
Trauma-informed practice for promotion of cervical cancer screening: an
exploration of factors influencing engagement with cervical cancer screening.
Br J Gen Pract. 2025;75.
Abstract
Exploring the health inequalities and potential solutions to cervical screening
uptake in primary care.
Br J Gen Pract. 2025;75.
Abstract
Understanding the barriers contributing to 'missingness' of patients from
deep-end practices within the cervical smear screening programme.
Br J Gen Pract. 2025;75.
Abstract
Improving cervical cancer screening uptake in general practice: a feedback
intervention feasibility study.
Br J Gen Pract. 2025;75.
Abstract
Repurposing HIV protease inhibitors as senotherapeutic agents in cervical cancer:
Dual targeting of CDK1/6-cell cycle arrest and p53/p21/p16 signaling axis.
Biochem Biophys Res Commun. 2025;771:152040.
Abstract
Human papillomavirus vaccination, cervical cancer screening, and acceptability of
self-sampling: a cross-sectional study in vulnerable women.
Eur J Cancer Prev. 2025 May 19. doi: 10.1097/CEJ.0000000000000975.
Abstract
The role of photodynamic therapy in treating LSIL in women with high-risk HPV: a
literature review.
Lasers Med Sci. 2025;40:237.
Abstract
Optimizing HPV vaccine effectiveness: impact of vaccination age and dose schedule
on immunogenicity and cervical cancer prevention.
Front Public Health. 2025;13:1544220.
Abstract
Nurses at the forefront in cervical cancer: HPV vaccine promotion to combat the
deadly disease in India.
J Educ Health Promot. 2025;14:153.
Abstract
HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for
targeted therapy.
Virol J. 2025;22:156.
Abstract
Diagnosis of cancer in the South and North of Nigeria: duration and causes of
delay.
BMC Health Serv Res. 2025;25:738.
Abstract
ASO Author Reflections: Laparoscopic Radical Hysterectomy has Equivalent Survival
Outcomes Compared with Open Abdominal Radical Hysterectomy in Early-Stage
Low-Risk Cervical Cancer.
Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-024-16767.
Abstract
Multimodal chemoradiotherapy including interstitial brachytherapy enhances
outcomes in FIGO stage IVA cervical cancer: a focus on tumor control and quality
of life.
Strahlenther Onkol. 2025 May 21. doi: 10.1007/s00066-025-02407.
Abstract
Optimized segmentation of overlapping cervical cells based on Mask2Former and
denoising.
Sci Rep. 2025;15:17715.
Abstract
125I inhibits the progression of cervical cancer by upregulating the
HSF1/PU.1/SYK signaling pathway and consequently enhancing the apoptotic response
mediated by ROS/USP7/P53.
Sci Rep. 2025;15:17690.
Abstract
The role of PAX1 and JAM3 methylation in predicting the pathological upgrading of
cervical intraepithelial neoplasia before conization.
Sci Rep. 2025;15:17684.
Abstract
Inhibitory effects of tetraselmis algae extract on cervical cancer cell
proliferation: a molecular and cellular approach.
Mol Biol Rep. 2025;52:473.
Abstract
Comprehensive Evaluation of the Utility of Cell Block Use in ThinPrep
Liquid-Based Cervical Specimens.
Turk Patoloji Derg. 2025;1.
Abstract
Development of a highly sensitive, label-free electrochemical immunosensor for
p16INK4a detection: a step toward early cervical cancer diagnosis.
Anal Methods. 2025 May 21. doi: 10.1039/d5ay00411.
Abstract
Detection of the Prognostic Gene CYB5D2 in Cervical Squamous Epithelial Lesions.
Mediators Inflamm. 2025;2025:2360364.
Abstract
Comprehensive Single-Cell RNA Sequencing Analysis of Cervical Cancer: Insights
Into Tumor Microenvironment and Gene Expression Dynamics.
Int J Genomics. 2025;2025:5027347.
Abstract
Indocyanine Green and Radioisotope Tracers for Sentinel Lymph Node Mapping in
Early-Stage Cervical Cancer: A Prospective Comparative Study.
Cureus. 2025;17:e82644.
Abstract
Retrospective analysis of 274 cases suspected vaginal intraepithelial neoplasia.
Sci Rep. 2025;15:17506.
Abstract
LncRNA NEAT1 regulation of the miR-101-3p/RAC1 axis affects cervical cancer
aerobic glycolysis and progression.
Sci Rep. 2025;15:17436.
Abstract
Mathematical modelling of the role of Langerhans cells in the dynamics of HPV
infection.
Sci Rep. 2025;15:17505.
Abstract
Beyond words: operationalizing inclusive language in Australian cervical
screening health promotion policy.
Health Promot Int. 2025;40:daaf058.
Abstract
Risk-Based Triage Strategy by Extended HPV Genotyping for Women With LSIL
Cytology: A Real-World Study.
J Med Virol. 2025;97:e70404.
Abstract
Improving Detection of CIN2+ and CIN3+ Lesions: Evaluation of E6/E7 mRNA, P16,
and Ki-67, Individually and in Combination.
J Med Virol. 2025;97:e70405.
Abstract
Reevaluating BED in cervical cancer HDR brachytherapy: source decay and
tissue-specific repair significantly impact radiobiological dose.
Front Oncol. 2025;15:1407606.
Abstract
Quantifying the dosimetric impact of online daily adaptation for MR-guided RT in
cervical cancer.
Acta Oncol. 2025;64:693-702.
Abstract
Insufficient knowledge of Human Papillomavirus among reproductive-aged women from
Arak, Iran.
BMC Womens Health. 2025;25:238.
Abstract
Novel marker genes and small molecule drugs for radiotherapy resistance in
cervical cancer identified based on single-cell multi-omics analysis.
Discov Oncol. 2025;16:823.
Abstract
Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method
for At-Home Use: A Nonrandomized Clinical Trial.
JAMA Netw Open. 2025;8:e2511081.
Abstract
Laparoscopic radical hysterectomy-karez technique for stage IB3 and IIA2 cervical
cancer: a multicenter retrospective cohort study.
Int J Surg. 2025 May 16. doi: 10.1097/JS9.0000000000002522.
Abstract
Single-cell and spatial transcriptome analysis revealed cellular heterogeneity of
glycosyltransferases in cervical cancer, and identified GALNT3-negative
epithelial cells as a protective factor: a retrospective cohort study based on
public database.
Int J Surg. 2025 May 16. doi: 10.1097/JS9.0000000000002520.
Abstract
CRISPR/Cas on Microfluidic Paper-Based Analytical Devices for Point-of-Care
Screening of Cervical Cancer.
ACS Sens. 2025 May 19. doi: 10.1021/acssensors.5c00863.
Abstract
Changes in Breast and Cervical Cancer Incidence by Stage at Diagnosis During the
COVID-19 Pandemic in Utah.
Cancer Med. 2025;14:e70952.
Abstract
Implementing 100% quality control in a cervical cytology workflow using whole
slide images and artificial intelligence provided by the Techcyte SureView
System.
Cancer Cytopathol. 2025;133:e70019.
Abstract
Harnessing unsupervised machine learning with [(18)F]FDG PET/CT to develop a
composite model for predicting overall survival in cervical cancer patients
undergoing concurrent chemoradiotherapy.
Front Oncol. 2025;15:1486654.
Abstract
Knowledge and Prevalence of Cervical Cancer Screening Among Women Receiving
Prenatal Care in Accra, Ghana: A Cross-Sectional Study.
Health Serv Insights. 2025;18:11786329251337851.
Abstract
Evaluation of Baseline Characteristics and Therapeutic Management Strategies in
Metastatic Cervical Cancer in Germany: A Multicentric Retrospective Longitudinal
Observational Study: A Quality Assurance Initiative of the AGO-Study Group and
AGO-OK Uter
Geburtshilfe Frauenheilkd. 2025;85:520-532.
Abstract
FXR activation suppresses NF-kappaB signaling, proliferation and migration in
cervical cancer cells.
Transl Cancer Res. 2025;14:2440-2456.
Abstract
First-Trimester Radical Hysterectomy for Bulky Cervical Cancer: A Case Report on
Oncologic and Reproductive Considerations.
Cureus. 2025;17:e82486.
Abstract
ITGA5 promotes cervical cancer progression by regulating IMP3 recruitment of HK2
mRNA.
Am J Transl Res. 2025;17:3031-3049.
Abstract
Modelling the cost-effectiveness of cervical cancer screening with HPV
self-sampling and molecular triage for women aged 60-69 years.
Discov Oncol. 2025;16:805.
Abstract
USP31 confers radio-resistance in cervical cancer cells via ferroptosis pathway
by deubiquitinating and stabilizing GPX4.
Biochem Biophys Res Commun. 2025;770:151990.
Abstract
Epstein-Barr virus nuclear antigen 1 (EBNA1) increases the expression levels of
MDM2 and MDM4 genes in HeLa cells: a review on MDM2 and MDM4 roles in cancer.
BMC Res Notes. 2025;18:221.
Abstract
Exploring potential methylation markers for ovarian cancer from cervical scraping
samples.
Hum Genomics. 2025;19:56.
Abstract
Association between knowledge of cervical cancer prevention and screening
behaviors among women aged 20 to 49 years: a cross-sectional study in six
provinces, China.
BMC Public Health. 2025;25:1821.
Abstract
From Normal to Optimal: Investigating Metabolic and Inflammatory Parameters as
Predictors of Survival in Locally Advanced Cervical Cancer.
Stud Health Technol Inform. 2025;327:572-576.
Abstract
Bias Detection in Histology Images Using Explainable AI and Image Darkness
Assessment.
Stud Health Technol Inform. 2025;327:203-207.
Abstract
Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and
Streptococcus with human papillomavirus infection, cervical intraepithelial
neoplasia, and cancer: a systematic review and meta-analysis.
BMC Infect Dis. 2025;25:708.
Abstract
USP25-driven KIFC1 regulates MYCBP expression and promotes the progression of
cervical cancer.
Cell Death Dis. 2025;16:390.
Abstract
[Optimization of cervical cancer screening in France: a prospective multicenter
clinical study].
Gynecol Obstet Fertil Senol. 2025 May 14:S2468-7189(25)00121.
Abstract
Clinical performance of the SureX PCR HPV test versus hybrid capture assays
(DH2/careHPV) in primary cervical cancer screening.
Tumour Virus Res. 2025;19:200319.
Abstract
Lineages and sublineages of high-risk HPV types associated with cervical cancer
and precancer: a systematic review and meta-analysis.
J Natl Cancer Inst. 2025 May 16:djaf118. doi: 10.1093.
Abstract
Optimizing dwell time weight for interstitial needles in
intracavitary/interstitial hybrid brachytherapy: balancing tumor coverage with
organ sparing using the inverse planning technique.
J Radiat Res. 2025;66:296-305.
Abstract
Role of extracellular vesicles in the pathophysiology, diagnosis, and prognosis
of gynecological cancers.
Pathol Res Pract. 2025;270:155987.
Abstract
A Comprehensive Review of Biologically Active Natural Products on Human
Papillomavirus (HPV) at a Glance.
Phytother Res. 2025;39:2262-2290.
Abstract
Association of intrauterine device use and risk of abnormal cervical cytology.
Eur J Contracept Reprod Health Care. 2025;30:87-92.
Abstract
Cancer Stem Cell Regulation as a Target of Therapeutic Intervention: Insights
into Breast, Cervical and Lung Cancer.
Cell Biochem Biophys. 2025;83:1521-1535.
Abstract
Endocervical adenocarcinoma with a micropapillary component: a clinicopathologic
analysis in the setting of current WHO classification.
Virchows Arch. 2025;486:1011-1021.
Abstract
High-grade squamous intraepithelial lesions and adenocarcinoma in situ with a
negative HPV cervical screening test. The role of HPV-ISH testing: A
retrospective review.
Aust N Z J Obstet Gynaecol. 2025;65:297-300.
Abstract
Deep learning-based applicator selection between Syed and T&O in high-dose-rate
brachytherapy for locally advanced cervical cancer: a retrospective study.
Phys Med Biol. 2025 May 29. doi: 10.1088/1361-6560.
Abstract
Comprehensive analysis of mRNA and lncRNA expression for predicting lymph node
metastasis in cervical cancer: a novel seven-gene signature approach.
Front Genet. 2025;16:1524821.
Abstract
Torsion Giant ovarian cysts in a postmenopausal woman with cervical cancer.
Oxf Med Case Reports. 2025;2025:omaf054.
Abstract
Prediction of clinical stages of cervical cancer via machine learning integrated
with clinical features and ultrasound-based radiomics.
Sci Rep. 2025;15:18862.
Abstract
Recent Advances in Applications of Machine Learning in Cervical Cancer Research:
A Focus on Prediction Models.
Obstet Gynecol Sci. 2025 May 29. doi: 10.5468/ogs.25041.
Abstract
LINC02593 impedes cell senescence via COP1-mediated p53 degradation in cervical
cancer.
Cell Signal. 2025 May 27:111907. doi: 10.1016/j.cellsig.2025.111907.
Abstract
Cervical adenocarcinoma misdiagnosed as a nabothian cyst during pregnancy: A case
report and review of the literatures.
Medicine (Baltimore). 2025;104:e42336.
Abstract
MFFUNet: A hybrid model with cross-attention-guided multi-feature fusion for
automated segmentation of organs at risk in cervical cancer brachytherapy.
Comput Med Imaging Graph. 2025;124:102571.
Abstract
To explore the molecular mechanisms and shared genetic characteristics of
rheumatoid arthritis and cervical cancer based on multiple omics and clinical
samples.
Discov Oncol. 2025;16:945.
Abstract
Mendelian randomization reveals limited causal effects of genetic variants on
cervical cancer risk: insights from immune cell populations.
Discov Oncol. 2025;16:944.
Abstract
CervicalMethDx: a precision DNA methylation test to identify risk of high-grade
intraepithelial lesions in cervical cancer screening algorithms.
Cancer Prev Res (Phila). 2025 May 29. doi: 10.1158/1940-6207.CAPR-25-0029.
Abstract
Barriers to Cervical Cancer Screening in India: Insights from National Family
Health Survey-5 Data.
Asian Pac J Cancer Prev. 2025;26:1853-1861.
Abstract
Quantification of Circulating HPV DNA as a Biomarker for Cervical pre-cancer and
cancer: A Pilot Study.
Asian Pac J Cancer Prev. 2025;26:1681-1687.
Abstract
Effect of a Nurse-Led Educational Intervention on the Knowledge, Perceptions and
Uptake of Cervical Cancer Screening among HIV-Infected Women in Kenya.
Asian Pac J Cancer Prev. 2025;26:1591-1597.
Abstract
Pancreatic metastasis from cervical cancer: A case report and literature review.
Oncol Lett. 2025;30:349.
Abstract
Fan beam computed tomography-guided online adaptive external radiotherapy for
cervical cancer achieves pathological complete response: A case report.
Oncol Lett. 2025;30:344.
Abstract
The Impact of Split Radiation Therapy on the Management of Locally Advanced
Cervical Cancer in Central Virginia.
Cureus. 2025;17:e83130.
Abstract
Immunological features of various molecular subtypes of cervical cancer and their
prognostic implications in the context of disulfidptosis.
Front Oncol. 2025;15:1574911.
Abstract
Lack of knowledge, not vaccine hesitancy, is the main cause of low human
papilloma virus vaccination rate among systemic lupus erythematosus patients in
Japan after suspension of proactive recommendation: Analysis of a patients'
survey.
J Obstet Gynaecol Res. 2025;51:e16330.
Abstract
Assessment of risk factors for high-grade cervical or endometrial lesions to
triage women with AGC-FN: a retrospective study.
BMC Womens Health. 2025;25:260.
Abstract
The impact of medical expert-led sex education on sexual health knowledge among
Japanese junior high school students: a quantitative study.
BMC Public Health. 2025;25:1971.
Abstract
Safety and antiemetic efficacy of weekly administration of
netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant
chemo-radiotherapy-the DANGER-emesis study.
Support Care Cancer. 2025;33:509.
Abstract
Deciphering the cellular and molecular landscape of cervical cancer progression
through single-cell and spatial transcriptomics.
NPJ Precis Oncol. 2025;9:158.
Abstract
A risk nomogram for assessing complications in patients undergoing surgical
procedures for cervical cancer. Does baseline quality of life play a role?
J Obstet Gynaecol Res. 2025;51:e16318.
Abstract
Study on human papillomavirus (HPV) infection, typing, peripheral blood immune
factor expression and vaginal microenvironment balance in cervical cancer
screening population.
Indian J Med Microbiol. 2025 May 26:100883. doi: 10.1016/j.ijmmb.2025.100883.
Abstract
Study of the application of the deformed dose summation (DDS) method in
brachytherapy for advanced cervical cancer and analysis of regional dosing in
recurrent cervical cancer.
Appl Radiat Isot. 2025;224:111945.
Abstract
Exploring program-cell death patterns to predict prognosis and sensitivity of
cervical cancer immunotherapy via multi-omics analysis and clinical samples.
Discov Oncol. 2025;16:940.
Abstract
Empirical Mode Decomposition and Grassmann Manifold-Based Cervical Cancer
Detection.
J Biophotonics. 2025 May 28:e202400584. doi: 10.1002/jbio.202400584.
Abstract
The intratumoral microbiota heterogenicity is related to the prognosis and
tumorigenesis of cervical cancer.
Front Cell Infect Microbiol. 2025;15:1574511.
Abstract
The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical
cancer: a game-changer for patients outcome?
Front Immunol. 2025;16:1573576.
Abstract
Geographical inequities in cervical cancer screening coverage in Bolivia: a
spatial nationwide ecological study.
Rev Panam Salud Publica. 2025;49:e44.
Abstract
Human Papillomavirus Genotyping and Viral Load as a Predictor of Cervical
Lesions: A Prospective Study.
J Med Virol. 2025;97:e70386.
Abstract
Human Papillomavirus Genotype Distribution and Viral Load in Relation to Cervical
Disease Severity: A Retrospective Study of Outpatient Data in Beijing, China.
J Med Virol. 2025;97:e70409.
Abstract
Molecular Insights into HPV-Driven Cervical Cancer: Oncoproteins, Immune Evasion,
and Epigenetic Modifications.
Microorganisms. 2025;13:1000.
Abstract
Oxidative Stress, Inflammation, and Antioxidant Strategies in Cervical Cancer-A
Narrative Review.
Int J Mol Sci. 2025;26:4961.
Abstract
Polyphyllin I Inhibits the Metastasis of Cervical Cancer Through the Regulation
of the beta-Catenin Signaling Pathway.
Int J Mol Sci. 2025;26:4630.
Abstract
Apoptosis and G2/M Phase Cell Cycle Arrest Induced by Alkaloid Erythraline
Isolated from Erythrina velutina in SiHa Cervical Cancer Cell.
Int J Mol Sci. 2025;26:4627.
Abstract
Characterization of the Antiproliferative and Antimetastatic Properties of
Centrapalus pauciflorus Meroterpenoid Centrapalus Coumarin F.
Int J Mol Sci. 2025;26:4489.
Abstract
Adaptive Target Volume and Dosimetry in Image-Guided Radiotherapy for Cervical
Cancer.
J Clin Med. 2025;14:3418.
Abstract
The Predictive Value of Preoperative Histological Risk Factors in Early Cervical
Cancer.
J Clin Med. 2025;14:3277.
Abstract
The Vaginal Microbiota, Human Papillomavirus, and Cervical Dysplasia-A Review.
Medicina (Kaunas). 2025;61:847.
Abstract
Cervical Cancer Detection Using Deep Neural Network and Hybrid Waterwheel Plant
Optimization Algorithm.
Bioengineering (Basel). 2025;12:478.
Abstract
Regional Alliance for Cervical Cancer Prevention in Eastern Europe and Central
Asia: Progressing Towards the Target 1 of the Global Strategy for Cervical Cancer
Elimination.
Healthcare (Basel). 2025;13:1209.
Abstract
Cervical Cancer Screening After Menopause.
Healthcare (Basel). 2025;13:1157.
Abstract
Barriers and Opportunities for HPV Self-Sampling in Underserved Rural
Communities: Insights from a Mixed Methods Study.
Int J Environ Res Public Health. 2025;22:783.
Abstract
Quality of Life of Emirati Women with Cervical Cancer Using EORTC QLQ-30 and
CX24: A First Look in the UAE.
Int J Environ Res Public Health. 2025;22:671.
Abstract
HPV genotype distribution and cervical lesions in Chongqing: a comprehensive
analysis of 229,770 females (2015?2023).
BMC Infect Dis. 2025;25:760.
Abstract
Factors associated with cervical cancer screening: results from cross-sectional
surveys in Kenya and Malawi.
BMC Public Health. 2025;25:1956.
Abstract
Curcumin nanoemulsion suppresses HPV oncogenes and inhibits cervical cancer
progression: in vitro and in vivo study.
Virol J. 2025;22:165.
Abstract
Barriers and facilitators of pap-smear test uptake in Asia: a systematic review.
BMC Public Health. 2025;25:1961.
Abstract
Effects of a theory driven and culturally tailored educational program on
promoting cervical cancer screening in rural populations.
Sci Rep. 2025;15:18540.
Abstract
Google Trends for the Human Papillomavirus Vaccine in India From 2010 to 2024:
Infodemiological Study.
J Med Internet Res. 2025;27:e69729.
Abstract
Proliferation of Human Cervical Cancer Cells Responds to Surface Properties of
Bicomponent Polymer Coatings.
Nanomaterials (Basel). 2025;15:716.
Abstract
De-escalating first-line treatment in stage IVB or recurrent cervical cancer:
outcomes of immunotherapy alone and systemic review.
Oncologist. 2025;30:oyaf096.
Abstract
An investigation of HPV vaccination willingness and influential factors among
college students in Beijing based on the BeSD framework and evaluation of
momentary intervention effect.
Hum Vaccin Immunother. 2025;21:2505354.
Abstract
Retraction notice: "MicroRNA-199a Inhibits Cell Proliferation, Migration, and
Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical
Cancer".
Technol Cancer Res Treat. 2025;24:15330338251343588.
Abstract
Computational investigation of stigmasterol as a potential therapeutic agent for
cervical cancer: insights from density functional theory (DFT) and molecular
docking studies.
In Silico Pharmacol. 2025;13:77.
Abstract
Editorial: Cervical cancer awareness - volume I: screening, vaccines, and
prevention.
Front Reprod Health. 2025;7:1579018.
Abstract
Awareness, Practice, and Barriers Regarding Cervical Cancer Screening Among Women
of Kageshwori Manohara Municipality, Nepal.
Obstet Gynecol Int. 2025;2025:5325540.
Abstract
Recent Advances in HPV Detection: From Traditional Methods to Nanotechnology and
the Application of Quantum Dots.
Int J Nanomedicine. 2025;20:6333-6356.
Abstract
Occupational therapy in oncogynecology - a pilot study.
Ceska Gynekol. 2025;90:113-121.
Abstract
Chemical profiling and anticancer activity of Alnus incana dichloromethane
fraction on HeLa cells via cell cycle arrest and apoptosis.
BMC Complement Med Ther. 2025;25:189.
Abstract
Cervical cancer screening uptake and its associated factor in Sub-Sharan Africa:
a machine learning approach.
BMC Med Inform Decis Mak. 2025;25:197.
Abstract
Rural-urban variations in cervical cancer screening uptake among women in Ghana:
Evidence from the 2022 Ghana Demographic and Health Survey.
BMC Womens Health. 2025;25:255.
Abstract
The impact of life tables on age standardized net survival of real-life example
databases.
BMC Med Res Methodol. 2025;25:145.
Abstract
A retrospective study on the relationship between delirium and long-term
cognitive function in elderly women following cervical cancer surgery.
Medicine (Baltimore). 2025;104:e42120.
Abstract
International Papillomavirus Society policy statement on human
papillomavirus-based cervical cancer screening for women living with HIV.
Prev Med. 2025;197:108314.
Abstract
Sialyltransferase-related genes as predictive factors for therapeutic response
and prognosis in cervical cancer.
PeerJ. 2025;13:e19422.
Abstract
Investigating Anti-Tumor Effects of Irisin in Cervical Cancer Cells: Cell
Viability, Migration, and Tumor-Associated Macrophage Polarization.
Discov Med. 2025;37:946-956.
Abstract
Neurological and Cardiac Adverse Events in Cervical Cancer Treatment: A Case of
Postoperative Sintilimab-Induced Encephalitis and Myocarditis.
Am J Case Rep. 2025;26:e947730.
Abstract
'I Don't Think There Is a One-Size-Fits-All': A Qualitative Study Exploring
Healthcare Professional and Service Provider Perspectives of Using Innovative
Models of Cervical Screening to Improve Equitable Access to Self-Collection.
Cancer Med. 2025;14:e70981.
Abstract
Integrative Analysis of Bulk Multiomics and Single-Cell Transcriptomics
Elucidates Age-Related Molecular Landscape Alterations in Cervical Cancer.
Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17464.
Abstract
Factors associated with parental hesitancy towards the human papillomavirus
vaccine: a cross-sectional study.
Sci Rep. 2025;15:18284.
Abstract
The mechanism of ECT1/E6E7 cervical intraepithelial neoplasia cells regulated by
Acinetobacter lwoffii through circ-LDHA/HMGB1.
BMC Microbiol. 2025;25:326.
Abstract
A novel network architecture for post-applicator placement CT auto-contouring in
cervical cancer HDR brachytherapy.
Med Phys. 2025 May 25. doi: 10.1002/mp.17908.
Abstract
Concurrent chemoradiotherapy for advanced cervical cancer during second trimester
pregnancy: A case report.
J Obstet Gynaecol Res. 2025;51:e16326.
Abstract
Aberrant WDR5 promotes the progression of cervical cancer through the YAP1- CTGF
pathway.
Life Sci. 2025;376:123712.
Abstract
Premature mortality due to cervical and ovarian cancers in Japan, 2000 to 2020.
J Obstet Gynaecol Res. 2025;51:e16327.
Abstract
The role and diagnostic value of deregulated miRNAs in cervical cancer.
Discov Oncol. 2025;16:922.
Abstract
Fear of cancer levels of women who applied cervical cancer screening: a
cross-sectional study of the effects of health beliefs related to cervical cancer
and Pap-Smear test.
Cancer Causes Control. 2025 May 25. doi: 10.1007/s10552-025-02008.
Abstract
Simple Hysterectomy as a Viable Alternative to Radical Hysterectomy for
Early-Stage Cervical Cancer: A Population-Based Cohort Study.
Ann Surg Oncol. 2025 May 24. doi: 10.1245/s10434-025-17520.
Abstract
Cancer Screening in Women.
Prim Care. 2025;52:233-248.
Abstract
Bhutan achieves the 90-70-90 targets on the path to elimination of cervical
cancer: Experience, challenges and way forward.
J Cancer Policy. 2025;44:100596.
Abstract
Changes in incidence of HPV-related cancers in South Africa (2011-21): a
cross-sectional analysis of the South African National Cancer Registry.
Lancet Glob Health. 2025;13:e1101-e1110.
Abstract
ASCCP Clinical Consensus: Screening Recommendations for Clear Cell
Adenocarcinomas in People Exposed to DES In Utero.
J Low Genit Tract Dis. 2024;28:351-355.
Abstract
Prevalence and determinants of cervical cancer screening among women aged 15-49
years in Tanzania: analysis of demographic and health survey 2022.
Arch Public Health. 2025;83:135.
Abstract
Androgen receptor plays critical role in regulating cervical cancer cell
migration.
Mol Cell Endocrinol. 2025;606:112583.
Abstract
A previously uncharacterized role of TAp73 in ferroptosis by modulating oxidative
homeostasis in cervical cancer.
Cancer Lett. 2025;627:217815.
Abstract
Induction chemotherapy followed by chemoradiotherapy for locally advanced
cervical cancer: A systematic review and meta-analysis.
Cancer Treat Rev. 2025;138:102959.
Abstract
The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers
and further therapy advances.
Biomol Biomed. 2025 May 22. doi: 10.17305/bb.2025.12597.
Abstract
Evaluating the necessity of endocone resection during LLETZ: Impact of routine
ECC and follow-up testing in predicting persistent/recurrent cervical dysplasia.
Women Health. 2025;65:442-452.
Abstract
FoxM1 promotes the proliferation of cervical adenocarcinoma cells through
transcriptional activation of FAM83D.
Life Sci. 2025;374:123691.
Abstract
GRHL3 specifically initiated by the TP63 transcription factor promotes the
metastasis of squamous cell carcinogenesis.
Cell Signal. 2025;132:111794.
Abstract
Postoperative Urinary Complications in Minimally Invasive Versus Abdominal
Radical Hysterectomy: A Meta-Analysis With a Focus on Ureterovaginal Fistula.
J Minim Invasive Gynecol. 2025;32:502-511.
Abstract
Attitudes towards being offered a choice of self-sampling or clinician sampling
for cervical screening: A cross-sectional survey of women taking part in a
clinical validation of HPV self-collection devices.
J Med Screen. 2025;32:93-99.
Abstract
Knowledge of the Human Papillomavirus Vaccine and Willingness to Accept
Vaccination in the Postpartum Period.
J Low Genit Tract Dis. 2024;28:340-344.
Abstract
Evaluation of Host Gene Methylation as a Triage Test for HPV-Positive Women-A
Cohort Study.
J Low Genit Tract Dis. 2024;28:326-331.
Abstract
Analysis of metabolic compounds and antitumorigenic effects of Albizia niopoides
and Senegalia polyphylla leaves.
Nat Prod Res. 2025;39:3140-3147.
Abstract
Use of Thermal Ablation in Low-Resource Settings: Experience From Three
Multicenter Noninferiority Randomized Clinical Trials.
JCO Glob Oncol. 2025;11:e2500050.
Abstract
RE: Invasive cervical cancer incidence following bivalent human papillomavirus
vaccination: a population-based observational study of age at immunization, dose,
and deprivation.
J Natl Cancer Inst. 2025 Jun 6:djaf130. doi: 10.1093.
Abstract
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The
PRESTIS Randomized Clinical Trial.
JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2971.
Abstract
HPV Self-Collection for Cervical Cancer Screening-There's No Place Like Home.
JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2978.
Abstract
Development of an innovative approach for early diagnosis of cervical cancer
using TCR?like antibodies targeting HPV18 E6 and E7 peptides.
Mol Med Rep. 2025;32:218.
Abstract
Automatic cervical tumors segmentation in PET/MRI by parallel encoder U-net.
Radiat Oncol. 2025;20:95.
Abstract
Quantitative and automatic plan-of-the-day assessment to facilitate adaptive
radiotherapy in cervical cancer.
Phys Med Biol. 2025 Jun 5. doi: 10.1088/1361-6560.
Abstract
Burden of cervical cancer in Martinique, 2012-2021.
Cancer Epidemiol. 2025;97:102857.
Abstract
Bardoxolone methyl blocks the efflux of Zn2+ by targeting hZnT1 to inhibit the
proliferation and metastasis of cervical cancer.
Protein Cell. 2025 Jun 5:pwaf044. doi: 10.1093.
Abstract
Demand-side barriers and economic burden in accessing Human Papillomavirus
screening for cervical cancer prevention in rural India: Evidence from a
cross-sectional study.
F1000Res. 2025;13:630.
Abstract
Male partner roles in cervical cancer transmission and prevention in central
Kenya: A quantitative approach.
Health SA. 2025;30:2858.
Abstract
Editorial: Cervical screening awareness week 2023: integrating cervical cancer
screening and precancer treatments.
Front Oncol. 2025;15:1614832.
Abstract
PET for predicting chemoradiotherapy survival in cervical cancer: the search
continues.
Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000001999.
Abstract
Emergency Radiation Therapy for Hemorrhage in Botryoides Sarcoma: A Pediatric
Case Report.
Am J Case Rep. 2025;26:e946434.
Abstract
Corrigendum to "METTL3-mediated HSPA9 m6A modification promotes malignant
transformation and inhibits cellular senescence by regulating exosomal mortalin
protein in cervical cancer" [Cancer Lett. 587 (2024) 216658].
Cancer Lett. 2025 Jun 3:217827. doi: 10.1016/j.canlet.2025.217827.
Abstract
Stakeholder perspectives on HPV vaccination uptake among Aboriginal and Torres
Strait Islander adolescents via the school immunisation programmes in Queensland:
a qualitative study.
BMJ Open. 2025;15:e097518.
Abstract
Impact of an educational physiotherapy-yoga intervention on perceived stress in
women treated with brachytherapy for cervical cancer: a randomised controlled
mixed study protocol (KYOCOL).
BMJ Open. 2025;15:e098570.
Abstract
EXPERIENCE OF IMPLEMENTING DIGITAL TELEMEDICINE TECHNOLOGIES TO IMPROVE ACCESS TO
CERVICAL CANCER SCREENING IN RURAL AREAS OF THE REPUBLIC OF KAZAKHSTAN.
Georgian Med News. 2025;:187-194.
Abstract
Interplay between human papillomavirus infection, cervical cancer history, and
the incidence of oral cancer: A cohort study.
Cancer Epidemiol. 2025;97:102858.
Abstract
Significance of PFKFB4 and gene risk signature in cervical cancer prognosis and
progression.
Biochem Biophys Res Commun. 2025;775:152084.
Abstract
ChatGPT SMART Goals for collaborative practices in the Global Strategy to
Accelerate the Elimination of Cervical Cancer.
Cien Saude Colet. 2025;30:e00662025.
Abstract
Identification and validation of a thirteen-gene signature based on ubiquitin
related genes in cervical cancer.
Discov Oncol. 2025;16:1000.
Abstract
Single-cell RNA sequencing analysis reveals a lack of CXCL13(+) T cell subsets
associated with the recurrence of cervical squamous cell carcinoma following
concurrent chemoradiotherapy.
Cancer Immunol Immunother. 2025;74:235.
Abstract
Comparative Evaluation of Dosimetric Parameters in Carcinoma Cervix Patients
Undergoing Intensity-Modulated Radiotherapy versus Three-Dimensional
Radiotherapy: A Retrospective Analysis.
Gulf J Oncolog. 2025;1:7-12.
Abstract
Comprehensive Pan-cancer Analysis and Experimental Verification of EGLN Family:
Potential Biomarkers in Cervical Cancer.
Curr Cancer Drug Targets. 2025 Jun 3. doi: 10.2174/0115680096362252250527060004.
Abstract
Innovative nomogram for cervical cancer prediction: integrating high-risk HPV
infection, p53 genotype, and blood routine parameters.
Front Oncol. 2025;15:1541928.
Abstract
Barriers associated with the parental acceptance of human papillomavirus (HPV)
vaccination of minors in Asir, Saudi Arabia: A cross-sectional study.
Hum Vaccin Immunother. 2025;21:2513708.
Abstract
Evaluation of lymph node metastasis in cervical cancer: A retrospective
comparison of preoperative MRI and PET/CT with postoperative histopathology
results.
Turk J Obstet Gynecol. 2025;22:129-133.
Abstract
Systemic Inflammatory Response Index in Cervical Pathologies (Human
Papillomavirus and Cervical Neoplasia) and its Prognostic Value in Disease
Prediction.
Niger J Clin Pract. 2025;28:615-623.
Abstract
Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via
strengthening CD8 + TILs function and recruiting B cells in cervical cancer.
J Nanobiotechnology. 2025;23:413.
Abstract
Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response
Monitoring of Cervical Cancer.
Mol Diagn Ther. 2025 Jun 3. doi: 10.1007/s40291-025-00790.
Abstract
Risk for Human Papillomavirus-Associated Gynecologic Cancers Among Women of
Childbearing Age With Rheumatic Diseases: A Population-Based Cohort Study.
J Korean Med Sci. 2025;40:e95.
Abstract
Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Cervical
Cancer (SCORE): a Systematic Review and Meta-analysis.
Crit Rev Oncol Hematol. 2025 Jun 1:104789. doi: 10.1016/j.critrevonc.2025.104789
Abstract
Metabolomic profiling reveals grade-specific niacinamide accumulation and its
therapeutic potential via SIRT1-CD38-EMT axis modulation in cervical cancer
progression.
Biochim Biophys Acta Mol Cell Res. 2025;1872:119994.
Abstract
Cellular Immune Response to High-Risk Human Papillomavirus Infection: A
Systematic Review.
Crit Rev Immunol. 2025;45:33-49.
Abstract
The efficacy and safety of Tisotumab vedotin in the treatment of
recurrent/metastatic cervical cancer: a systematic review and meta-analysis of
single-arm studies.
Front Pharmacol. 2025;16:1538980.
Abstract
Analysis of the correlation between RFC4 expression and tumor immune
microenvironment and prognosis in patients with cervical cancer.
Front Genet. 2025;16:1514383.
Abstract
Research progress on tumor-infiltrating lymphocyte therapy for cervical cancer.
Front Immunol. 2025;16:1524842.
Abstract
Multi-omics analyses construct an inflammatory response based prognostic gene
signature for cervical cancer and suggest tumor infiltrating monocytes subgroups
as key players.
Front Immunol. 2025;16:1563593.
Abstract
Insights on the prognostic value of visceral obesity in stage IVB cervical cancer
treatment.
Cancer Pathog Ther. 2025;3:267-268.
Abstract
Commentary on the "Relationship between visceral obesity and prognosis in
patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy".
Cancer Pathog Ther. 2025;3:269-270.
Abstract
Study on the relationship between vaginal dose and radiation-induced vaginal
injury following cervical cancer radiotherapy, and model development.
Front Public Health. 2025;13:1585481.
Abstract
Community-based Screening of Cervical Cancer in an Urban Setting in Nepal: A
Cross-sectional Study.
Kathmandu Univ Med J (KUMJ). 2024;22:413-418.
Abstract
Prevalence of Depression and Associated Factors among Cervical Cancer Patients
Attending Tertiary Center in Bhaktapur, Nepal.
Kathmandu Univ Med J (KUMJ). 2024;22:385-392.
Abstract
Deregulation of LIMD1-VHL-HIF-1alpha-VEGF pathway is associated with different stages
of cervical cancer.
Biochem J. 2025;482:BCJ20170649.
Abstract
High-risk human papillomavirus testing in first-void urine as a novel and
non-invasive cervical cancer screening modality-a Danish diagnostic test accuracy
study.
BMC Med. 2025;23:327.
Abstract
Sociocultural factors influencing women's adherence to colorectal, breast, and
cervical cancer screening: a systematic review.
BMC Public Health. 2025;25:2034.
Abstract
High HPV viral load predicts worse prognosis in patients with cervical cancer
treated with radiochemotherapy.
Int J Radiat Biol. 2025 Jun 2:1-14. doi: 10.1080/09553002.2025.2510668.
Abstract
Trends in cervical cancer screening modality in the active component U.S.
military, 2013-2023.
MSMR. 2025;32:14-18.
Abstract
APG-115 synergizes with bortezomib to induce apoptosis in cervical cancer cells.
Anticancer Drugs. 2025 Jun 3. doi: 10.1097/CAD.0000000000001735.
Abstract
Efficacy of digital educational intervention using I-Change model in promoting
preventive behaviors for cervical cancer among Iranian women: A randomized
controlled trial.
Health Promot Perspect. 2025;15:44-53.
Abstract
Chemo-radiotherapy after neoadjuvant chemotherapy and radical hysterectomy in
women with stage IB-IIB cervical cancer: Do we need to change the therapeutic
approach? A cohort study.
Surg Pract Sci. 2025;21:100284.
Abstract
The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with
Experimental Validation.
Int J Womens Health. 2025;17:1511-1532.
Abstract
Investigation of Dosimetric Evaluation and Treatment Planning Time of Inverse
Planning Optimization in Combined Intracavitary and Interstitial Brachytherapy
for Cervical Cancer.
Cureus. 2025;17:e83330.
Abstract
Changes of Microbiome in Human Papillomavirus Infection and Cervical Cancer: A
Systematic Review and Meta-Analysis.
Cancer Rep (Hoboken). 2025;8:e70246.
Abstract
HPV genotyping agreement between paired cervical cytological sample and biopsy
across lesion severity and vaccination.
Virol J. 2025;22:176.
Abstract
Community-level Social Vulnerability and Cervical Cancer Mortality Among Young
and Old Adults in the State of Alabama.
J Community Health. 2025 Jun 1. doi: 10.1007/s10900-025-01482.
Abstract
Exploring the mechanism by which BXSD decoction treats cervical cancer through
the combination of network pharmacology and molecular docking analysis: Molecular
mechanism of AKT1 and CASP3 protein.
Int J Biol Macromol. 2025;317.
Abstract
Design, synthesis, and in vitro and in vivo anti-drug resistant cervical cancer
activity of novel licochalcone A derivatives based on dual targeting of
VEGFR-2/P-gp.
Bioorg Chem. 2025;163:108639.
Abstract
ASO Author Reflections: Multi-omic and Single-Cell Insights into the Age-Related
Molecular Landscape of Cervical Cancer.
Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17543.
Abstract
Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions
of the cervix through a targeted RNA next generation sequencing assay.
Mol Med. 2025;31:215.
Abstract
The American Brachytherapy Society (ABS) consensus guidance for hybrid
intracavitary interstitial brachytherapy for locally advanced cervical cancer.
Brachytherapy. 2025 May 29:S1538-4721(25)00086.
Abstract
Postnatal instead of normally-timed cervical screening (PINCS-1): a protocol for
a feasibility study of paired-sample cervical screening and urine self-sampling
at 6 weeks and 12 weeks postnatal in the UK.
BMJ Open. 2025;15:e092701.
Abstract
Osthole inhibits proliferation and induces autophagy-dependent ferroptosis of
cervical cancer cells through induction of TFR1.
Food Chem Toxicol. 2025;203:115577.
Abstract
Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management
Guidelines.
J Gen Intern Med. 2025 May 30. doi: 10.1007/s11606-025-09611.
Abstract
"The only vaccine that we really question is the new vaccine": A qualitative
exploration of the social and behavioural drivers of human papillomavirus (HPV)
vaccination in Tonga.
Vaccine. 2025;59:127280.
Abstract
Factors associated with HPV vaccine hesitancy: A nationally representative
cross-sectional study.
Vaccine. 2025;59:127278.
Abstract
Understanding the Influences of Cervical Screening Attendance among Women of Low
Socioeconomic Position Using the Integrated Screening Action Model: A Qualitative
Study.
Semin Oncol Nurs. 2025;41:151891.
Abstract
Microbial and metabolic profiles associated with HPV infection and cervical
intraepithelial neoplasia: a multi-omics study.
Microbiol Spectr. 2025;13:e0019225.
Abstract
Study on the correlation between BRCA1 gene polymorphism and hrHPV infection in
cervical precancerous lesions.
Cancer Genet. 2025;294-295:99-110.
Abstract
Deep Learning-Enhanced Hand-Driven Microfluidic Chip for Multiplexed Nucleic Acid
Detection Based on RPA/CRISPR.
Adv Sci (Weinh). 2025;12:e2414918.
Abstract
Prevalence of Human Papillomavirus and Genotype Correlation with Cervical Lesions
at the University Teaching Hospital of Kigali.
Am J Trop Med Hyg. 2025;112:1335-1340.
Abstract
Age-related changes in the radiologic findings of lobular endocervical glandular
hyperplasia: a multicenter study.
Jpn J Radiol. 2025;43:985-994.
Abstract
Association of Socio-Environmental Burden and Inequality With Cancer Screening
and Mortality.
J Surg Oncol. 2025;131:1110-1117.
Abstract
[Diagnosis, treatment and oncological outcome of cervical CUP-syndrome depending
on p16 status].
Laryngorhinootologie. 2025;104:361-370.
Abstract
Endocervical Adenocarcinoma With Micropapillary Component, a Distinct
Histological Subtype Associated With Aggressive Behavior and Poor Prognosis: A
Clinicopathologic Study of 10 Patients.
Int J Surg Pathol. 2025;33:801-808.
Abstract
Radiation Nephropathy Complicated by Tubulointerstitial Nephritis with
Predominantly Lymphocyte and Plasma Cell Infiltration.
Intern Med. 2025;64:1696-1705.
Abstract
Topical imiquimod treatment of residual or recurrent cervical intraepithelial
neoplasia lesions (TOPIC-2): A randomised controlled trial.
BJOG. 2025;132:1056-1064.
Abstract
p16INK4a/Ki67 Dual-Staining Immunocytochemistry to Refer Women Infected by
High-Risk Human Papillomavirus for Colposcopy.
Acta Cytol. 2025;69:16-25.
Abstract
Critical Evaluation of Pap Test Adherence to Routine Screening in Amazonas State,
Brazil.
Acta Cytol. 2025;69:144-153.
Abstract
Image Quantification Analysis of Cytoplasmic Mucin and Interpretation of Mucin
Color in Lobular Endocervical Glandular Hyperplasia.
Acta Cytol. 2025;69:131-143.
Abstract
The complexity and challenges of fertility preservation in women with cervix
cancer-A prospective cohort study reporting on reproductive outcome and overall
survival.
Acta Obstet Gynecol Scand. 2025;104:86-94.
Abstract
High rate of persistent HPV detection after diagnostic cervical excision in older
screen-positive women.
Acta Obstet Gynecol Scand. 2025;104:342-349.
Abstract
Predictors for regression and progression of actively surveilled cervical
intraepithelial neoplasia grade 2: A prospective cohort study.
Acta Obstet Gynecol Scand. 2025;104:763-773.
Abstract
Self-collected vaginal HPV samples for long-term non-attendees in the Swedish
organized cervical cancer screening program.
Acta Obstet Gynecol Scand. 2025 Apr 7. doi: 10.1111/aogs.15112.
Abstract
Validation of data quality in the Swedish quality register of gynecologic cancer
for cervical cancer and vulvar cancer-a Swedish gynecologic cancer group
(Swe-GCG) study.
Acta Obstet Gynecol Scand. 2025 May 7. doi: 10.1111/aogs.15152.
Abstract
Outcomes associated with large loop excision of the cervical transformation zone
in women 60-64 years of age: A population-based register study from Denmark.
Acta Obstet Gynecol Scand. 2025;104:1112-1119.
Abstract
Claudin-18 and Mutation Surrogate Immunohistochemistry in Gastric-type
Endocervical Lesions and their Differential Diagnoses.
Am J Surg Pathol. 2025;49:206-216.
Abstract
Extensive Pathologic Invasion and Prognostic Implication of Gastric-Type Cervical
Adenocarcinoma: A Comparative Analysis With Human Papillomavirus-Associated
Adenocarcinoma.
Am J Surg Pathol. 2025;49:471-480.
Abstract
Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated
Squamous Cell Carcinoma of the Uterine Cervix and Vulva.
Am J Surg Pathol. 2025 Jan 31. doi: 10.1097/PAS.0000000000002367.
Abstract
The triage role of cytological DNA methylation in women with non-16/18,
specifically genotyping high-risk HPV infection.
Br J Cancer. 2025 Apr 10. doi: 10.1038/s41416-025-03005.
Abstract
Burden of female-specific cancers in China from 1990 to 2021: A systematic
analysis for the Global Burden of Disease Study 2021.
Cancer. 2025;131:e35712.
Abstract
Association of mental health treatment receipt with cancer screening among US
adults with a history of anxiety or depression.
Cancer. 2025;131:e35724.
Abstract
Overall survival benefit of pembrolizumab plus chemoradiotherapy for patients
with high-risk locally advanced cervical cancer.
Cancer. 2025;131:e35688.
Abstract
Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III-IVa
cervical cancer: is the ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial practice changing?
Cancer. 2025;131:e35749.
Abstract
Update on safety and feasibility of the combination of pembrolizumab and pelvic
chemoradiation in locally advanced cervical cancer.
Cancer. 2025;131:e35757.
Abstract
New standard of care for patients with locally advanced cervical cancer.
Cancer. 2025;131:e35739.
Abstract
Cervical cancer stigma - A silent barrier to the elimination of cervical cancer.
Cancer. 2025;131:e35776.
Abstract
Recent advances in gynecologic radiation oncology.
Cancer. 2025;131:e35888.
Abstract
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade
Cervical Intraepithelial Neoplasia: A Phase II Trial.
Clin Cancer Res. 2025;31:1016-1026.
Abstract
Integration of AI-Assisted in Digital Cervical Cytology Training: A Comparative
Study.
Cytopathology. 2025;36:156-164.
Abstract
Digital Cytology Combined With Artificial Intelligence Compared to Conventional
Microscopy for Anal Cytology: A Preliminary Study.
Cytopathology. 2025;36:250-258.
Abstract
Clinical Performance of a Liquid Preservation Medium for Cervicovaginal Samples
in DNA-HPV Testing and Liquid-Based Cytology for Cervical Cancer Screening.
Cytopathology. 2025 Apr 23. doi: 10.1111/cyt.13495.
Abstract
Contaminant Suggesting Rotifer in Liquid-Based Cytology of the Cervix.
Diagn Cytopathol. 2025;53:136-138.
Abstract
Cytology Triage for HPV-Positive Postmenopausal Women in a Setting of Cervical
Cancer Screening.
Diagn Cytopathol. 2025 Feb 26. doi: 10.1002/dc.25456.
Abstract
Poor Performance of Applicator Tampon-Based Self-Collection for Liquid-Based
Cytology Among Women Attending a Tertiary Hospital in South Africa.
Diagn Cytopathol. 2025;53:150-160.
Abstract
Evaluating the Cytomorphologic Features of Cervical Adenosquamous Carcinoma.
Diagn Cytopathol. 2025;53:256-261.
Abstract
The Value of P16 Protein Detection in the Screening for High-Grade Squamous
Intraepithelial and Higher Lesions of the Cervix by the Combined Detection of
HR-HPV and TCT.
Diagn Cytopathol. 2025;53:283-289.
Abstract
Utility of CINtec PLUS in Identification of High-Grade Lesions on Short-Term
Follow-Up in Patients With Negative Cytologic Interpretation.
Diagn Cytopathol. 2025;53:265-271.
Abstract
Determination of Prevalence and Genotype Distribution of High-Risk Human
Papillomavirus in Varamin (Iran).
Diagn Cytopathol. 2025;53:325-332.
Abstract
Human Papillomavirus Prevalence and Genotype Distribution Among Women With
Cervical Cytological Abnormalities in Urumqi, Xinjiang, China.
Diagn Cytopathol. 2025;53:315-324.
Abstract
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in
the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Eur J Cancer. 2025;216:115146.
Abstract
Tegafur-uracil maintenance chemotherapy post-chemoradiotherapy for cervical
cancer: Randomized trial.
Eur J Cancer. 2025;219:115304.
Abstract
Induction chemotherapy followed by chemoradiation in locally advanced cervical
cancer: Quality of life outcomes of the GCIG INTERLACE trial.
Eur J Cancer. 2025;220:115375.
Abstract
Letter comments on: "Induction chemotherapy followed by chemoradiation in locally
advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial".
Eur J Cancer. 2025 Apr 22:115448. doi: 10.1016/j.ejca.2025.115448.
Abstract
Response to letter Re: Induction chemotherapy followed by chemoradiation in
locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE
trial.
Eur J Cancer. 2025 Apr 22:115449. doi: 10.1016/j.ejca.2025.115449.
Abstract
Letter Re: Induction chemotherapy followed by chemoradiation in locally advanced
cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.
Eur J Cancer. 2025 May 19:115515. doi: 10.1016/j.ejca.2025.115515.
Abstract
Cervical screening with self-sampling for postmenopausal women with molecular
triage using extended genotyping and methylation.
Eur J Obstet Gynecol Reprod Biol. 2025;305:404-409.
Abstract
The relationship between HPV-Associated LSIL and HSIL lesions and overactive
bladder in postmenopausal women.
Eur J Obstet Gynecol Reprod Biol. 2025;306:69-74.
Abstract
Prevalence rate of high-grade cytological lesions of the cervix in women aged
under 25 years in French Guiana.
Eur J Obstet Gynecol Reprod Biol. 2025;306:21-24.
Abstract
Should men whose female partners have cervical high grade intraepithelial lesion
(HSIL) be screened?
Eur J Obstet Gynecol Reprod Biol. 2025;308:257-260.
Abstract
Risk of cervical stenosis after cervical excision in postmenopausal patients.
Eur J Obstet Gynecol Reprod Biol. 2025;308:208-213.
Abstract
Diagnostic accuracy of available methylation assays in advanced cervical
intraepithelial neoplasia from high-risk HPV-positive women: A systematic review
and network meta-analysis.
Eur J Obstet Gynecol Reprod Biol. 2025;308:54-65.
Abstract
Can contrast-enhanced ultrasound differentiate cervical lesions?
Eur J Obstet Gynecol Reprod Biol. 2025;310:113998.
Abstract
Impact of Human papillomavirus 9-valent vaccine on viral clearance after surgical
treatment: A single-center retrospective observational study.
Eur J Obstet Gynecol Reprod Biol. 2025;310:113994.
Abstract
Thromboprophylaxis in patients with locally advanced cervical cancer treated with
chemoradiation and brachytherapy.
Gynecol Oncol. 2025;193:41-48.
Abstract
The value of magnetic resonance imaging in predicting vesicovaginal fistula in
cervical cancer with bladder invasion treated with definitive chemoradiotherapy.
Gynecol Oncol. 2025;193:136-140.
Abstract
Living in a food desert in Louisiana and its effects on gynecologic cancer
outcomes.
Gynecol Oncol. 2024;192:137-144.
Abstract
Efficacy of induction chemotherapy during the COVID-19 pandemic for treatment of
locally advanced cervical cancer in Botswana.
Gynecol Oncol. 2025;194:91-97.
Abstract
Sentinel lymph node biopsy at the time of hysterectomy for early-stage cervical
cancer: A cost-effectiveness analysis.
Gynecol Oncol. 2025;195:1-5.
Abstract
Cost-effectiveness of an additional hysterectomy after initially conservative
treatment for cervical adenocarcinoma in situ.
Gynecol Oncol. 2025;193:113-118.
Abstract
Evaluation of physical function and quality of life before and after nonradical
surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278).
Gynecol Oncol. 2025;195:50-58.
Abstract
Evaluation of efficacy and fertility after nonradical surgical therapy (extra
fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1,
IA2, and IB1 cervical cancer (GOG-0278).
Gynecol Oncol. 2025;195:59-65.
Abstract
Validating the predicted impact of HPV vaccination on HPV prevalence, cervical
lesions, and cervical cancer: A systematic review of population level data and
modelling studies.
Gynecol Oncol. 2025;195:134-143.
Abstract
Which factors predict the effectiveness of adjuvant treatment in patients with
non-high-risk early-stage cervical cancer? Ancillary analysis of KGOG-1028.
Gynecol Oncol. 2025;196:10-15.
Abstract
Preoperative conization in cervical cancer patients undergoing open abdominal
radical hysterectomy: Results from a propensity-score matched study.
Gynecol Oncol. 2025;196:69-77.
Abstract
Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2
clinical trial.
Gynecol Oncol. 2025;196:28-35.
Abstract
Cross-language insights: Comparing Spanish and English-language cervical cancer
content on TikTok.
Gynecol Oncol. 2025;194:131-136.
Abstract
Preoperative tumour size assessment in patients with early-stage cervical cancer:
Final results of the SENTIX study.
Gynecol Oncol. 2025;196:160-167.
Abstract
Temporal trends of sentinel lymph node biopsy without lymphadenectomy at cervical
cancer surgery.
Gynecol Oncol. 2025;196:182-191.
Abstract
Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally
advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III
randomized trial.
Gynecol Oncol. 2025;195:122-133.
Abstract
Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in
patients with low-risk, early-stage cervical cancer: A retrospective analysis of
KGOG 1028 data based on SHAPE trial eligibility criteria.
Gynecol Oncol. 2025;197:91-95.
Abstract
Redefining stage IVB cervical cancer: The unique prognosis of distant lymph node
metastasis which is comparable to stage IIIC.
Gynecol Oncol. 2025;198:17-24.
Abstract
Topographic mapping of pelvic and aortic lymph node metastases in stage IIIC1r
locally advanced cervical cancer: A retrospective study by the Spain-GOG group.
Gynecol Oncol. 2025;198:49-54.
Abstract
AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab
plus tislelizumab and tislelizumab alone in patients with previously treated
recurrent or metastatic cervical cancer.
Gynecol Oncol. 2025;198:25-32.
Abstract
Postoperative hypofractionated intensity-modulated radiation therapy in cervical
cancer: prospective phase 2 trial (POHIM_RT study).
Gynecol Oncol. 2025;198:84-89.
Abstract
Hepatocyte nuclear factor 4alpha as a sensitive marker for uterine endocervical
adenocarcinomas and their precursors.
Hum Pathol. 2025;155:105714.
Abstract
Clinicopathologic and molecular characterization of primitive neuroectodermal
tumors (PNET) in the female genital tract: a retrospective study of 8 cases.
Hum Pathol. 2025;157:105769.
Abstract
Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation
and/or HPV genotyping in HPV positive women with low-grade cytology from a
population-based Dutch primary HPV screening trial.
Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35289.
Abstract
The variations in the natural history of high-risk human papillomavirus
infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A
prospective cohort study.
Int J Cancer. 2025;156:1043-1054.
Abstract
Performance of the WID-qEC test to detect uterine cancers in black women with
abnormal uterine bleeding: A prospective observational cohort study in Ghana.
Int J Cancer. 2024 Dec 10. doi: 10.1002/ijc.35260.
Abstract
Nationwide cohort study on the risk of high-grade cervical dysplasia and
carcinoma after conservative treatment or hysterectomy for adenocarcinoma in
situ.
Int J Cancer. 2024 Nov 4. doi: 10.1002/ijc.35237.
Abstract
Cervical cancer incidence rates considering migration status in mainland China
using Bayesian model-Estimation based on 2016 cancer registry data.
Int J Cancer. 2025 Jan 23. doi: 10.1002/ijc.35346.
Abstract
Participation and relative cost of attendance by direct-mail compared to opt-in
invitation strategy for HPV self-sampling targeting cervical screening
non-attenders: A large-scale, randomized, pragmatic study.
Int J Cancer. 2024 Nov 23. doi: 10.1002/ijc.35263.
Abstract
Global landscape of cervical cancer incidence and mortality in 2022 and
predictions to 2030: The urgent need to address inequalities in cervical cancer.
Int J Cancer. 2025 Mar 3. doi: 10.1002/ijc.35369.
Abstract
Socioeconomic position and risk of cervical cancer in the Nordic countries:
Results from the Nordic Occupational Cancer Study.
Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35349.
Abstract
High-risk human papillomavirus genotypes in previously unscreened
reproductive-age women in Ethiopia: A community-based cohort study.
Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35335.
Abstract
p16/ki-67 dual stain triage of individuals positive for HPV to detect cervical
precancerous lesions.
Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35353.
Abstract
Should the age range of the Dutch hrHPV-based cervical cancer screening program
be broadened? A modelling study using cohort effects.
Int J Cancer. 2025 Apr 28. doi: 10.1002/ijc.35435.
Abstract
Technical, legal and ethical framework of cancer audit in cervical screening -
Summary of best practices for organised programmes delineated through an expert
group consultation.
Int J Cancer. 2025;157:32-40.
Abstract
DNA methylation signatures of cervical pre-invasive and invasive disease: An
epigenome-wide association study.
Int J Cancer. 2025;157:305-316.
Abstract
Risk of high-grade cervical lesions in the second round of primary human
papillomavirus testing in CervicalScreen Norway: A population-based cohort study.
Int J Cancer. 2025;157:251-259.
Abstract
Cost-effectiveness analysis of 9-valent human papillomavirus vaccine combined
with screening for cervical cancer in Japan.
Int J Gynaecol Obstet. 2024 Dec 28. doi: 10.1002/ijgo.16125.
Abstract
Review of triage strategies for atypical squamous cells of undetermined
significance among young women.
Int J Gynaecol Obstet. 2025;168:428-435.
Abstract
HPV 16/18 E7 oncoprotein detection as a promising triage strategy for HPV
16/18-positive patients: A prospective multicenter study with a 2-year follow up.
Int J Gynaecol Obstet. 2024 Sep 8. doi: 10.1002/ijgo.15897.
Abstract
A pilot study of upcycled smartphone-based colposcopy for visual inspection of
cervix performed by community healthcare workers in rural Vietnam.
Int J Gynaecol Obstet. 2025;168:518-524.
Abstract
Yield of endocervical curettage in detecting cervical intraepithelial neoplasia
grade 2 or higher during colposcopy: A prospective, cross-sectional study.
Int J Gynaecol Obstet. 2025;169:105-111.
Abstract
Efficacy of chitosan powder in reducing vaginal bleeding following a loop
electrosurgical excision procedure: A randomized control trial.
Int J Gynaecol Obstet. 2025;169:240-246.
Abstract
High acceptability of point-of-care HIV testing at the colposcopy outpatient
clinic in hospitals in the Netherlands.
Int J Gynaecol Obstet. 2025;169:155-162.
Abstract
Roles of probiotics against HPV through the gut-vaginal axis.
Int J Gynaecol Obstet. 2024 Nov 9. doi: 10.1002/ijgo.16005.
Abstract
The association between additional radiotherapy after systemic chemotherapy and
the prognosis of stage FIGO 2018 IVB cervical cancer.
Int J Gynaecol Obstet. 2025 Mar 22. doi: 10.1002/ijgo.70077.
Abstract
Cervical precancer screening and treatment in Nouakchott, Mauritania: Pilot
program to inform development of Mauritania's national cervical cancer prevention
program.
Int J Gynaecol Obstet. 2025 Apr 11. doi: 10.1002/ijgo.70145.
Abstract
Cytologic DNA methylation for managing minimally abnormal cervical cancer
screening results.
Int J Gynaecol Obstet. 2025 Apr 16. doi: 10.1002/ijgo.70167.
Abstract
Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society
of Gynecological Oncology (ESGO) prevention committee opinion.
Int J Gynaecol Obstet. 2024 Dec 30. doi: 10.1002/ijgo.16120.
Abstract
Safety and adherence to self-administered intravaginal 5-fluorouracil cream
following cervical intraepithelial neoplasia (CIN) 2/3 treatment among
HIV-positive women in Kenya: A phase 1 clinical trial.
Int J Gynaecol Obstet. 2024 Dec 26. doi: 10.1002/ijgo.16093.
Abstract
Comprehensive cross-sectional study of CIN prevalence, HPV genotyping, genetic
alterations, and microbiota as molecular biomarkers for early cervical cancer
detection: A pilot clinical study among women in Russia.
Int J Gynaecol Obstet. 2025 May 5. doi: 10.1002/ijgo.70090.
Abstract
Accuracy analysis of cervical cancer screening using urine and vaginal
self-sampling versus clinician-collected samples: A systematic review and
meta-analysis.
Int J Gynaecol Obstet. 2025 May 13. doi: 10.1002/ijgo.70207.
Abstract
Role of pre-sacral sentinel lymph nodes in endometrium and cervical cancer:
experience with minimally invasive indocyanine green sentinel lymph node mapping.
Int J Gynecol Cancer. 2025;35:100032.
Abstract
Correspondence on "Fertility-sparing treatment with conization versus radical
hysterectomy in patients with early-stage cervical cancer: inverse propensity
score weighted analysis," by Ditto et al.
Int J Gynecol Cancer. 2025;35:100028.
Abstract
Men's role in women's health: Engaging male partners in cervical cancer
prevention efforts in low-to-middle-income countries.
Int J Gynecol Cancer. 2025;35:100021.
Abstract
Vulvar inspection at the time of cervical cancer screening: European Society of
Gynaecological Oncology (ESGO), International Society for the Study of
Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease
(ECSVD), and European
Int J Gynecol Cancer. 2025;35:100007.
Abstract
Minimally invasive surgery for simple hysterectomy in early-stage cervical
cancer: 'SHAPing' a path forward.
Int J Gynecol Cancer. 2025;35:101619.
Abstract
Cervical cancer stage distribution and survival outcomes in Africa: a systematic
review and meta-analysis.
Int J Gynecol Cancer. 2025;35:100008.
Abstract
Minimally invasive compared to open surgery in patients with low-risk cervical
cancer following simple hysterectomy: An exploratory analysis from the
Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
Int J Gynecol Cancer. 2025;35:100001.
Abstract
Progression-free survival as a potential surrogate end point for overall survival
in advanced cervical carcinoma.
Int J Gynecol Cancer. 2025;35:100012.
Abstract
RELEVANT-C study: patient-reported prevalence of lower extremity lymphedema after
sentinel lymph node mapping vs lymphadenectomy after surgery for early-stage
cervical cancer.
Int J Gynecol Cancer. 2025;35:100063.
Abstract
Global survey on training and practice in sentinel lymph node mapping for
endometrial and cervical cancer among early-career gynecologic oncologists.
Int J Gynecol Cancer. 2025;35:100050.
Abstract
Reply to "Correspondence on 'Fertility-sparing treatment with conization versus
radical hysterectomy in patients with early-stage cervical cancer: Inverse
propensity score-weighted analysis,' by Ditto et al" by Phillippe Morice and
Sebastien Gouy.
Int J Gynecol Cancer. 2025;35:100026.
Abstract
Wunderlich syndrome as a presenting symptom in cervical cancer.
Int J Gynecol Cancer. 2025 Jan 30:101675. doi: 10.1016/j.ijgc.2025.101675.
Abstract
Addition of chemotherapy to radiation is associated with improved survival in
older patients with cervical cancer: a Surveillance, Epidemiology, and End
Results database analysis.
Int J Gynecol Cancer. 2025 Jan 9:101633. doi: 10.1016/j.ijgc.2025.101633.
Abstract
Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for
fertilItY-sparing approach: an analysis of the ETERNITY project.
Int J Gynecol Cancer. 2025 Jan 17:101643. doi: 10.1016/j.ijgc.2025.101643.
Abstract
Laparoscopic para-uterine lymphovascular tissue sentinel lymph node biopsy with
indocyanine green in cervical cancer.
Int J Gynecol Cancer. 2025 Feb 27:101744. doi: 10.1016/j.ijgc.2025.101744.
Abstract
Radical hysterectomy and ovarian transposition during cesarean section for newly
diagnosed cervical cancer in pregnancy.
Int J Gynecol Cancer. 2025 Jan 25:101663. doi: 10.1016/j.ijgc.2025.101663.
Abstract
SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in
cervical cancer.
Int J Gynecol Cancer. 2025 Feb 6:101690. doi: 10.1016/j.ijgc.2025.101690.
Abstract
Modified radical hysterectomy for stage IB1 (
Int J Gynecol Cancer. 2025 Feb 1:101676. doi: 10.1016/j.ijgc.2025.101676.
Abstract
Neuroendocrine cervical carcinomas: genomic insights, controversies in treatment
strategies, and future directions: a NeCTuR study.
Int J Gynecol Cancer. 2025;35:101639.
Abstract
External validation of the annual recurrence risk model for tailored surveillance
strategy in patients with cervical cancer.
Int J Gynecol Cancer. 2025 Mar 1:101756. doi: 10.1016/j.ijgc.2025.101756.
Abstract
Circulating human papillomavirus DNA sequencing as a biomarker of response in
advanced cervical cancer.
Int J Gynecol Cancer. 2025 Mar 1:101755. doi: 10.1016/j.ijgc.2025.101755.
Abstract
Neoadjuvant chemotherapy in stage IB2 to IB3 cervical cancer: because we can or
because we must?
Int J Gynecol Cancer. 2025 Mar 14:101770. doi: 10.1016/j.ijgc.2025.101770.
Abstract
Revolutionizing first-line cervical cancer treatment: bevacizumab, immunotherapy,
and emerging insights.
Int J Gynecol Cancer. 2025 Jan 28:101661. doi: 10.1016/j.ijgc.2025.101661.
Abstract
The impact of chemotherapy on survival in patients aged >/=65 years with
locoregionally cervical cancer who undergo radiotherapy: a Surveillance,
Epidemiology, and End Results database analysis.
Int J Gynecol Cancer. 2025 Mar 3:101747. doi: 10.1016/j.ijgc.2025.101747.
Abstract
ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for
early-stage cervical cancer.
Int J Gynecol Cancer. 2025 Feb 28:101760. doi: 10.1016/j.ijgc.2025.101760.
Abstract
Long-term survival in patients with para-aortic metastatic cervical cancer
receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a
single-center experience.
Int J Gynecol Cancer. 2024;34:1536-1546.
Abstract
Considerations for route of hysterectomy in low-risk cervical cancer.
Int J Gynecol Cancer. 2024;34:1481.
Abstract
Assessment of postoperative therapy de-escalation for early-stage,
intermediate-risk cervical cancer.
Int J Gynecol Cancer. 2024;34:1349-1358.
Abstract
Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set
up for the LASH trial.
Int J Gynecol Cancer. 2024;34:1805-1808.
Abstract
Association between Silva pattern-based classification and endocervical
adenocarcinoma: a systematic review and meta-analysis.
Int J Gynecol Cancer. 2024;34:1704-1710.
Abstract
Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical
excision procedure (LEEP) specimens.
Int J Gynecol Cancer. 2024;34:1698-1703.
Abstract
Comparing visual inspection with acetic acid, with and without Lugol's Iodine for
triage of HPV self-sample positive women in Ethiopia: a randomized controlled
trial.
Int J Gynecol Cancer. 2024;34:1691-1697.
Abstract
Are we making progress in curing advanced cervical cancer-again?
Int J Gynecol Cancer. 2024;34:1940-1945.
Abstract
Para-aortic lymph node recurrence in surgically treated early-stage cervical
cancer without para-aortic lymph node surgical staging.
Int J Gynecol Cancer. 2024;34:1867-1873.
Abstract
Accuracy of pre-operative tumor size assessment compared to final pathology and
frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical
cancer.
Int J Gynecol Cancer. 2024;34:1861-1866.
Abstract
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab
plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer
(SKYSCRAPER-04).
Int J Gynecol Cancer. 2024;34:1140-1148.
Abstract
Methods of surgical quality assurance in cervical and endometrial cancer trials:
a systematic review and meta-analysis.
Int J Gynecol Cancer. 2025;35:100018.
Abstract
Critical view of safety assessment in sentinel node dissection for endometrial
and cervical cancer: artificial intelligence to enhance surgical safety and lymph
node detection (LYSE study).
Int J Gynecol Cancer. 2025;35:101789.
Abstract
Cervical cancer elimination in low-resource countries: low-cost strategy.
Int J Gynecol Cancer. 2025 Apr 11:101828. doi: 10.1016/j.ijgc.2025.101828.
Abstract
Patterns of pembrolizumab use for recurrent cervical cancer.
Int J Gynecol Cancer. 2025;35:101802.
Abstract
Whole-uterine versus individualized-uterine radiotherapy in locally advanced
cervical cancer: clinical outcome and toxicity.
Int J Gynecol Cancer. 2025;35:101817.
Abstract
Scale-up of cervical cancer prevention services in Zambia.
Int J Gynecol Cancer. 2025;35:101816.
Abstract
Minimally invasive simple hysterectomy in low-risk cervical cancer: a single-arm
trial with stopping rules (ENGOT-cx23/MITO/LASH trial).
Int J Gynecol Cancer. 2025;35:101818.
Abstract
Pocket guide based on the TNM and FIGO staging systems for classifying patients
with locally advanced cervical cancer: a practical tool from the GINECO group for
quick and easy management.
Int J Gynecol Cancer. 2025;35:101908.
Abstract
Association between magnetic resonance imaging-measured bone marrow cellularity
and clinical outcomes among patients with cervical cancer treated with programmed
cell death protein-1 inhibitors.
Int J Gynecol Cancer. 2025;35:101808.
Abstract
Regression of high-grade squamous intraepithelial cervical lesions and associated
risk factors (RECER).
Int J Gynecol Cancer. 2025;35:101768.
Abstract
A randomized clinical trial to assess the effectiveness of thermal ablation
versus loop electrosurgical excision procedure for cervical cancer risk reduction
in women living with HIV in Mozambique.
Int J Gynecol Cancer. 2025 Apr 26:101905. doi: 10.1016/j.ijgc.2025.101905.
Abstract
Urinary reconstruction using enterocystoplasty after partial cystectomy in
surgical recurrence of cervical cancer.
Int J Gynecol Cancer. 2025;35:101813.
Abstract
The art of prevention: merging creativity and medicine to transform cervical
cancer awareness.
Int J Gynecol Cancer. 2025;35:101909.
Abstract
Declaration on cervical cancer elimination: literature review and perspectives
from early-career clinicians.
Int J Gynecol Cancer. 2025;35:101902.
Abstract
Cervical cancer prevention in Colombian indigenous communities, a project by
Acacia de Vida Foundation.
Int J Gynecol Cancer. 2025 Jan 9:101623. doi: 10.1016/j.ijgc.2024.101623.
Abstract
Survival outcomes and safety of nimotuzumab combined with radiotherapy +/-
chemotherapy for locally advanced cervical cancer.
Int J Gynecol Cancer. 2025;35:101930.
Abstract
High human papillomavirus viral load and local immune dysregulation are
associated with poor clinical outcomes in patients with cervical cancer.
Int J Gynecol Cancer. 2025;35:101924.
Abstract
Carbon-ion radiotherapy for adenocarcinoma of the uterine cervix: clinical
outcomes of a multicenter prospective registry-based study in Japan (2016-2020).
Int J Radiat Oncol Biol Phys. 2024 Oct 16:S0360-3016(24)03467.
Abstract
Long Term Results of a Phase II Study of Adjuvant Proton Radiotherapy for
Node-Positive Cancer of the Uterus and Cervix: Proton Radiation for
Uterine/Cervical Cancer.
Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00238.
Abstract
A prospective single-arm study of daily online adaptive radiotherapy for cervical
cancer with reduced PTV margin: acute toxicity and dosimetric outcomes.
Int J Radiat Oncol Biol Phys. 2025 Apr 1:S0360-3016(25)00309.
Abstract
Fully Automated Online Adaptive Radiotherapy Decision Making for Cervical Cancer
Using Artificial Intelligence.
Int J Radiat Oncol Biol Phys. 2025 Apr 17:S0360-3016(25)00379.
Abstract
Distant metastasis after chemoradiation and IGABT in locally advanced cervical
cancer.
Int J Radiat Oncol Biol Phys. 2025 May 10:S0360-3016(25)00436.
Abstract
Understanding hydronephrosis occurrence by an individual-kidney level analysis of
all events post-chemoradiotherapy for locally advanced cervical cancer.
Int J Radiat Oncol Biol Phys. 2025 May 8:S0360-3016(25)00430.
Abstract
Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or
Persistent Cervical Cancer: Results from a Phase II Multi-Institutional Study.
Int J Radiat Oncol Biol Phys. 2025 May 14:S0360-3016(25)00446.
Abstract
Impact of patient selection on real-world outcomes by using the EMBRACE-II
treatment protocol in locally advanced cervical cancer.
Int J Radiat Oncol Biol Phys. 2025 Jun 1:S0360-3016(25)00554.
Abstract
Oncologic Outcomes of Laparoscopic Radical Hysterectomy Incorporating Modified
Tumor-Free Techniques.
Obstet Gynecol. 2024 Dec 19. doi: 10.1097/AOG.0000000000005805.
Abstract
Fragmented Care and Guideline-Concordant Treatment in Locally Advanced Cervical
Cancer.
Obstet Gynecol. 2025 Feb 27. doi: 10.1097/AOG.0000000000005869.
Abstract
Survival After Simple Compared With Radical Hysterectomy for Patients With
Early-Stage Cervical Cancer.
Obstet Gynecol. 2025;145:e139.
Abstract
Guideline-Concordant Surveillance After Treatment for High-Grade Cervical
Dysplasia.
Obstet Gynecol. 2025;145:461-468.
Abstract
Detection of Human Papillomavirus DNA on Red Blood Cells in Patients With
Cervical Cancer.
Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005932.
Abstract
IFITM1 as a modulator of surfaceome dynamics and aggressive phenotype in cervical
cancer cells.
Oncol Rep. 2025;53:71.
Abstract
Development and external validation of a multi-task feature fusion network for
CTV segmentation in cervical cancer radiotherapy.
Radiother Oncol. 2024;204:110699.
Abstract
Dose-volume constraints for severe acute gastrointestinal toxicity in cervical
cancer patients receiving extended-field intensity-modulated radiotherapy and
concurrent chemotherapy.
Radiother Oncol. 2025 Feb 4:110777. doi: 10.1016/j.radonc.2025.110777.
Abstract
Can knowledge-based planning models validated on ethnically diverse patients lead
to global standardisation of external beam radiation therapy for locally advanced
cervix cancer?
Radiother Oncol. 2025;204:110694.
Abstract
Dosimetric evaluation of variation in Library of plans selection for cervical
cancer radiotherapy.
Radiother Oncol. 2025;206:110835.
Abstract
Detecting epithelial-mesenchymal transition signaling molecules in cervical
epithelial cells aids in the early diagnosis of cervical lesions.
BMC Cancer. 2024;24:1582.
Abstract
Integrative machine learning frameworks to uncover specific protein signature in
neuroendocrine cervical carcinoma.
BMC Cancer. 2025;25:57.
Abstract
Barriers to cervical cancer screening among immigrant Yemeni women in Malaysia.
BMC Cancer. 2025;25:4.
Abstract
Incidence, trends and patterns of female breast, cervical, colorectal and
prostate cancers in Antigua and Barbuda, 2017-2021: a retrospective study.
BMC Cancer. 2025;25:72.
Abstract
Urban-rural disparities in cervical cancer screening among Indian women between
30-49 years: a geospatial and decomposition analysis using a nationally
representative survey.
BMC Cancer. 2025;25:67.
Abstract
MRI delta radiomics during chemoradiotherapy for prognostication in locally
advanced cervical cancer.
BMC Cancer. 2025;25:122.
Abstract
Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer
tissue.
BMC Cancer. 2025;25:111.
Abstract
ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer
prevention in children and adolescents living with HIV.
BMC Cancer. 2025;25:151.
Abstract
The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and
cervical cancer biomarkers.
BMC Cancer. 2025;25:202.
Abstract
Evaluation of pathology resources for cervical cancer detection between 2018 and
2022: a retrospective study at Moi Teaching and Referral Hospital, Western Kenya.
BMC Cancer. 2025;25:203.
Abstract
Construction and evaluation of a prognostic model for cervical cancer based on
dynamic hematological and clinical features.
BMC Cancer. 2025;25:207.
Abstract
Knowledge, attitude, and practice towards uterine cervical cancer screening in
Egyptian females: a nationwide cross-sectional study.
BMC Cancer. 2025;25:237.
Abstract
Radiomics feature is a risk factor for locally advanced cervical cancer treated
using concurrent chemoradiotherapy based on magnetic resonance imaging: a
retrospective study.
BMC Cancer. 2025;25:230.
Abstract
Dosimetric effects of bladder volume changes in MR-guided radiotherapy for
cervical cancer.
BMC Cancer. 2025;25:324.
Abstract
Correction: Barriers to cervical cancer screening among immigrant Yemeni women in
Malaysia.
BMC Cancer. 2025;25:320.
Abstract
Multiple sexual partnership as an independent predictor of cervical cancer
screening among women of reproductive age: an analysis of the 2022 Kenya
demographic and health survey.
BMC Cancer. 2025;25:259.
Abstract
Predictors of distant metastasis or local recurrent after radiotherapy in
patients with cervical cancer.
BMC Cancer. 2025;25:364.
Abstract
Performance of a six-methylation-marker assay in predicting LEEP specimen
histology results of cervical HSIL patients: a retrospective study.
BMC Cancer. 2025;25:340.
Abstract
Limonoid-rich fraction from Azadirachta indica A. Juss. (neem) stem bark triggers
ROS-independent ER stress and induces apoptosis in 2D cultured cervical cancer
cells and 3D cervical tumor spheroids.
BMC Cancer. 2025;25:334.
Abstract
Global, regional, and national burden of breast, cervical, uterine, and ovarian
cancer and their risk factors among women from 1990 to 2021, and projections to
2050: findings from the global burden of disease study 2021.
BMC Cancer. 2025;25:330.
Abstract
Low pretreatment prognostic nutritional index predicts unfavorable survival in
stage III-IVA squamous cervical cancer undergoing chemoradiotherapy.
BMC Cancer. 2025;25:377.
Abstract
The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for
advanced cervical cancer: a phase 3 randomized controlled trials based
meta-analysis.
BMC Cancer. 2025;25:450.
Abstract
Single-cell transcriptomic analysis reveals CD8 + T cell heterogeneity and
identifies a prognostic signature in cervical cancer.
BMC Cancer. 2025;25:498.
Abstract
Prognostic evaluation and treatment strategies for cervical cancer in pregnancy:
a systematic review and meta-analysis.
BMC Cancer. 2025;25:502.
Abstract
What is the impact of perineural invasion on the prognosis of cervical cancer: a
systematic review and meta-analysis.
BMC Cancer. 2025;25:491.
Abstract
CausalCervixNet: convolutional neural networks with causal insight (CICNN) in
cervical cancer cell classification-leveraging deep learning models for enhanced
diagnostic accuracy.
BMC Cancer. 2025;25:607.
Abstract
Development of a m6A- and ferroptosis-related LncRNA signature for forecasting
prognosis and treatment response in cervical cancer.
BMC Cancer. 2025;25:580.
Abstract
Prevalence of HPV infection and cervical lesions among women with pelvic organ
prolapse and implications for preoperative evaluation.
BMC Cancer. 2025;25:624.
Abstract
6-Methoxyflavone inhibits glycolytic energy metabolism in HeLa cells.
BMC Cancer. 2025;25:719.
Abstract
Nomogram model for predicting the long-term prognosis of cervical cancer
patients: a population-based study in Mato Grosso, Brazil.
BMC Cancer. 2025;25:684.
Abstract
Trends and projections in cervical cancer incidence in northern Tunisia
(1994-2040).
BMC Cancer. 2025;25:739.
Abstract
Comparison of oncological outcomes and complication rate between radical
hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer
without parametrial invasion.
BMC Cancer. 2025;25:811.
Abstract
Unlocking the potential of immune checkpoint inhibitors in advanced cervical
cancer: a meta-analysis and systematic review.
BMC Cancer. 2025;25:863.
Abstract
HPV integration status conversion and CIN2 + cancer risk stratification based on
HPV integration levels among HPV integration-positive women: a 1-year follow-up
study.
BMC Cancer. 2025;25:885.
Abstract
Integrating SEResNet101 and SE-VGG19 for advanced cervical lesion detection: a
step forward in precision oncology.
BMC Cancer. 2025;25:963.
Abstract
In situ phenotypic and karyotypic co-detection of aneuploid TCs and TECs in
cytological specimens with abnormal cervical screening results.
BMC Cancer. 2025;25:945.
Abstract
Evaluation of primary HPV-based cervical screening among older women: Long-term
follow-up of a randomized healthcare policy trial in Sweden.
PLoS Med. 2024;21:e1004505.
Abstract
Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence
of HPV related disease after local surgical treatment: A systematic review and
meta-analysis.
PLoS One. 2024;19:e0312128.
Abstract
Behavioural and social drivers of human papillomavirus vaccination in eThekwini
District of KwaZulu-Natal Province, South Africa.
PLoS One. 2024;19:e0311509.
Abstract
Cervical cancer care at a tertiary oncology facility in Uganda: Comparing daily
practice with national treatment targets on cervical cancer control.
PLoS One. 2025;20:e0316323.
Abstract
Problems of magnetic resonance diagnosis for gastric-type mucin-positive cervical
lesions of the uterus and its solutions using artificial intelligence.
PLoS One. 2024;19:e0315862.
Abstract
Effects of different educational interventions on cervical cancer knowledge and
human papillomavirus vaccination uptake among young women in Japan: Preliminary
results of a cluster randomized controlled trial.
PLoS One. 2025;20:e0311588.
Abstract
Correction: Knowledge of Thai women in cervical cancer etiology and screening.
PLoS One. 2025;20:e0318184.
Abstract
A prospective model of the potential clinical and economic impact of cervical
cancer screening supported by a mobile phone app.
PLoS One. 2025;20:e0316001.
Abstract
Screening attendance of breast or cervical cancers and its associated factors
among 30-49 year old women in Gedeo zone, South Ethiopia: Cross-sectional study.
PLoS One. 2025;20:e0315891.
Abstract
Breast and cervical cancer screening among women at reproductive age in Cambodia:
A secondary analysis of Cambodia Demographic and Health Survey 2022.
PLoS One. 2025;20:e0295881.
Abstract
Retraction: Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to
EZH2 and Repressing E-Cadherin in Cervical Cancer.
PLoS One. 2025;20:e0318789.
Abstract
Factors associated with uptake and acceptability of cervical cancer screening
among female sex workers in Northeastern Uganda: A cross-sectional study.
PLoS One. 2025;20:e0312988.
Abstract
Analysis of cervical and breast cancer screening behavior and its influencing
factors among urban and rural women in Beijing.
PLoS One. 2025;20:e0316898.
Abstract
Study protocol for a hybrid implementation-effectiveness trial of Game Changers
for Cervical Cancer Prevention in Uganda.
PLoS One. 2025;20:e0317491.
Abstract
Correction: Association between cancer stigma and cervical cancer screening
uptake among women of Dhulikhel and Banepa, Nepal.
PLoS One. 2025;20:e0318367.
Abstract
Photodiagnosis and photodynamic recognition of cervical cancer with SEM and AFM
images.
PLoS One. 2025;20:e0316544.
Abstract
Design and validation of ultra-compact metamaterial-based biosensor for
non-invasive cervical cancer diagnosis in terahertz regime.
PLoS One. 2025;20:e0311431.
Abstract
The Cancer Tracking System (CATSystem): Study protocol of a randomized control
trial to evaluate a systems level intervention for cervical cancer screening,
treatment, referral and follow up in Kenya.
PLoS One. 2025;20:e0318941.
Abstract
Navigating the risks: Stakeholder views on risk-based cervical cancer screening.
PLoS One. 2025;20:e0317986.
Abstract
Factors associated with uptake of human papilloma virus vaccine among adolescent
girls: A cross sectional survey on insights into HPV Infection Prevention in
Kabarole District, Western Uganda.
PLoS One. 2025;20:e0306960.
Abstract
Gynecologic health of women with multiple sclerosis: An overview on the current
status and findings of Pap tests in a low-income setting.
PLoS One. 2025;20:e0320069.
Abstract
Healthcare-seeking behaviors and factors influencing non-adherence among cervical
cancer patients attending Bugando Oncology Clinic in Mwanza, Tanzania: A
qualitative Phenomenological study.
PLoS One. 2025;20:e0317609.
Abstract
A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for
FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and
safety in a resource-limited setting.
PLoS One. 2025;20:e0319405.
Abstract
Findings from a qualitative analysis: Social media influencers of color as
trusted messengers of HPV vaccination messages.
PLoS One. 2025;20:e0319160.
Abstract
Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk
HPV genotyping in cervical samples.
PLoS One. 2025;20:e0320978.
Abstract
Transcriptomic profile induced by calcitriol in CaSki human cervical cancer cell
line.
PLoS One. 2025;20:e0319812.
Abstract
Scutellaria Barbata inhibits epithelial-mesenchymal transformation through
PI3K/AKT and MDM2 thus inhibiting the proliferation, migration and promoting
apoptosis of Cervical Cancer cells.
PLoS One. 2025;20:e0321556.
Abstract
Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma
virus in Bahir Dar, Amhara Regional State, Ethiopia.
PLoS One. 2025;20:e0321076.
Abstract
Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and
treatment.
PLoS One. 2025;20:e0320739.
Abstract
Utilization of screening services on cervical cancer and associated factors among
female health workers in Addis Ababa, Ethiopia.
PLoS One. 2025;20:e0321662.
Abstract
Identification of a disulfidptosis-related genes signature for diagnostic and
immune infiltration characteristics in cervical cancer.
PLoS One. 2025;20:e0322387.
Abstract
Strengthening the role of community pharmacy in HPV vaccination roll-out in
Serbia at national and local levels: A pharmacy-based education approach.
PLoS One. 2025;20:e0322584.
Abstract
Public Health Implications of Introducing Human Papillomavirus (HPV) Vaccination
in Pakistan: A protocol for a mixed-method study to explore community perceptions
and health system preparedness.
PLoS One. 2025;20:e0323826.
Abstract
Boosting immune response against cervical cancer: A combined approach using
oncolytic virus and targeted therapies.
PLoS One. 2025;20:e0312979.
Abstract
Sexual function outcomes in prostate and cervical cancer patients treated with
radiotherapy in sub-Saharan Africa: A cross-sectional study.
PLoS One. 2025;20:e0324662.
Abstract
Correction: Health disparities in cervical cancer: Estimating geographic
variations of disease burden and association with key socioeconomic and
demographic factors in the US.
PLoS One. 2025;20:e0324971.
Abstract
Effectiveness of integrating cervical cancer prevention strategies into HIV care
programmes: A mixed-methods systematic review protocol.
PLoS One. 2025;20:e0306496.
Abstract
A cross-sectional study of factors influencing sexual health among spouses of
patients with cervical cancer.
PLoS One. 2025;20:e0322141.
Abstract
Validity of the process and outcome specific measure in women with abnormal
Papanicolaou screening test.
PLoS One. 2025;20:e0325131.
Abstract
Computational investigation and experimental validation of the molecular
mechanism of Solanecio mannii aqueous roots extract against cervical cancer.
PLoS One. 2025;20:e0323680.
Abstract
Thank you for your interest in scientific medicine.
